(dp0
(S'ZEB1'
p1
S'FOXA1'
p2
S'increases'
p3
tp4
(lp5
s(S'FOXJ1'
p6
S'GATA6'
p7
S'increases'
p8
tp9
(lp10
s(S'TFAP4'
p11
S'FOXD3'
p12
S'increases'
p13
tp14
(lp15
s(S'TBP'
p16
S'MEIS1'
p17
S'increases'
p18
tp19
(lp20
s(S'GCM1'
p21
S'GATA6'
p22
S'increases'
p23
tp24
(lp25
s(S'T-DHT'
p26
S'SRC'
p27
S'adds_modification'
p28
tp29
(lp30
s(S'MAZ'
p31
S'GABPB2'
p32
S'increases'
p33
tp34
(lp35
s(S'HMGA1'
p36
S'EN1'
p37
S'increases'
p38
tp39
(lp40
s(S'CYP26A1'
p41
S'NRAS'
p42
S'increases'
p43
tp44
(lp45
s(S'CUX1'
p46
S'MEIS1'
p47
S'increases'
p48
tp49
(lp50
s(S'REPIN1'
p51
S'BACH1'
p52
S'increases'
p53
tp54
(lp55
s(S'TFDP1'
p56
S'HOXA9'
p57
S'increases'
p58
tp59
(lp60
s(S'NFE2L1'
p61
S'CYP26A1'
p62
S'increases'
p63
tp64
(lp65
s(S'MAZ'
p66
S'GATA1'
p67
S'increases'
p68
tp69
(lp70
s(S'TCF12'
p71
S'GABPB2'
p72
S'increases'
p73
tp74
(lp75
s(S'ETS2'
p76
S'FOXO3'
p77
S'increases'
p78
tp79
(lp80
s(S'hsa-let-7c-5p'
p81
S'NRAS'
p82
S'decreases'
p83
tp84
(lp85
s(S'SPI1'
p86
S'CYP26A1'
p87
S'increases'
p88
tp89
(lp90
s(S'RAC1/GTP'
p91
S'MKK4'
p92
S'adds_modification'
p93
tp94
(lp95
s(S'Quercetin'
p96
S'KRAS MRNA'
p97
S'decreases'
p98
tp99
(lp100
s(S'INSULIN RECEPTOR/INSULIN/SHC'
p101
S'GRB2'
p102
S'binds'
p103
tp104
(lp105
s(S'TAp63a (tetramer)'
p106
S'PKC DELTA'
p107
S'increases'
p108
tp109
(lp110
s(S'FOXO1'
p111
S'POU2F1'
p112
S'increases'
p113
tp114
(lp115
s(S'FOXL1'
p116
S'EN1'
p117
S'increases'
p118
tp119
(lp120
s(S'TBP'
p121
S'CYP26A1'
p122
S'increases'
p123
tp124
(lp125
s(S'Heptachlor'
p126
S'HRAS MRNA'
p127
S'decreases'
p128
tp129
(lp130
s(S'PCBP1'
p131
S'CYP26A1'
p132
S'increases'
p133
tp134
(lp135
s(S'ZBTB18'
p136
S'CYP26A1'
p137
S'increases'
p138
tp139
(lp140
s(S'GATA2'
p141
S'CYP26A1'
p142
S'increases'
p143
tp144
(lp145
s(S'Cadmium'
p146
S'KRAS MRNA'
p147
S'increases'
p148
tp149
(lp150
s(S'HNF1A'
p151
S'POU2F1'
p152
S'increases'
p153
tp154
(lp155
s(S'ABT-100'
p156
S'HRAS PROTEIN'
p157
S'inhibits_modification'
p158
tp159
(lp160
s(S'ELF1'
p161
S'CYP26A1'
p162
S'increases'
p163
tp164
(lp165
s(S'LEF1'
p166
S'KRAS'
p167
S'increases'
p168
tp169
(lp170
s(S'NKX2-1'
p171
S'FOXD3'
p172
S'increases'
p173
tp174
(lp175
s(S'PI-3-4-5-P3'
p176
S'BTK-ITK'
p177
S'translocates'
p178
tp179
(lp180
s(S'POU6F1'
p181
S'HOXA9'
p182
S'increases'
p183
tp184
(lp185
s(S'Myb'
p186
S'MYB'
p187
S'increases'
p188
tp189
(lp190
s(S'PAX5'
p191
S'CYP26A1'
p192
S'increases'
p193
tp194
(lp195
s(S'FOXO4'
p196
S'FOXD3'
p197
S'increases'
p198
tp199
(lp200
s(S'CYP26A1'
p201
S'FOXO4'
p202
S'increases'
p203
tp204
(lp205
s(S'cell adhesion'
p206
S'HRAS/GDP'
p207
S'increases_activity'
p208
tp209
(lp210
s(S'IRF7'
p211
S'CYP26A1'
p212
S'increases'
p213
tp214
(lp215
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p216
S'KRAS PROTEIN'
p217
S'increases'
p218
tp219
(lp220
s(S'PITX2'
p221
S'POU2F1'
p222
S'increases'
p223
tp224
(lp225
s(S'E2F1'
p226
S'CYP26A1'
p227
S'increases'
p228
tp229
(lp230
s(S'ATF1'
p231
S'CYP26A1'
p232
S'increases'
p233
tp234
(lp235
s(S'PI3K'
p236
S'PKC DELTA'
p237
S'adds_modification'
p238
tp239
(lp240
s(S'SOX5'
p241
S'HOXA9'
p242
S'increases'
p243
tp244
(lp245
s(S'FOXO4'
p246
S'POU2F1'
p247
S'increases'
p248
tp249
(lp250
S'Among all genes with FDR values <0.005, there were 25 transcriptional factors: POU3F1, HEY1, TEAD1, POU4F2, VEZF1, KCNIP4, KLF12, E2F1, REST, FOXO4, NR4A1, HOXB8, POU2F1, HOXD9, HIC1, ZBTB16, TCF7, KLF11, IGFBP7, NFIC, PKNOX1, TWIST1, ING1, MEF2A and LITAF.'
p251
as(S'FOXO4'
p252
S'GATA6'
p253
S'increases'
p254
tp255
(lp256
s(S'LEF1'
p257
S'FOXF2'
p258
S'increases'
p259
tp260
(lp261
s(S'Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos'
p262
S'HRAS/GDP'
p263
S'increases_activity'
p264
tp265
(lp266
s(S'TLX2'
p267
S'RUNX1'
p268
S'increases'
p269
tp270
(lp271
s(S'ALX4'
p272
S'JUN'
p273
S'increases'
p274
tp275
(lp276
s(S'RHOA/GTP'
p277
S'RHOGDI'
p278
S'binds'
p279
tp280
(lp281
s(S'GCM1'
p282
S'CYP26A1'
p283
S'increases'
p284
tp285
(lp286
s(S'RB1'
p287
S'ONECUT1'
p288
S'increases'
p289
tp290
(lp291
s(S'NHLH1'
p292
S'CYP26A1'
p293
S'increases'
p294
tp295
(lp296
s(S'NR3C1'
p297
S'BACH1'
p298
S'increases'
p299
tp300
(lp301
s(S'HNF4A'
p302
S'CYP26A1'
p303
S'increases'
p304
tp305
(lp306
s(S'YY1'
p307
S'FOXO3'
p308
S'increases'
p309
tp310
(lp311
s(S'GRB2:SOS1'
p312
S'P-EGFR MUTANTS DIMER'
p313
S'binds'
p314
tp315
(lp316
s(S'P-Y349,350-SHC1:P-ERBB4'
p317
S'GRB2:SOS1'
p318
S'binds'
p319
tp320
(lp321
s(S'FOXN1'
p322
S'ONECUT1'
p323
S'increases'
p324
tp325
(lp326
s(S'TFAP4'
p327
S'MYC'
p328
S'increases'
p329
tp330
(lp331
s(S'MYC'
p332
S'EN1'
p333
S'increases'
p334
tp335
(lp336
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p337
S'SHC/GRB2/SOS1'
p338
S'increases_activity'
p339
tp340
(lp341
s(S'14-3-3 BETA, ZETA'
p342
S'GARNL4'
p343
S'binds'
p344
tp345
(lp346
s(S'SMAD1'
p347
S'EN1'
p348
S'increases'
p349
tp350
(lp351
s(S'Raf-1'
p352
S'MEK1-2'
p353
S'adds_modification'
p354
tp355
(lp356
s(S'POU2F1'
p357
S'FOXO3'
p358
S'increases'
p359
tp360
(lp361
s(S'NGF (dimer)/TRKA'
p362
S'RASGRF1'
p363
S'adds_modification'
p364
tp365
(lp366
s(S'TCF4'
p367
S'CYP26A1'
p368
S'increases'
p369
tp370
(lp371
s(S'STAT5B'
p372
S'TLX2'
p373
S'increases'
p374
tp375
(lp376
s(S'CYP26A1'
p377
S'SRF'
p378
S'increases'
p379
tp380
(lp381
s(S'STAT1'
p382
S'NRAS'
p383
S'increases'
p384
tp385
(lp386
s(S'TFDP1'
p387
S'GATA1'
p388
S'increases'
p389
tp390
(lp391
s(S'PI3K'
p392
S'ALPHA6/BETA4 INTEGRIN/LAMININ'
p393
S'binds'
p394
tp395
(lp396
s(S'FOXF2'
p397
S'NRAS'
p398
S'increases'
p399
tp400
(lp401
s(S'CUX1'
p402
S'POU2F1'
p403
S'increases'
p404
tp405
(lp406
s(S'ETS2'
p407
S'STAT4'
p408
S'increases'
p409
tp410
(lp411
s(S'EN1'
p412
S'CYP26A1'
p413
S'increases'
p414
tp415
(lp416
s(S'COMPLEX (RAS/GTP)'
p417
S'RAF'
p418
S'binds'
p419
tp420
(lp421
s(S'LEF1'
p422
S'EN1'
p423
S'increases'
p424
tp425
(lp426
s(S'FOXL1'
p427
S'NRAS'
p428
S'increases'
p429
tp430
(lp431
s(S'ELF2'
p432
S'CYP26A1'
p433
S'increases'
p434
tp435
(lp436
s(S'Src Family Kinases-active'
p437
S'EGF/EGFR'
p438
S'adds_modification'
p439
tp440
(lp441
s(S'RUNX1'
p442
S'POU2F1'
p443
S'increases'
p444
tp445
(lp446
s(S'RHOA/GTP'
p447
S'CITRON-N'
p448
S'increases_activity'
p449
tp450
(lp451
s(S'PAX4'
p452
S'SRF'
p453
S'increases'
p454
tp455
(lp456
s(S'Vitamin E'
p457
S'HRAS MRNA'
p458
S'increases'
p459
tp460
(lp461
s(S'CDX2'
p462
S'FOXD3'
p463
S'increases'
p464
tp465
(lp466
s(S'Plant Extracts'
p467
S'KEAP1 PROTEIN'
p468
S'decreases'
p469
tp470
(lp471
s(S'PAX4'
p472
S'CBFA2T3'
p473
S'increases'
p474
tp475
(lp476
s(S'FOXD1'
p477
S'CYP26A1'
p478
S'increases'
p479
tp480
(lp481
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p482
S'VAV1'
p483
S'adds_modification'
p484
tp485
(lp486
s(S'PCBP1'
p487
S'MEIS1'
p488
S'increases'
p489
tp490
(lp491
s(S'FOXI1'
p492
S'FOXD3'
p493
S'increases'
p494
tp495
(lp496
s(S'GATA4'
p497
S'MEIS1'
p498
S'increases'
p499
tp500
(lp501
s(S'STAT5B'
p502
S'CEBPG'
p503
S'increases'
p504
tp505
(lp506
s(S'TFDP2'
p507
S'MAZ'
p508
S'increases'
p509
tp510
(lp511
s(S'PI3K'
p512
S'SHP2'
p513
S'binds'
p514
tp515
(lp516
S'Gab2 can stimulate both Erk and AKT signaling through its interactions with SHP2 and p85 subunit of PI3K respectively.'
p517
as(S'SPI1'
p518
S'ONECUT1'
p519
S'increases'
p520
tp521
(lp522
s(S'STAT6'
p523
S'EN1'
p524
S'increases'
p525
tp526
(lp527
s(S'TLX2'
p528
S'CYP26A1'
p529
S'increases'
p530
tp531
(lp532
s(S'RAF1'
p533
S'MEK1-2'
p534
S'increases_activity'
p535
tp536
(lp537
s(S'STAT5A'
p538
S'IRF1'
p539
S'increases'
p540
tp541
(lp542
s(S'2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine'
p543
S'HRAS MRNA'
p544
S'increases'
p545
tp546
(lp547
s(S'MAZ'
p548
S'POU2F1'
p549
S'increases'
p550
tp551
(lp552
s(S'MAZ'
p553
S'SRF'
p554
S'increases'
p555
tp556
(lp557
s(S'GATA1'
p558
S'JUN'
p559
S'increases'
p560
tp561
(lp562
s(S'FOXA1'
p563
S'NRAS'
p564
S'increases'
p565
tp566
(lp567
s(S'STAT1'
p568
S'EN1'
p569
S'increases'
p570
tp571
(lp572
s(S'GTF2A2'
p573
S'MAX'
p574
S'increases'
p575
tp576
(lp577
s(S'LMO2'
p578
S'EN1'
p579
S'increases'
p580
tp581
(lp582
s(S'MYOD1'
p583
S'LEF1'
p584
S'increases'
p585
tp586
(lp587
s(S'ATF3'
p588
S'JUN'
p589
S'increases'
p590
tp591
(lp592
s(S'GRB2:SOS1'
p593
S'ACTIVATED FGFR:P-SHC1'
p594
S'binds'
p595
tp596
(lp597
s(S'MAFG'
p598
S'BACH1'
p599
S'increases'
p600
tp601
(lp602
s(S'POU3F2'
p603
S'POU2F1'
p604
S'increases'
p605
tp606
(lp607
s(S'K 7174'
p608
S'KRAS MRNA'
p609
S'increases'
p610
tp611
(lp612
s(S'POU1F1'
p613
S'RUNX1'
p614
S'increases'
p615
tp616
(lp617
s(S'HRAS protein'
p618
S'CCND1 MRNA'
p619
S'increases'
p620
tp621
(lp622
s(S'YY1'
p623
S'EN1'
p624
S'increases'
p625
tp626
(lp627
s(S'resveratrol'
p628
S'HRAS MRNA'
p629
S'increases'
p630
tp631
(lp632
s(S'NKX2-1'
p633
S'HOXA9'
p634
S'increases'
p635
tp636
(lp637
s(S'HSF1'
p638
S'CYP26A1'
p639
S'increases'
p640
tp641
(lp642
s(S'MYC'
p643
S'HOXA9'
p644
S'increases'
p645
tp646
(lp647
s(S'Raf'
p648
S'MEK'
p649
S'adds_modification'
p650
tp651
(lp652
S'The Ras-Raf-MEK1/2-ERK1/2 pathway couples signal from the cell surface receptors to cytoplasmic substrates and transcription factors, which regulate gene expression ['
p653
aS'The inhibition of renal cAMP production by treatment with a vasopressin V2 receptor antagonist or by increasing water intake to reduce plasma vasopressin decreases cell proliferation and ameliorates kidney cystogenesis with an associated reduction in B-Raf/MEK/ERK activity, leading to improved renal function in PCK rats ['
p654
aS'ERK-1 activation is regulated by Raf-1 and MEK.'
p655
aS'Raf-1 kinase and MEK regulate NF-kB activation: Gene expression of NF-'
p656
aS'In order to understand the role of MEK, a down-stream signaling step of Raf-1 activation, in glucose-induced apoptosis of retinal endothelial cells, we investigated the effect of a specific and noncompetitive inhibitor of MEK phosphorylation, PD098059, on glucose-induced activation of NF-'
p657
aS'Activation of Ras-Raf appears to result in the apoptosis of retinal capillary cells via Ras-Raf-MEK-ERK pathway.'
p658
aS'Binding of Ras to Raf initiates activation of MEK that has divergent physiological and pathological responses.'
p659
aS'Activated Raf phosphorylates MEK, which in turn, activates ERK ('
p660
aS'ERK is a downstream component of the Raf-MEK activated signaling pathway.'
p661
aS'Activation of MEK by Raf is followed by phosphorylation of ERK.'
p662
aS'Glucose-induced activation of caspase-3 in the endothelial cells is inhibited by GW5074 suggesting that the Ras-Raf-MEK-ERK-mediated apoptosis of retinal capillary cells in high glucose conditions occurs via activation of caspase-3.'
p663
aS'ERK is one of the main components of the Ras/Raf/MEK/ERK cascade, which mediates signal from cell surface receptors to transcription factors to regulate different gene expression.'
p664
aS'To study the effect of chemotherapy on Raf/MEK/ERK pathway, the expression of ERK1/2 and phospho-ERK was compared in MCF-7 and MDA-MB-231 cells after DOX treatment.'
p665
aS'HDIs mainly induce activation of both intrinsic and extrinsic apoptotic pathways of neoplastic cells by affecting protein stability, protein-protein interactions through interference with the function of cell cycle proteins such as p21, inhibition of signaling pathways implicated with Raf/MEK and activation of Reactive Oxygen Species\n['
p666
aS'Raf1 is a MAP kinase kinase kinase, which phosphorylates the MAP kinase kinase MEK1/2.'
p667
aS'Ras in turn activates Raf/MEK/ERk and PI3K/Akt kinase cascades that are involved in cell survival and proliferation.'
p668
aS'Raf phosphorylates MAPKK (MEK) which in turn phosphorylates MAPK-ERK.'
p669
aS'The best-studied mitogen activated protein kinase (MAPK) pathway is the extracellular signal-regulated kinase (ERK) cascade, which transmits signal from Raf (MAP kinase kinase kinase) to MEK (MAP kinase kinase) to ERK (MAP kinase).'
p670
aS'IQGAP1 is a scaffold for MAPK signaling, binding to B-Raf, MEK1/2, and ERK1/2, and regulating their activity in response to epidermal growth factor (EGF) (reviewed in ['
p671
aS'KRAS, a member of the rat sarcoma viral oncogene homolog (RAS) proto-oncogene family, is a key protein in the EGFR pathway, and plays an important role in the activation of various downstream proteins, including Raf, MEK and ERK '
p672
aS'Sorafenib is known to inhibit tumor cell proliferation and vascularization through activation of the receptor for tyrosine kinase, which in turn signals the Ras/Raf/mitogen-activated protein kinase kinase (MEK)/extracellular-signal-regulated kinase (ERK) cascade pathway.'
p673
aS'Phorbol 13-myristate 12-acetate (PMA) is a known activator of protein kinase C (PKC) and the Raf/MEK/Erk pathway ('
p674
aS'The mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitor blocks the Raf/MEK/extracellular signal-related kinase (ERK) pathway and is involved in proliferation and anti-apoptosis '
p675
aS'Initiation of DNA synthesis\nwas preceded by activation of Raf-1, MEK and\nMAP kinases (Erk 1 and Erk2).'
p676
aS'The two most important oncogenic signaling pathways are PI3K/AKT/mTOR and Ras/Raf/MEK/ERK.'
p677
aS'Raf/MEK/ERK and PI3K/Akt pathway dysregulation is a common alteration responsible of tumor initiation and progression.'
p678
aS'The overexpression or constitutive activation of receptors for growth factors, cytokines, and CKs potentiates the activation of Ras/Raf/MEK/ERK pathway also in pituitary adenoma ['
p679
aS'The intracellular signaling pathway Raf/MEK/ERK and the extracellular receptors VEGFR and PDGFR have been implicated in the molecular pathogenesis of HCC ('
p680
aS'Treatment with phloroglucinol significantly inhibited the expression of Ras, Raf, mitogen-activated protein kinase (MEK), extracellular-signal regulated kinase (ERK) phosphorylation, PI3K and Akt.'
p681
aS'IGF-1R signaling involves activation of Ras, Raf, MEK and ERK ('
p682
aS'Dose-dependent effect of phloroglucinol on the (A) protein and (B) mRNA expression of Ras, Raf, MEK and phospho-ERK in HT-29 colon cancer cells.'
p683
aS'In melanoma, both the Ras/Raf/MEK/ERK (MAPK) and the PI3K/AKT (AKT) signalling pathways are constitutively activated through multiple mechanisms.'
p684
aS'MEK1 and MEK2 display a similar structural organization, are closely related and they participate in the Ras/Raf/MEK/ERK signal transduction cascade ('
p685
aS'This review pays attention on the clinical application of both Raf/MEK/ERK and PI3K/AKT/mTOR pathway inhibitors as novel treatment strategy for melanoma.'
p686
aS'Raf/MEK/ERK and PI3K/AKT pathways and mechanism of action of their inhibitors in melanoma.'
p687
aS'ERK kinase participates in the Ras/Raf/MEK/ERK signaling pathway, which is activated by mitogens and growth factors ('
p688
aS'The class I phosphatidylinositol 3-phosphate kinase (PI3K)/AKT/Raptor-mTOR (mTORC1) signaling pathway and the Ras/Raf/MEK1/2/ERK1/2 pathway are two well-known signaling cascades involved in the regulation of autophagy ('
p689
aS'The HBV-encoded protein, HBx, has been shown to promote cell proliferation by activating intracellular signaling transduction cascades, including the Ras/Raf/MEK/ERK, PI-3K-Akt/PKB, c-Jun '
p690
aS'The Rafs regulate cellular proliferation and differentiation through the Raf/MEK/ERK/MAPK signaling cascade, which is hyperactivated in ~30% of all cancers ['
p691
aS'Our data implicate that the phosphorylation of HSP27 is probably induced by the pathway, including EGF/EGFR, Ras/Raf/MEK1/2/ERK1/2, as well as p38 MAPK.'
p692
aS'Validation of Ras, Raf, ERK1/2, MEK1/2, p38MAPK and MAPKAPK2 by Western blotting analysis.'
p693
aS'As a result, the activated Raf-1 stimulates the MEK1/2 and its cascade which then phosphorylate the MAPK protein ERK1/2.'
p694
aS'The Ras/Raf/MEK/ERK system is definitely the best characterized MAPK pathway.'
p695
aS'Activated HER-2 can transduce its signals via p52Shc (blocked by dominant-negative (DN) HER-2 cDNA transfection or an HER-2 inhibitor, AG879) to activate the downstream ERK/MAPK pathway (blocked by p52Shc Y317F mutant cDNA transfection or an MEK inhibitor, PD 98059 and U0126) through Ras/Raf mediation.'
p696
aS'Sorafenib is an orally active multikinase inhibitor that blocks intracellular kinases in the Raf/MEK/ERK pathway that are involved in tumor proliferation, such as Raf-1, as well as those promoting angiogenesis, including VEGFR-2, VEGFR-3, FLT, PDGFR-'
p697
aS'The Arabidopsis genome contains approximately 80 MAPKKK genes, which include 48 Raf kinases, 21 MEKK kinases and 11 ZIK kinases ['
p698
aS'receptor pathway: To block Ras/Raf-1/MEKK1 signaling pathway through upregulation of 14-3-3 and calmodulin expression; to inhibit the PKC to activate and then catalyze the phosphorylation of threonine (Thr) residues on EGF receptor through upregulation of annexin A5.'
p699
aS'Upon its activation, Raf transmits the signal further downstream to MEK1/2 (MAPK/ERK kinases 1 and 2), which are the second tier in the MAPK cascade.'
p700
aS'MEK1/2 (also known as p45/p46) are activated by Raf-mediated phosphorylation at Ser218 and Ser222 (hMEK1) ['
p701
aS'Whereas it constitutively associates with MEK, it interacts with C-Raf and ERK only upon growth factor stimulation ['
p702
aS'IMP (impedes mitogenic signal propagation) inhibits signal propagation by disrupting KSR1 homo-oligomerization, which is necessary to join Raf with its substrate, since it seems that different complexes of KSR1-MEK, KSR1-C-Raf and KSR1-B-Raf exist in the cells (reviewed in ['
p703
aS'It seems that the endocytosis of the activated receptors and their associated signaling complexes is crucial for maximal MAPK activation, and activated Ras, C-Raf, MEK1 and ERK1 can be found on endosomes ['
p704
aS'For example, MORG1 binds to Raf, MEK and ERK, but also associates with the MP1 scaffold in the endosomes ['
p705
aS'Flotillin-1, which is found in hetero-oligomers with flotillin-2, is a scaffolding protein for C-Raf, MAPK/ERK kinase 1 (MEK1) and extracellular signal-regulated kinase 2 (ERK2) independently of kinase suppressor of Ras (KSR1).'
p706
aS'Upon EGFR activation, the downstream intracellular signaling cascades such as the PI3K/Akt, Raf/MEK/Erk, and STAT pathways are subsequently activated leading cell survival.'
p707
aS'Results of the CFU assay clearly indicated that astaxanthin can actively improve proliferation of NPCs, which was associated with significant activation of PI3K and its downstream mediators, p-Rac, p-c-Raf, p-MEK, p-ERK, p-Akt, p-mTOR, and p-Stat3 in a time-dependent manner.'
p708
aS'Here, we report that LicoA suppresses sUV-induced COX-2 expression by acting as a potent direct physical inhibitor of PI3K, MEK1, and B-Raf.'
p709
aS'To confirm whether PI3K, MEK1, and Raf are plausible molecular targets of LicoA in the inhibition of cell proliferation, we next determined their effects on these proteins and C-Raf kinase activity '
p710
aS'Effect of LicoA on phosphoinositide 3-kinase PI3K, MEK1, B-Raf, and C-Raf kinase activity.'
p711
aS'To determine whether LicoA exerts its effects by direct physical interaction with PI3K, MEK1, and B-Raf, we performed an immunoprecipitation assay using LicoA-conjugated Sepharose 4B beads.'
p712
aS'LicoA directly binds with PI3K, MEK1, and B-Raf.'
p713
aS'The crystal coordinates of PI3K (PDB entry 1E8X), B-Raf (PDB entry 3C4E), and MEK1 (PDB entry 1S9J) were used for the docking of licochalcone A.'
p714
aS'All Rafs can bind and phosphorylate MEK, but B-Raf has the strongest activity towards MEK, while A-Raf and Raf-1 have MEK-independent functions ['
p715
aS'All of these syndromes are associated with autosomal-dominant germline mutations within either the core components (Ras, B-Raf, Raf-1, MEK) of the Ras-ERK1/2 pathway or its modulators (NF1, SHP2, SOS, and Spred).'
p716
aS'Multiple signaling pathways are involved in cell growth and apoptosis, including the Ras/Raf/MEK/ERK1/2 signaling pathway, which is central for transporting the complex signals received by the cell surface receptors to transcription factors in the nucleus.'
p717
aS'Our data showed that the expression levels of P-ERK1/2 and P-STAT3 proteins in the Ras/Raf/MEK/ERK1/2 and JAK-STAT3 signaling pathways were significantly reduced 48 hours after '
p718
as(S'TFDP1'
p719
S'MAZ'
p720
S'increases'
p721
tp722
(lp723
s(S'SPRED1'
p724
S'HRAS'
p725
S'binds'
p726
tp727
(lp728
s(S'MYCN'
p729
S'CYP26A1'
p730
S'increases'
p731
tp732
(lp733
s(S'AHR'
p734
S'FOXD3'
p735
S'increases'
p736
tp737
(lp738
s(S'SF1'
p739
S'CYP26A1'
p740
S'increases'
p741
tp742
(lp743
s(S'MEIS1'
p744
S'ETS1'
p745
S'increases'
p746
tp747
(lp748
s(S'Copper Sulfate'
p749
S'HRAS MRNA'
p750
S'decreases'
p751
tp752
(lp753
s(S'MAZ'
p754
S'MYC'
p755
S'increases'
p756
tp757
(lp758
s(S'E4F1'
p759
S'HOXA9'
p760
S'increases'
p761
tp762
(lp763
s(S'GATA1'
p764
S'GATA6'
p765
S'increases'
p766
tp767
(lp768
S'To date, six members of the GATA family have been identified in vertebrates (GATA1 to GATA6), of which GATA4, GATA5 and GATA6 are broadly expressed in various mesoderm and endoderm derived tissues, dominantly in embryonic heart '
p769
as(S'RUNX2'
p770
S'POU2F1'
p771
S'increases'
p772
tp773
(lp774
s(S'CYP26A1'
p775
S'GATA6'
p776
S'increases'
p777
tp778
(lp779
s(S'PAX4'
p780
S'GATA1'
p781
S'increases'
p782
tp783
(lp784
s(S'ELF2'
p785
S'STAT5A'
p786
S'increases'
p787
tp788
(lp789
s(S'CART1'
p790
S'NRAS'
p791
S'increases'
p792
tp793
(lp794
s(S'IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc'
p795
S'HRAS/GDP'
p796
S'increases_activity'
p797
tp798
(lp799
s(S'RB1'
p800
S'CYP26A1'
p801
S'increases'
p802
tp803
(lp804
s(S'CEBPG'
p805
S'HOXA9'
p806
S'increases'
p807
tp808
(lp809
s(S'GRB2/SOS1/SHC'
p810
S'IGF-1R HETEROTETRAMER/IGF1'
p811
S'binds'
p812
tp813
(lp814
s(S'PRRX2'
p815
S'CYP26A1'
p816
S'increases'
p817
tp818
(lp819
s(S'TEAD1'
p820
S'CYP26A1'
p821
S'increases'
p822
tp823
(lp824
s(S'STAT5A'
p825
S'FOXA1'
p826
S'increases'
p827
tp828
(lp829
s(S'ATF2'
p830
S'FOXD3'
p831
S'increases'
p832
tp833
(lp834
s(S'REPIN1'
p835
S'FOXO4'
p836
S'increases'
p837
tp838
(lp839
s(S'FOXF2'
p840
S'ETS1'
p841
S'increases'
p842
tp843
(lp844
s(S'ETV7'
p845
S'MEIS1'
p846
S'increases'
p847
tp848
(lp849
s(S'RUNX2'
p850
S'RUNX1'
p851
S'increases'
p852
tp853
(lp854
S'Human runt-related transcription factor (RUNX) family is composed of three members including RUNX1, RUNX2, and RUNX3.'
p855
aS'Human runt-related transcription factor (RUNX) family is composed of three members including RUNX1, RUNX2, and RUNX3 ['
p856
aS'RUNX1 and RUNX3 enhance proapoptotic activity of p53, whereas RUNX2 prohibits p53-dependent apoptotic cell death following DNA damage ('
p857
aS'Under our experimental conditions, RUNX1 as well as RUNX3 acts as a positive regulator for p53 in response to DNA damage, whereas DNA damage-induced proapoptotic activity of p53 is strongly abrogated by RUNX2.'
p858
as(S'OR5I1'
p859
S'GATA1'
p860
S'increases'
p861
tp862
(lp863
s(S'MSX1'
p864
S'EN1'
p865
S'increases'
p866
tp867
(lp868
s(S'GTF3A'
p869
S'IRF1'
p870
S'increases'
p871
tp872
(lp873
s(S'POU2F1'
p874
S'SRF'
p875
S'increases'
p876
tp877
(lp878
s(S'PLC-GAMMA'
p879
S'COMPLEX (GADS/SLP-76)'
p880
S'binds'
p881
tp882
(lp883
s(S'STAT4'
p884
S'STAT5A'
p885
S'increases'
p886
tp887
(lp888
s(S'JUN'
p889
S'BACH1'
p890
S'increases'
p891
tp892
(lp893
s(S'POU1F1'
p894
S'HOXA9'
p895
S'increases'
p896
tp897
(lp898
s(S'docetaxel'
p899
S'HRAS PROTEIN'
p900
S'increases'
p901
tp902
(lp903
s(S'MAX'
p904
S'LEF1'
p905
S'increases'
p906
tp907
(lp908
s(S'FOXA1'
p909
S'CYP26A1'
p910
S'increases'
p911
tp912
(lp913
s(S'GATA4'
p914
S'FOXD3'
p915
S'increases'
p916
tp917
(lp918
s(S'ZBTB18'
p919
S'RUNX1'
p920
S'increases'
p921
tp922
(lp923
s(S'ATF3'
p924
S'RUNX1'
p925
S'increases'
p926
tp927
(lp928
s(S'NKX2-1'
p929
S'CYP26A1'
p930
S'increases'
p931
tp932
(lp933
s(S'NR3C1'
p934
S'FOXA1'
p935
S'increases'
p936
tp937
(lp938
s(S'RAS family/GTP'
p939
S'RIN1'
p940
S'increases_activity'
p941
tp942
(lp943
s(S'COMPLEX (RAS/GTP/ RAF)'
p944
S'MEK'
p945
S'binds'
p946
tp947
(lp948
s(S'CDC5L'
p949
S'NRAS'
p950
S'increases'
p951
tp952
(lp953
s(S'Vitamin E'
p954
S'NRAS MRNA'
p955
S'decreases'
p956
tp957
(lp958
s(S'NF1'
p959
S'LEF1'
p960
S'increases'
p961
tp962
(lp963
s(S'ETS1'
p964
S'EN1'
p965
S'increases'
p966
tp967
(lp968
s(S'CRAF'
p969
S'YWHAB'
p970
S'binds'
p971
tp972
(lp973
s(S'CEBPD'
p974
S'JUN'
p975
S'increases'
p976
tp977
(lp978
s(S'MAX'
p979
S'RUNX2'
p980
S'increases'
p981
tp982
(lp983
s(S'CEBPA'
p984
S'MECOM'
p985
S'increases'
p986
tp987
(lp988
s(S'PAX2'
p989
S'GATA1'
p990
S'increases'
p991
tp992
(lp993
s(S'CYP26A1'
p994
S'TLX2'
p995
S'increases'
p996
tp997
(lp998
s(S'GFI1'
p999
S'ETS1'
p1000
S'increases'
p1001
tp1002
(lp1003
s(S'14-3-3:P-S259,Y340,Y341,S621-RAF1:RAS:GTP'
p1004
S'MEK'
p1005
S'binds'
p1006
tp1007
(lp1008
s(S'P-S,T-MEK2'
p1009
S'ERK2'
p1010
S'binds'
p1011
tp1012
(lp1013
s(S'HRAS/GTP'
p1014
S'RIN2'
p1015
S'increases_activity'
p1016
tp1017
(lp1018
s(S'Ras-GTP'
p1019
S'P42/P44MAPKS'
p1020
S'adds_modification'
p1021
tp1022
(lp1023
s(S'SRF'
p1024
S'CYP26A1'
p1025
S'increases'
p1026
tp1027
(lp1028
s(S'FOXL1'
p1029
S'RUNX2'
p1030
S'increases'
p1031
tp1032
(lp1033
s(S'EGR4'
p1034
S'LEF1'
p1035
S'increases'
p1036
tp1037
(lp1038
s(S'P-IRS1,2'
p1039
S'GRB2:SOS1'
p1040
S'binds'
p1041
tp1042
(lp1043
s(S'VEGFR2 (dimer)/VEGFA (dimer)/alphav/beta3 Integrin/Vitronectin'
p1044
S'SRC'
p1045
S'adds_modification'
p1046
tp1047
(lp1048
s(S'BACH2'
p1049
S'BACH1'
p1050
S'increases'
p1051
tp1052
(lp1053
s(S'ONECUT1'
p1054
S'RUNX1'
p1055
S'increases'
p1056
tp1057
(lp1058
s(S'FOXJ2'
p1059
S'RUNX2'
p1060
S'increases'
p1061
tp1062
(lp1063
s(S'PI-3-4-5-P3'
p1064
S'AKT1'
p1065
S'translocates'
p1066
tp1067
(lp1068
s(S'TFAP4'
p1069
S'BACH1'
p1070
S'increases'
p1071
tp1072
(lp1073
s(S'MEKK1/4'
p1074
S'MKK3/6'
p1075
S'adds_modification'
p1076
tp1077
(lp1078
s(S'VSX1'
p1079
S'MECOM'
p1080
S'increases'
p1081
tp1082
(lp1083
s(S'IRF1'
p1084
S'GATA6'
p1085
S'increases'
p1086
tp1087
(lp1088
s(S'MAX'
p1089
S'HOXA9'
p1090
S'increases'
p1091
tp1092
(lp1093
s(S'RB1'
p1094
S'MAZ'
p1095
S'increases'
p1096
tp1097
(lp1098
s(S'GATA1'
p1099
S'EN1'
p1100
S'increases'
p1101
tp1102
(lp1103
s(S'HIF1A'
p1104
S'SRF'
p1105
S'increases'
p1106
tp1107
(lp1108
s(S'IRF8'
p1109
S'CYP26A1'
p1110
S'increases'
p1111
tp1112
(lp1113
s(S'MTF1'
p1114
S'CYP26A1'
p1115
S'increases'
p1116
tp1117
(lp1118
s(S'PI-3-4-5-P3'
p1119
S'GAB1'
p1120
S'translocates'
p1121
tp1122
(lp1123
s(S'PI-3-4-5-P3'
p1124
S'AKT1'
p1125
S'adds_modification'
p1126
tp1127
(lp1128
s(S'RXRA'
p1129
S'HOXA9'
p1130
S'increases'
p1131
tp1132
(lp1133
s(S'AKT1'
p1134
S'RAF1'
p1135
S'binds'
p1136
tp1137
(lp1138
s(S'HSF2'
p1139
S'JUN'
p1140
S'increases'
p1141
tp1142
(lp1143
s(S'PAX2'
p1144
S'CYP26A1'
p1145
S'increases'
p1146
tp1147
(lp1148
s(S'ETV7'
p1149
S'CYP26A1'
p1150
S'increases'
p1151
tp1152
(lp1153
s(S'FOXO3'
p1154
S'NRAS'
p1155
S'increases'
p1156
tp1157
(lp1158
s(S'TP53'
p1159
S'REPIN1'
p1160
S'increases'
p1161
tp1162
(lp1163
s(S'STAT6'
p1164
S'CYP26A1'
p1165
S'increases'
p1166
tp1167
(lp1168
s(S'JUN'
p1169
S'NRAS'
p1170
S'increases'
p1171
tp1172
(lp1173
s(S'MYCN'
p1174
S'NRAS'
p1175
S'increases'
p1176
tp1177
(lp1178
s(S'STAT3'
p1179
S'YY1'
p1180
S'increases'
p1181
tp1182
(lp1183
s(S'Methyl Methanesulfonate'
p1184
S'HRAS MRNA'
p1185
S'increases'
p1186
tp1187
(lp1188
s(S'RHOA/GTP'
p1189
S'PKN'
p1190
S'increases_activity'
p1191
tp1192
(lp1193
s(S'NHLH1'
p1194
S'FOXJ2'
p1195
S'increases'
p1196
tp1197
(lp1198
s(S'RAS family/GTP'
p1199
S'BRAF'
p1200
S'adds_modification'
p1201
tp1202
(lp1203
s(S'RELA'
p1204
S'FOXJ2'
p1205
S'increases'
p1206
tp1207
(lp1208
s(S'TCF3'
p1209
S'RUNX1'
p1210
S'increases'
p1211
tp1212
(lp1213
s(S'FOXF2'
p1214
S'FOXO4'
p1215
S'increases'
p1216
tp1217
(lp1218
s(S'ATF4'
p1219
S'FOXD3'
p1220
S'increases'
p1221
tp1222
(lp1223
s(S'HAND1'
p1224
S'MECOM'
p1225
S'increases'
p1226
tp1227
(lp1228
s(S'RHOA/GTP'
p1229
S'P27KIP1'
p1230
S'adds_modification'
p1231
tp1232
(lp1233
s(S'SRF'
p1234
S'NRAS'
p1235
S'increases'
p1236
tp1237
(lp1238
s(S'ESRRA'
p1239
S'POU3F2'
p1240
S'increases'
p1241
tp1242
(lp1243
s(S'BRAF'
p1244
S'MEK1'
p1245
S'adds_modification'
p1246
tp1247
(lp1248
S'PD0325901 is another important inhibitor of the BRAF signal cascade (MEK1 and MEK2) and its efficiency has been tested in preclinical models as well as PLX40323 ['
p1249
aS'Costello syndrome is caused by mutations in HRAS, NF1 by mutations in Neurofibromin and CFC syndrome by mutations in BRAF, KRAS, and MEK1/2.'
p1250
aS'The syndrome is caused by gain-of-function mutations in four different genes BRAF, KRAS, mitogen-activated protein/extracellular signal-regulated kinase MEK1 and MEK2, all belonging to the same RAS extracellular signal-regulated kinase (ERK) pathway that regulates cell differentiation, proliferation and apoptosis.'
p1251
aS'The stimulation of the MAPK pathway induces RAS to interact with RAF family kinases (ARAF, BRAF and CRAF), leading to the phosphorylation and activation of MEK1/2 and ERK1/2.'
p1252
as(S'Cadmium Chloride'
p1253
S'KRAS PROTEIN'
p1254
S'increases'
p1255
tp1256
(lp1257
s(S'PRRX2'
p1258
S'MEIS1'
p1259
S'increases'
p1260
tp1261
(lp1262
s(S'MYC'
p1263
S'NRAS'
p1264
S'increases'
p1265
tp1266
(lp1267
s(S'MAZ'
p1268
S'KRAS'
p1269
S'increases'
p1270
tp1271
(lp1272
s(S'Rho Family GTPase-active'
p1273
S'PI3K'
p1274
S'increases_activity'
p1275
tp1276
(lp1277
s(S'STAT2'
p1278
S'CYP26A1'
p1279
S'increases'
p1280
tp1281
(lp1282
s(S'hsa-let-7a-5p'
p1283
S'KRAS'
p1284
S'decreases'
p1285
tp1286
(lp1287
s(S'POU3F2'
p1288
S'NRAS'
p1289
S'increases'
p1290
tp1291
(lp1292
s(S'SRF'
p1293
S'FOXO4'
p1294
S'increases'
p1295
tp1296
(lp1297
s(S'S1P1/Sphingosine-1-phosphate/PDGF-BB/PDGFRB (dimer)'
p1298
S'SRC FAMILY KINASES'
p1299
S'increases_activity'
p1300
tp1301
(lp1302
s(S'MYC/Max'
p1303
S'ERBB2'
p1304
S'decreases'
p1305
tp1306
(lp1307
s(S'SREBF1'
p1308
S'CBFA2T3'
p1309
S'increases'
p1310
tp1311
(lp1312
s(S'PI3K'
p1313
S'GELSOLIN/PI-3-4-5-P3'
p1314
S'binds'
p1315
tp1316
(lp1317
s(S'NHLH1'
p1318
S'EN1'
p1319
S'increases'
p1320
tp1321
(lp1322
s(S'LMO2'
p1323
S'GATA6'
p1324
S'increases'
p1325
tp1326
(lp1327
s(S'POU1F1'
p1328
S'FOXD3'
p1329
S'increases'
p1330
tp1331
(lp1332
s(S'hsa-miR-148b-3p'
p1333
S'NRAS'
p1334
S'decreases'
p1335
tp1336
(lp1337
s(S'Quercetin'
p1338
S'KRAS PROTEIN'
p1339
S'decreases'
p1340
tp1341
(lp1342
s(S'PAK2'
p1343
S'MEKK1'
p1344
S'adds_modification'
p1345
tp1346
(lp1347
s(S'LMO2'
p1348
S'MAZ'
p1349
S'increases'
p1350
tp1351
(lp1352
s(S'FOXO1'
p1353
S'POU3F2'
p1354
S'increases'
p1355
tp1356
(lp1357
s(S'NKX2-1'
p1358
S'MAZ'
p1359
S'increases'
p1360
tp1361
(lp1362
s(S'GRB2/SOS1'
p1363
S'PDGF-BB/PDGFRB (DIMER)/P52 SHC'
p1364
S'binds'
p1365
tp1366
(lp1367
s(S'PI3K'
p1368
S'CRK/P130 CAS/PAXILLIN'
p1369
S'increases_activity'
p1370
tp1371
(lp1372
s(S'ATF1'
p1373
S'FOXD3'
p1374
S'increases'
p1375
tp1376
(lp1377
s(S'GATA1'
p1378
S'SRF'
p1379
S'increases'
p1380
tp1381
(lp1382
s(S'TFAP2C'
p1383
S'CYP26A1'
p1384
S'increases'
p1385
tp1386
(lp1387
s(S'AHR'
p1388
S'MEIS1'
p1389
S'increases'
p1390
tp1391
(lp1392
s(S'ETS2'
p1393
S'CYP26A1'
p1394
S'increases'
p1395
tp1396
(lp1397
s(S'Estradiol'
p1398
S'NRAS MRNA'
p1399
S'increases'
p1400
tp1401
(lp1402
s(S'E2F1'
p1403
S'HOXA9'
p1404
S'increases'
p1405
tp1406
(lp1407
s(S'PDGF-BB/PDGFRB (DIMER)'
p1408
S'RASGAP'
p1409
S'binds'
p1410
tp1411
(lp1412
s(S'E2F1'
p1413
S'GABPB2'
p1414
S'increases'
p1415
tp1416
(lp1417
s(S'FOXJ1'
p1418
S'POU3F2'
p1419
S'increases'
p1420
tp1421
(lp1422
s(S'VSX1'
p1423
S'CYP26A1'
p1424
S'increases'
p1425
tp1426
(lp1427
s(S'SPI1'
p1428
S'CDC5L'
p1429
S'increases'
p1430
tp1431
(lp1432
s(S'Gi family'
p1433
S'HRAS/GDP'
p1434
S'increases_activity'
p1435
tp1436
(lp1437
s(S'TCF3'
p1438
S'CYP26A1'
p1439
S'increases'
p1440
tp1441
(lp1442
s(S'IGF-1R HETEROTETRAMER/IGF1/IRS1'
p1443
S'GRB2/SOS1'
p1444
S'binds'
p1445
tp1446
(lp1447
s(S'RAS family/GTP'
p1448
S'RALGDS'
p1449
S'translocates'
p1450
tp1451
(lp1452
s(S'PI3K'
p1453
S'RAC1/GDP'
p1454
S'increases_activity'
p1455
tp1456
(lp1457
s(S'Ca2+'
p1458
S'PKC'
p1459
S'increases_activity'
p1460
tp1461
(lp1462
s(S'ZIC1'
p1463
S'CYP26A1'
p1464
S'increases'
p1465
tp1466
(lp1467
s(S'IRF7'
p1468
S'TLX2'
p1469
S'increases'
p1470
tp1471
(lp1472
s(S'SHC/SHIP'
p1473
S'HRAS/GDP'
p1474
S'decreases_activity'
p1475
tp1476
(lp1477
s(S'hsa-let-7a-5p'
p1478
S'HRAS'
p1479
S'decreases'
p1480
tp1481
(lp1482
s(S'GATA4'
p1483
S'MAZ'
p1484
S'increases'
p1485
tp1486
(lp1487
s(S'EN1'
p1488
S'NRAS'
p1489
S'increases'
p1490
tp1491
(lp1492
s(S'PI3K'
p1493
S'BAM32'
p1494
S'adds_modification'
p1495
tp1496
(lp1497
s(S'GABPB1'
p1498
S'CYP26A1'
p1499
S'increases'
p1500
tp1501
(lp1502
s(S'Trifluoroethanol'
p1503
S'HRAS'
p1504
S'increases_activity'
p1505
tp1506
(lp1507
s(S'SOX5'
p1508
S'CYP26A1'
p1509
S'increases'
p1510
tp1511
(lp1512
s(S'GRB2/SOS1'
p1513
S'HGF(DIMER)/MET(DIMER)/P52 SHC'
p1514
S'binds'
p1515
tp1516
(lp1517
s(S'TCF12'
p1518
S'EN1'
p1519
S'increases'
p1520
tp1521
(lp1522
s(S'SOX9'
p1523
S'MEIS1'
p1524
S'increases'
p1525
tp1526
(lp1527
s(S'RB1'
p1528
S'MYC'
p1529
S'increases'
p1530
tp1531
(lp1532
s(S'RXRA'
p1533
S'FOXA1'
p1534
S'increases'
p1535
tp1536
(lp1537
s(S'decitabine'
p1538
S'HRAS MRNA'
p1539
S'decreases'
p1540
tp1541
(lp1542
s(S'VSX1'
p1543
S'EN1'
p1544
S'increases'
p1545
tp1546
(lp1547
s(S'FOXL1'
p1548
S'CYP26A1'
p1549
S'increases'
p1550
tp1551
(lp1552
s(S'PAX2'
p1553
S'RUNX1'
p1554
S'increases'
p1555
tp1556
(lp1557
s(S'MEKK1/4'
p1558
S'MKK4/7'
p1559
S'adds_modification'
p1560
tp1561
(lp1562
s(S'HOXA9'
p1563
S'CYP26A1'
p1564
S'increases'
p1565
tp1566
(lp1567
s(S'TRKC'
p1568
S'NT3 (DIMER)'
p1569
S'binds'
p1570
tp1571
(lp1572
s(S'PTF1A'
p1573
S'REPIN1'
p1574
S'increases'
p1575
tp1576
(lp1577
s(S'TGIF'
p1578
S'CYP26A1'
p1579
S'increases'
p1580
tp1581
(lp1582
s(S'MYOD1'
p1583
S'MYC'
p1584
S'increases'
p1585
tp1586
(lp1587
s(S'PKCT'
p1588
S'KRAS ISO2'
p1589
S'adds_modification'
p1590
tp1591
(lp1592
s(S'RAS family/GTP'
p1593
S'BRAF'
p1594
S'increases_activity'
p1595
tp1596
(lp1597
s(S'SPZ1'
p1598
S'CYP26A1'
p1599
S'increases'
p1600
tp1601
(lp1602
s(S'HRAS/GTP'
p1603
S'GALECTIN-1'
p1604
S'binds'
p1605
tp1606
(lp1607
s(S'DBP'
p1608
S'FOXD3'
p1609
S'increases'
p1610
tp1611
(lp1612
s(S'E2F1'
p1613
S'POU2F1'
p1614
S'increases'
p1615
tp1616
(lp1617
g251
as(S'MEIS1'
p1618
S'CYP26A1'
p1619
S'increases'
p1620
tp1621
(lp1622
s(S'YY1'
p1623
S'NRAS'
p1624
S'increases'
p1625
tp1626
(lp1627
s(S'RAS:RAF'
p1628
S'YWHAB'
p1629
S'binds'
p1630
tp1631
(lp1632
s(S'NFE2L2'
p1633
S'CYP26A1'
p1634
S'increases'
p1635
tp1636
(lp1637
s(S'FARNESYL'
p1638
S'KRAS'
p1639
S'increases_activity'
p1640
tp1641
(lp1642
s(S'MTF1'
p1643
S'MECOM'
p1644
S'increases'
p1645
tp1646
(lp1647
s(S'TLX2'
p1648
S'FOXD3'
p1649
S'increases'
p1650
tp1651
(lp1652
s(S'Insulin Receptor/Insulin/SHC/GRB2/Sos1'
p1653
S'HRAS/GDP'
p1654
S'increases_activity'
p1655
tp1656
(lp1657
s(S'MYC'
p1658
S'ELK1'
p1659
S'increases'
p1660
tp1661
(lp1662
S'PXN, YWHAH, PTK2B, RAC1, PRKAR2A, PLA2G2A, STAT3, MYC, YWHAQ (includes EG:10971), PPP2R1A, PAK3, PIK3C3, PRKCD, PRKACA, PIK3CB, PIK3R2, ELK1, FYN, PRKAR1A.'
p1663
aS'IL1R2, MYC, TGFB1, MAP3K7IP2, IL1B, PLA2G2A, EEF2K, MAPKAPK2, ELK1.'
p1664
aS'MYC, JAK1, PIK3C3, STAT3, PIK3R2, JAK2, ELK1, INPP5D.'
p1665
aS'MYC, STAT5A, MTOR, PTPN11, HSP90AB1, PRKCD, PIK3R2, CDKN1B, ELK1, EGFR.'
p1666
as(S'ONECUT1'
p1667
S'POU2F1'
p1668
S'increases'
p1669
tp1670
(lp1671
s(S'Paraquat'
p1672
S'HRAS MRNA'
p1673
S'translocates'
p1674
tp1675
(lp1676
s(S'GRB2/SOS1'
p1677
S'PDGF-BB/PDGFRB (DIMER)/SHP2'
p1678
S'binds'
p1679
tp1680
(lp1681
s(S'ONECUT1'
p1682
S'CYP26A1'
p1683
S'increases'
p1684
tp1685
(lp1686
s(S'MYC'
p1687
S'FOXO3'
p1688
S'increases'
p1689
tp1690
(lp1691
s(S'PAX3'
p1692
S'ELK1'
p1693
S'increases'
p1694
tp1695
(lp1696
s(S'DOK-R'
p1697
S'RASGAP'
p1698
S'binds'
p1699
tp1700
(lp1701
s(S'HOXA4'
p1702
S'HOXA9'
p1703
S'increases'
p1704
tp1705
(lp1706
s(S'MAX'
p1707
S'POU3F2'
p1708
S'increases'
p1709
tp1710
(lp1711
s(S'Estradiol'
p1712
S'KRAS MRNA'
p1713
S'decreases'
p1714
tp1715
(lp1716
s(S'KRAS ISOFORM 4B/GTP'
p1717
S'CAM/CA2+'
p1718
S'binds'
p1719
tp1720
(lp1721
s(S'MAZ'
p1722
S'FOXO4'
p1723
S'increases'
p1724
tp1725
(lp1726
s(S'hsa-miR-181a-5p'
p1727
S'KRAS'
p1728
S'decreases'
p1729
tp1730
(lp1731
s(S'GATA1'
p1732
S'CYP26A1'
p1733
S'increases'
p1734
tp1735
(lp1736
s(S'PGR'
p1737
S'ETS1'
p1738
S'increases'
p1739
tp1740
(lp1741
s(S'GATA1'
p1742
S'POU2F1'
p1743
S'increases'
p1744
tp1745
(lp1746
s(S'BRAF'
p1747
S'MEK1-2'
p1748
S'increases_activity'
p1749
tp1750
(lp1751
s(S'LEF1'
p1752
S'GABPB2'
p1753
S'increases'
p1754
tp1755
(lp1756
s(S'CYP26A1'
p1757
S'MYC'
p1758
S'increases'
p1759
tp1760
(lp1761
s(S'STAT1'
p1762
S'IRF1'
p1763
S'increases'
p1764
tp1765
(lp1766
S'The inhibition of vIRF1 in PEL cells led to elevation of protein levels of important genes in IFN signaling, including IRF3 and STAT1, indicating the activation of the pathway.'
p1767
aS'STAT1, a transcription factor upstream of IRF1 and mediator of IFN signaling, is also considered a tumor suppressor gene ['
p1768
as(S'SMAD1'
p1769
S'RUNX2'
p1770
S'increases'
p1771
tp1772
(lp1773
s(S'ZEB1'
p1774
S'TLX2'
p1775
S'increases'
p1776
tp1777
(lp1778
s(S'STAT5B'
p1779
S'IRF1'
p1780
S'increases'
p1781
tp1782
(lp1783
s(S'POU6F1'
p1784
S'CYP26A1'
p1785
S'increases'
p1786
tp1787
(lp1788
s(S'Vincristine'
p1789
S'HRAS MRNA'
p1790
S'increases'
p1791
tp1792
(lp1793
s(S'DAG'
p1794
S'RASGRP1'
p1795
S'adds_modification'
p1796
tp1797
(lp1798
s(S'PI3K'
p1799
S'PDK1'
p1800
S'increases_activity'
p1801
tp1802
(lp1803
S'PI3K phosphorylates phospholipids inducing the recruitment of Akt to the plasma membrane and its activation by PDK1.'
p1804
aS'Activation of PI3K converts phosphatidylinositol 4,5-biphosphate (PIP2) into phosphatidylinositol 3,4,5 phosphate (PIP3), which leads to plasma membrane localization of phosphoinositol-dependent kinase-1 (PDK1) via its pleckstrin homology (PH) domain ('
p1805
aS'The dual specificity inhibitors, such as GNE477, NVP-BEZ235, PI-103, XL765, WJDOOS, LY294002 and BGT226, disable PI3K, mTORC1, mTORC2, Akt and PDK1 ('
p1806
aS'mTORC1 activates S6K and inhibits 4E-BP in response to extracellular (growth factors, amino acids, glucose and cellular conditions) and intracellular signals (PI3K, AKT, PDK1, TSC1/2, AMPK, Rheb and Rag GTPases), resulting in activation of protein synthesis and suppression of autophagy.'
p1807
aS'These five natural products have significantly contributed the understanding of molecular mechanisms of action in PI3K/PDK1/PKB pathways activated by insulin and other growth factors.'
p1808
aS'Nonetheless, these compounds greatly helped in exploring molecular activation mechanisms on the functional activation of PI3K, PDK1 and PKB, as well as their substrate proteins upon insulin treatment.'
p1809
aS'The Akt signaling pathway, from PI3K to phosphoinositide-dependent kinase-1 (PDK1) and from PDK1 to Akt, mediates apoptosis in human cancer cells ('
p1810
aS'The pathway-based phosphor profiling approach identifies and quantifies clinically relevant, drug-specific biomarkers for PI3K pathway inhibitors that target AKT, phosphoinositide dependent kinase 1 (PDK1), PI3K and mammalian target of rapamycin (mTOR) ['
p1811
aS'(b) Upregulation of HER2 downstream signaling pathways: PTEN loss, increased PI3K/Akt activity and PDK1 changes.'
p1812
as(S'ETS2'
p1813
S'PAX4'
p1814
S'increases'
p1815
tp1816
(lp1817
s(S'NR3C1'
p1818
S'ONECUT1'
p1819
S'increases'
p1820
tp1821
(lp1822
s(S'CUX1'
p1823
S'CYP26A1'
p1824
S'increases'
p1825
tp1826
(lp1827
s(S'ZEB1'
p1828
S'GATA1'
p1829
S'increases'
p1830
tp1831
(lp1832
s(S'NRF1'
p1833
S'POU2F1'
p1834
S'increases'
p1835
tp1836
(lp1837
s(S'FOXJ2'
p1838
S'MECOM'
p1839
S'increases'
p1840
tp1841
(lp1842
s(S'MAZ'
p1843
S'MYCN'
p1844
S'increases'
p1845
tp1846
(lp1847
s(S'Hydrogen Peroxide'
p1848
S'HRAS MRNA'
p1849
S'increases'
p1850
tp1851
(lp1852
s(S'RASA1'
p1853
S'P-EPHBS:EFNBS'
p1854
S'binds'
p1855
tp1856
(lp1857
s(S'SPI1'
p1858
S'CEBPG'
p1859
S'increases'
p1860
tp1861
(lp1862
s(S'EGR1'
p1863
S'LEF1'
p1864
S'increases'
p1865
tp1866
(lp1867
s(S'RET51/GFRALPHA1/GDNF'
p1868
S'P62DOK'
p1869
S'binds'
p1870
tp1871
(lp1872
s(S'TFDP2'
p1873
S'CYP26A1'
p1874
S'increases'
p1875
tp1876
(lp1877
s(S'matrine'
p1878
S'NRAS MRNA'
p1879
S'increases'
p1880
tp1881
(lp1882
s(S'Isotretinoin'
p1883
S'KRAS MRNA'
p1884
S'decreases'
p1885
tp1886
(lp1887
s(S'PITX2'
p1888
S'FOXF2'
p1889
S'increases'
p1890
tp1891
(lp1892
s(S'MYOD1'
p1893
S'POU2F1'
p1894
S'increases'
p1895
tp1896
(lp1897
s(S'sodium arsenite'
p1898
S'KRAS PROTEIN'
p1899
S'increases'
p1900
tp1901
(lp1902
s(S'TCF4'
p1903
S'CBFA2T3'
p1904
S'increases'
p1905
tp1906
(lp1907
s(S'CYP26A1'
p1908
S'FOXA1'
p1909
S'increases'
p1910
tp1911
(lp1912
s(S'TP53'
p1913
S'CYP26A1'
p1914
S'increases'
p1915
tp1916
(lp1917
s(S'ATF3'
p1918
S'FOXD3'
p1919
S'increases'
p1920
tp1921
(lp1922
s(S'POU2F1'
p1923
S'NRAS'
p1924
S'increases'
p1925
tp1926
(lp1927
s(S'NRF1'
p1928
S'GABPB2'
p1929
S'increases'
p1930
tp1931
(lp1932
s(S'PAX4'
p1933
S'TLX2'
p1934
S'increases'
p1935
tp1936
(lp1937
s(S'PITX2'
p1938
S'FOXA1'
p1939
S'increases'
p1940
tp1941
(lp1942
s(S'GTF3A'
p1943
S'POU2F1'
p1944
S'increases'
p1945
tp1946
(lp1947
s(S'HLF'
p1948
S'FOXO3'
p1949
S'increases'
p1950
tp1951
(lp1952
s(S'PAX4'
p1953
S'FOXO4'
p1954
S'increases'
p1955
tp1956
(lp1957
s(S'CEBPA'
p1958
S'FOXD3'
p1959
S'increases'
p1960
tp1961
(lp1962
s(S'NFE2'
p1963
S'CYP26A1'
p1964
S'increases'
p1965
tp1966
(lp1967
s(S'MYB'
p1968
S'GABPB2'
p1969
S'increases'
p1970
tp1971
(lp1972
s(S'MYC'
p1973
S'CEBPA'
p1974
S'increases'
p1975
tp1976
(lp1977
s(S'ELK1'
p1978
S'EN1'
p1979
S'increases'
p1980
tp1981
(lp1982
s(S'E2F1'
p1983
S'CDC5L'
p1984
S'increases'
p1985
tp1986
(lp1987
s(S'YWHAZ (DIMER)'
p1988
S'RAF1'
p1989
S'binds'
p1990
tp1991
(lp1992
s(S'ATF6'
p1993
S'CYP26A1'
p1994
S'increases'
p1995
tp1996
(lp1997
s(S'sodium arsenite'
p1998
S'HRAS MRNA'
p1999
S'increases'
p2000
tp2001
(lp2002
s(S'EGR3'
p2003
S'CYP26A1'
p2004
S'increases'
p2005
tp2006
(lp2007
s(S'lead acetate'
p2008
S'HRAS PROTEIN'
p2009
S'increases_activity'
p2010
tp2011
(lp2012
s(S'REPIN1'
p2013
S'MYC'
p2014
S'increases'
p2015
tp2016
(lp2017
s(S'CEBPA'
p2018
S'NRAS'
p2019
S'increases'
p2020
tp2021
(lp2022
s(S'Quercetin'
p2023
S'NRAS MRNA'
p2024
S'decreases'
p2025
tp2026
(lp2027
s(S'14-3-3 E'
p2028
S'TERT'
p2029
S'binds'
p2030
tp2031
(lp2032
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p2033
S'BTK'
p2034
S'adds_modification'
p2035
tp2036
(lp2037
s(S'HSF2'
p2038
S'CBFA2T3'
p2039
S'increases'
p2040
tp2041
(lp2042
s(S'Fluorouracil'
p2043
S'HRAS MRNA'
p2044
S'increases'
p2045
tp2046
(lp2047
s(S'STAT4'
p2048
S'MECOM'
p2049
S'increases'
p2050
tp2051
(lp2052
s(S'ETS2'
p2053
S'ETS1'
p2054
S'increases'
p2055
tp2056
(lp2057
s(S'CEBPG'
p2058
S'CYP26A1'
p2059
S'increases'
p2060
tp2061
(lp2062
s(S'Complex (PDGF receptor A/PDGF receptor B)'
p2063
S'NCK'
p2064
S'adds_modification'
p2065
tp2066
(lp2067
s(S'Fog1'
p2068
S'MYB'
p2069
S'decreases'
p2070
tp2071
(lp2072
s(S'CREB1'
p2073
S'FOXD3'
p2074
S'increases'
p2075
tp2076
(lp2077
s(S'Numb'
p2078
S'NICS'
p2079
S'translocates'
p2080
tp2081
(lp2082
s(S'STAT6'
p2083
S'STAT5A'
p2084
S'increases'
p2085
tp2086
(lp2087
s(S'RAF1/14-3-3'
p2088
S'BRAF/14-3-3'
p2089
S'binds'
p2090
tp2091
(lp2092
s(S'B-cell antigen/BCR complex/LYN/SYK/BLNK'
p2093
S'SHC/GRB2/SOS1'
p2094
S'increases_activity'
p2095
tp2096
(lp2097
s(S'IRF2'
p2098
S'CYP26A1'
p2099
S'increases'
p2100
tp2101
(lp2102
s(S'GATA6'
p2103
S'CYP26A1'
p2104
S'increases'
p2105
tp2106
(lp2107
s(S'HMGA1'
p2108
S'CYP26A1'
p2109
S'increases'
p2110
tp2111
(lp2112
s(S'MTF1'
p2113
S'FOXO4'
p2114
S'increases'
p2115
tp2116
(lp2117
s(S'STAT1'
p2118
S'GABPB2'
p2119
S'increases'
p2120
tp2121
(lp2122
s(S'manumycin'
p2123
S'HRAS PROTEIN'
p2124
S'decreases'
p2125
tp2126
(lp2127
s(S'STAT5A'
p2128
S'ETS1'
p2129
S'increases'
p2130
tp2131
(lp2132
s(S'SPI1'
p2133
S'CBFA2T3'
p2134
S'increases'
p2135
tp2136
(lp2137
s(S'GMCSF/GMR ALPHA/CSF2RB/JAK2 (DODECAMER)/SHC'
p2138
S'GRB2/SOS1'
p2139
S'binds'
p2140
tp2141
(lp2142
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2143
S'NRAS PROTEIN'
p2144
S'increases'
p2145
tp2146
(lp2147
s(S'CDC5L'
p2148
S'CYP26A1'
p2149
S'increases'
p2150
tp2151
(lp2152
s(S'PAX4'
p2153
S'POU3F2'
p2154
S'increases'
p2155
tp2156
(lp2157
s(S'SPRED2'
p2158
S'HRAS'
p2159
S'binds'
p2160
tp2161
(lp2162
s(S'PITX2'
p2163
S'FOXO4'
p2164
S'increases'
p2165
tp2166
(lp2167
s(S'FOXD3'
p2168
S'CYP26A1'
p2169
S'increases'
p2170
tp2171
(lp2172
s(S'NFIL3'
p2173
S'FOXO3'
p2174
S'increases'
p2175
tp2176
(lp2177
s(S'MTF1'
p2178
S'POU2F1'
p2179
S'increases'
p2180
tp2181
(lp2182
s(S'TFCP2'
p2183
S'BACH1'
p2184
S'increases'
p2185
tp2186
(lp2187
s(S'NF1'
p2188
S'MECOM'
p2189
S'increases'
p2190
tp2191
(lp2192
s(S'FOXO3'
p2193
S'FOXD3'
p2194
S'increases'
p2195
tp2196
(lp2197
s(S'STAT5A'
p2198
S'TLX2'
p2199
S'increases'
p2200
tp2201
(lp2202
s(S'RIN1'
p2203
S'HRAS/GTP'
p2204
S'adds_modification'
p2205
tp2206
(lp2207
s(S'STAT5A'
p2208
S'CEBPG'
p2209
S'increases'
p2210
tp2211
(lp2212
s(S'DAG'
p2213
S'PKC'
p2214
S'increases_activity'
p2215
tp2216
(lp2217
S'When considering possible mechanisms of diabetic cardiomyopathies, diacylglycerol (DAG) and its effects on protein kinase C (PKC) signaling have been implicated ['
p2218
aS'Another cellular signaling pathway that is altered in the presence of high glucose and contributes to endothelial dysfunction is the increased de novo synthesis of diacylglycerides (DAG) and the subsequent activation of protein kinase C (PKC) ['
p2219
aS'DGKH (diacylglycerol kinase isoenzyme): one of the lipid kinases catalyzing conversion of diacylglycerol (DAG) to phosphatidic acid with an overall reduction in DAG which is a cofactor in the activation of PKC.'
p2220
aS'FATP: fatty acid transport protein; FFA: free fatty acid; LC-CoA: long-chain fatty acid-CoA; DAG: diacylglycerol; PKC: protein kinase C; IR: insulin receptor; IRS: insulin receptor substrate; PI3K: phosphatidylinositol 3-kinase; GLUT4: glucose transporter protein 4.'
p2221
aS'Renal injury in diabetes is known to be associated with the activation of the diacylglycerol (DAG)-PKC pathway.'
p2222
aS'Melatonin (MEL) binds to membrane receptors (MT2/MT1) to activate PKC through the diacylglycerol (DAG) pathway.'
p2223
aS'It is thought that activation of protein kinase C (PKC) due to elevation of DAG and intracellular calcium is responsible for cortical granule exocytosis, cortical contraction, reformation of the nuclear envelope and sperm chromatin decondensation.'
p2224
aS'The domain architectures of DGKs reflect this common function, as each of the ten isoforms has a catalytic domain as well as at least two C1 domains that are homologous to protein kinase C (PKC) C1 phorbol-ester/DAG binding domains.'
p2225
aS'As DGK C1 domains are homologous to DAG/phorbol ester-binding PKC C1 domains, DGK C1 domains were presumed to mediate the binding of DGK to DAG.'
p2226
as(S'HNF4A'
p2227
S'FOXA1'
p2228
S'increases'
p2229
tp2230
(lp2231
s(S'LEF1'
p2232
S'MAZ'
p2233
S'increases'
p2234
tp2235
(lp2236
s(S'hsa-miR-124-3p'
p2237
S'NRAS'
p2238
S'decreases'
p2239
tp2240
(lp2241
s(S'RAF1'
p2242
S'14-3-3 E'
p2243
S'binds'
p2244
tp2245
(lp2246
s(S'GATA1'
p2247
S'MYB'
p2248
S'decreases'
p2249
tp2250
(lp2251
s(S'LMO2'
p2252
S'GATA1'
p2253
S'increases'
p2254
tp2255
(lp2256
s(S'HRAS/GTP'
p2257
S'RAF1'
p2258
S'increases_activity'
p2259
tp2260
(lp2261
s(S'MYCN'
p2262
S'RUNX2'
p2263
S'increases'
p2264
tp2265
(lp2266
s(S'STAT5B'
p2267
S'CYP26A1'
p2268
S'increases'
p2269
tp2270
(lp2271
s(S'ZIC2'
p2272
S'MYCN'
p2273
S'increases'
p2274
tp2275
(lp2276
s(S'FOXL1'
p2277
S'FOXD3'
p2278
S'increases'
p2279
tp2280
(lp2281
s(S'ZBTB18'
p2282
S'CBFA2T3'
p2283
S'increases'
p2284
tp2285
(lp2286
s(S'HSF1'
p2287
S'IRF1'
p2288
S'increases'
p2289
tp2290
(lp2291
s(S'SPZ1'
p2292
S'MAZ'
p2293
S'increases'
p2294
tp2295
(lp2296
s(S'SRY'
p2297
S'CYP26A1'
p2298
S'increases'
p2299
tp2300
(lp2301
s(S'FOXO4'
p2302
S'HOXA9'
p2303
S'increases'
p2304
tp2305
(lp2306
s(S'IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos'
p2307
S'HRAS/GDP'
p2308
S'increases_activity'
p2309
tp2310
(lp2311
s(S'hsa-miR-615-3p'
p2312
S'HRAS'
p2313
S'decreases'
p2314
tp2315
(lp2316
s(S'ESRRA'
p2317
S'FOXD3'
p2318
S'increases'
p2319
tp2320
(lp2321
s(S'ELK1'
p2322
S'CYP26A1'
p2323
S'increases'
p2324
tp2325
(lp2326
s(S'Hexane-1,6-Diol'
p2327
S'HRAS'
p2328
S'increases_activity'
p2329
tp2330
(lp2331
s(S'MAZ'
p2332
S'NRAS'
p2333
S'increases'
p2334
tp2335
(lp2336
s(S'MIF'
p2337
S'CYP26A1'
p2338
S'increases'
p2339
tp2340
(lp2341
s(S'AHR'
p2342
S'POU2F1'
p2343
S'increases'
p2344
tp2345
(lp2346
s(S'SMAD3'
p2347
S'CYP26A1'
p2348
S'increases'
p2349
tp2350
(lp2351
s(S'PI-3-4-5-P3'
p2352
S'GELSOLIN'
p2353
S'binds'
p2354
tp2355
(lp2356
s(S'ADP'
p2357
S'P-S724-IRE1 DIMER'
p2358
S'binds'
p2359
tp2360
(lp2361
s(S'testosterone enanthate'
p2362
S'KRAS MRNA'
p2363
S'increases'
p2364
tp2365
(lp2366
s(S'CYP26A1'
p2367
S'ONECUT1'
p2368
S'increases'
p2369
tp2370
(lp2371
s(S'Valproic Acid'
p2372
S'NRAS MRNA'
p2373
S'decreases'
p2374
tp2375
(lp2376
s(S'GTF2A2'
p2377
S'CYP26A1'
p2378
S'increases'
p2379
tp2380
(lp2381
s(S'CEBPA'
p2382
S'FOXO3'
p2383
S'increases'
p2384
tp2385
(lp2386
s(S'GATA3'
p2387
S'POU2F1'
p2388
S'increases'
p2389
tp2390
(lp2391
s(S'PI3K'
p2392
S'RAC1B/GDP'
p2393
S'increases_activity'
p2394
tp2395
(lp2396
s(S'CDC25C'
p2397
S'YWHAB'
p2398
S'binds'
p2399
tp2400
(lp2401
s(S'RAC1/GTP'
p2402
S'PAK1/BETAPIX/PKL/NCK1-2'
p2403
S'increases_activity'
p2404
tp2405
(lp2406
s(S'SMAD1'
p2407
S'CYP26A1'
p2408
S'increases'
p2409
tp2410
(lp2411
s(S'PI3K'
p2412
S'FAK'
p2413
S'adds_modification'
p2414
tp2415
(lp2416
S'EGFR: epidermal growth factor receptor; FAK: focal adhesion kinase; Grb2: growth factor receptor-bound protein 2; GAB1: Grb2-associated binding protein; MEK, mitogen-activated protein kinase/ERK kinase; PI3K: phosphoinositide 3-kinase; mTOR: mammalian target of rapamycin; RAS: renin-angiotensin system; VEGF: vascular endothelial growth factor.'
p2417
aS'FAK autophosphorylation at Y397 provides a binding site for SH2 domain-containing proteins such as Src family kinases and the p85 subunit of PI3K, which is important for integrin-mediated cell growth and migration ['
p2418
aS'Laminin influences several signaling proteins in cultured OLGs, including Fyn, FAK, MAPK, and PI3K ['
p2419
aS'Eph receptors are known to signal through a number of different pathways and molecules, including small GTPases of the Rho and Ras family, focal adhesion kinase (FAK), the Jak/Stat pathway and the PI3K pathway '
p2420
aS'Fangchinoline inhibits the the expression of FAKPI3K.'
p2421
aS'FAK is the link between integrins and downstream signaling transduction pathways and activates ERK and PI3K/AKT pathways involved in cell proliferation and migration ('
p2422
aS'Some upstream regulators of RhoA, including PI3K, focal adhesion kinase (FAK), GC-binding factor 2 (GCF2) and GTPase regulator associated with focal adhesion kinase-1 (GRAF1), have been reported to participate in endocytosis and membrane protein trafficking by regulating RhoA activation.'
p2423
aS'Treatment with the PI3K inhibitor (LY294002) or the FAK inhibitor (PF573228) suppresses compensatory endocytosis by ~30% and ~70%, respectively, by inhibiting the activation of RhoA and then reducing the recruitment of ROCK ['
p2424
aS'As such, FAK can be activated at tyr397 by many protein tyrosine kinases such as PI3K and Grb7 and subsequently regulate focal adhesion dynamics during cell migration and activate prosurvival and mitogenic signaling pathways ['
p2425
aS'cMET activates several pathways including SRC/FAK, the signal transducer and activator of transcription 3 (STAT3), PI3K/AKT, and RAS ['
p2426
as(S'NRF1'
p2427
S'MAX'
p2428
S'increases'
p2429
tp2430
(lp2431
s(S'FOXI1'
p2432
S'RUNX2'
p2433
S'increases'
p2434
tp2435
(lp2436
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2437
S'HRAS MRNA'
p2438
S'increases'
p2439
tp2440
(lp2441
s(S'ETS1'
p2442
S'CBFA2T3'
p2443
S'increases'
p2444
tp2445
(lp2446
s(S'hsa-miR-98-5p'
p2447
S'NRAS'
p2448
S'decreases'
p2449
tp2450
(lp2451
s(S'PHOSPHORYLATED BRF1 (SER92, SER203):MRNA COMPLEX'
p2452
S'YWHAB'
p2453
S'binds'
p2454
tp2455
(lp2456
s(S'LMO2'
p2457
S'CYP26A1'
p2458
S'increases'
p2459
tp2460
(lp2461
s(S'SOS1'
p2462
S'GRB2:PFAK BOUND TO NCAM1:PFYN'
p2463
S'binds'
p2464
tp2465
(lp2466
s(S'GTF3A'
p2467
S'GATA6'
p2468
S'increases'
p2469
tp2470
(lp2471
s(S'ZIC2'
p2472
S'CYP26A1'
p2473
S'increases'
p2474
tp2475
(lp2476
s(S'PAX2'
p2477
S'POU3F2'
p2478
S'increases'
p2479
tp2480
(lp2481
s(S'CEBPD'
p2482
S'FOXO3'
p2483
S'increases'
p2484
tp2485
(lp2486
s(S'NF1'
p2487
S'CYP26A1'
p2488
S'increases'
p2489
tp2490
(lp2491
s(S'BRAF'
p2492
S'MEK2'
p2493
S'adds_modification'
p2494
tp2495
(lp2496
g1249
ag1251
as(S'TFAP4'
p2497
S'RUNX1'
p2498
S'increases'
p2499
tp2500
(lp2501
s(S'FAK'
p2502
S'SOS'
p2503
S'binds'
p2504
tp2505
(lp2506
s(S'EGR1'
p2507
S'RUNX1'
p2508
S'increases'
p2509
tp2510
(lp2511
s(S'TCF4'
p2512
S'FOXO4'
p2513
S'increases'
p2514
tp2515
(lp2516
s(S'MAZ'
p2517
S'CBFA2T3'
p2518
S'increases'
p2519
tp2520
(lp2521
s(S'MEIS1'
p2522
S'HRAS'
p2523
S'increases'
p2524
tp2525
(lp2526
s(S'RELA'
p2527
S'CYP26A1'
p2528
S'increases'
p2529
tp2530
(lp2531
s(S'hsa-miR-877-3p'
p2532
S'NRAS'
p2533
S'decreases'
p2534
tp2535
(lp2536
s(S'MYC'
p2537
S'LEF1'
p2538
S'increases'
p2539
tp2540
(lp2541
s(S'FOXO4'
p2542
S'RUNX1'
p2543
S'increases'
p2544
tp2545
(lp2546
s(S'LEF1'
p2547
S'RUNX1'
p2548
S'increases'
p2549
tp2550
(lp2551
s(S'TFDP2'
p2552
S'GATA1'
p2553
S'increases'
p2554
tp2555
(lp2556
s(S'AHR'
p2557
S'CYP26A1'
p2558
S'increases'
p2559
tp2560
(lp2561
s(S'4-Nitroquinoline-1-oxide'
p2562
S'PTGS2 MRNA'
p2563
S'increases'
p2564
tp2565
(lp2566
s(S'TGIF'
p2567
S'FOXO3'
p2568
S'increases'
p2569
tp2570
(lp2571
s(S'FOXF2'
p2572
S'CEBPA'
p2573
S'increases'
p2574
tp2575
(lp2576
s(S'NFE2L1'
p2577
S'POU2F1'
p2578
S'increases'
p2579
tp2580
(lp2581
s(S'LHX3'
p2582
S'CYP26A1'
p2583
S'increases'
p2584
tp2585
(lp2586
s(S'HMGA1'
p2587
S'MEIS1'
p2588
S'increases'
p2589
tp2590
(lp2591
s(S'POU2F1'
p2592
S'CYP26A1'
p2593
S'increases'
p2594
tp2595
(lp2596
s(S'PRRX2'
p2597
S'HOXA9'
p2598
S'increases'
p2599
tp2600
(lp2601
s(S'ETS2'
p2602
S'CEBPG'
p2603
S'increases'
p2604
tp2605
(lp2606
s(S'hsa-miR-193b-3p'
p2607
S'KRAS'
p2608
S'decreases'
p2609
tp2610
(lp2611
s(S'RREB1'
p2612
S'RUNX1'
p2613
S'increases'
p2614
tp2615
(lp2616
s(S'IL2/IL2R BETA/GAMMA/JAK1/FYN/JAK3'
p2617
S'PI3K'
p2618
S'binds'
p2619
tp2620
(lp2621
s(S'ELK1'
p2622
S'MEIS1'
p2623
S'increases'
p2624
tp2625
(lp2626
s(S'CYP26A1'
p2627
S'HOXA9'
p2628
S'increases'
p2629
tp2630
(lp2631
s(S'SPZ1'
p2632
S'HOXA9'
p2633
S'increases'
p2634
tp2635
(lp2636
s(S'ERK1'
p2637
S'P-S218,222-MEK1'
p2638
S'binds'
p2639
tp2640
(lp2641
s(S'NHLH1'
p2642
S'MYC'
p2643
S'increases'
p2644
tp2645
(lp2646
s(S'Daunorubicin'
p2647
S'NRAS MRNA'
p2648
S'increases'
p2649
tp2650
(lp2651
s(S'HNF1A'
p2652
S'FOXA1'
p2653
S'increases'
p2654
tp2655
(lp2656
s(S'MYC'
p2657
S'ONECUT1'
p2658
S'increases'
p2659
tp2660
(lp2661
s(S'Vanadates'
p2662
S'HRAS PROTEIN'
p2663
S'increases'
p2664
tp2665
(lp2666
s(S'Purine nucleotide'
p2667
S'H+'
p2668
S'translocates'
p2669
tp2670
(lp2671
s(S'NFE2'
p2672
S'BACH1'
p2673
S'increases'
p2674
tp2675
(lp2676
S'Real-time PCR (RT-qPCR) was performed with StepOne real-time PCR system (Applied Biosystems, Foster City, CA, USA) using TaqMan Gene Expression Master Mix and ready-made human HMOX1 (Hs 01110250_m1), ACTB (Hs 99999903_m1), NQO1 (Hs00168547_m1), GSTP1 (Hs00943351_g1), BACH1 (Hs00230917_m1), NFE2L2 (Hs00975960_m1), and KEAP1 (Hs00202227_m1) Gene Expression Assays (Applied Biosystems, Foster City, CA, USA).'
p2677
aS'Real-time PCR analyses showed that there were no drastic changes in the expression of BACH1, NFE2L2 (NRF2), and KEAP1 genes when PC-3 cells were treated with ZnPP.'
p2678
as(S'EGR4'
p2679
S'CYP26A1'
p2680
S'increases'
p2681
tp2682
(lp2683
s(S'NRF1'
p2684
S'ONECUT1'
p2685
S'increases'
p2686
tp2687
(lp2688
s(S'GFI1'
p2689
S'HOXA9'
p2690
S'increases'
p2691
tp2692
(lp2693
s(S'NR1H4'
p2694
S'FOXD3'
p2695
S'increases'
p2696
tp2697
(lp2698
s(S'STAT6'
p2699
S'FOXA1'
p2700
S'increases'
p2701
tp2702
(lp2703
s(S'INSULIN RECEPTOR/INSULI/IRS1/GRB2/SHC'
p2704
S'SOS1'
p2705
S'binds'
p2706
tp2707
(lp2708
s(S'Tetrachlorodibenzodioxin'
p2709
S'KRAS MRNA'
p2710
S'increases'
p2711
tp2712
(lp2713
s(S'TCF3'
p2714
S'MYC'
p2715
S'increases'
p2716
tp2717
(lp2718
s(S'BACH1'
p2719
S'EN1'
p2720
S'increases'
p2721
tp2722
(lp2723
s(S'RFX1'
p2724
S'CYP26A1'
p2725
S'increases'
p2726
tp2727
(lp2728
s(S'ZEB1'
p2729
S'FOXD3'
p2730
S'increases'
p2731
tp2732
(lp2733
s(S'IRF7'
p2734
S'EN1'
p2735
S'increases'
p2736
tp2737
(lp2738
s(S'GAB2/GRB2/SOS1'
p2739
S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/SHC'
p2740
S'binds'
p2741
tp2742
(lp2743
s(S'GATA3'
p2744
S'FOXA1'
p2745
S'increases'
p2746
tp2747
(lp2748
s(S'TFAP4'
p2749
S'CYP26A1'
p2750
S'increases'
p2751
tp2752
(lp2753
s(S'FOXF2'
p2754
S'MECOM'
p2755
S'increases'
p2756
tp2757
(lp2758
s(S'NF1'
p2759
S'POU2F1'
p2760
S'increases'
p2761
tp2762
(lp2763
s(S'IRF1'
p2764
S'FOXA1'
p2765
S'increases'
p2766
tp2767
(lp2768
s(S'Rho Family GTPase-active'
p2769
S'PIP5K1A'
p2770
S'increases_activity'
p2771
tp2772
(lp2773
s(S'POU6F1'
p2774
S'EN1'
p2775
S'increases'
p2776
tp2777
(lp2778
s(S'TCF4'
p2779
S'LEF1'
p2780
S'increases'
p2781
tp2782
(lp2783
s(S'MAZ'
p2784
S'FOXO3'
p2785
S'increases'
p2786
tp2787
(lp2788
s(S'POU3F2'
p2789
S'MECOM'
p2790
S'increases'
p2791
tp2792
(lp2793
s(S'GTF3A'
p2794
S'CYP26A1'
p2795
S'increases'
p2796
tp2797
(lp2798
s(S'PI-3-4-5-P3'
p2799
S'AKT2'
p2800
S'adds_modification'
p2801
tp2802
(lp2803
s(S'VSX1'
p2804
S'POU2F1'
p2805
S'increases'
p2806
tp2807
(lp2808
s(S'PHOSPHORYLATED TTP:MRNA COMPLEX'
p2809
S'YWHAB'
p2810
S'binds'
p2811
tp2812
(lp2813
s(S'MEIS1'
p2814
S'MYC'
p2815
S'increases'
p2816
tp2817
(lp2818
s(S'Complex (PDGF receptor A/PDGF receptor B)'
p2819
S'RASGAP'
p2820
S'adds_modification'
p2821
tp2822
(lp2823
s(S'RORA'
p2824
S'CYP26A1'
p2825
S'increases'
p2826
tp2827
(lp2828
s(S'ATF4'
p2829
S'CDC5L'
p2830
S'increases'
p2831
tp2832
(lp2833
s(S'SHC/RasGAP'
p2834
S'RAS FAMILY/GTP'
p2835
S'increases_activity'
p2836
tp2837
(lp2838
s(S'NKX2-1'
p2839
S'MYC'
p2840
S'increases'
p2841
tp2842
(lp2843
s(S'NF1'
p2844
S'SRF'
p2845
S'increases'
p2846
tp2847
(lp2848
s(S'STAT4'
p2849
S'NRAS'
p2850
S'increases'
p2851
tp2852
(lp2853
s(S'POU6F1'
p2854
S'MEIS1'
p2855
S'increases'
p2856
tp2857
(lp2858
s(S'P-KIT COMPLEX'
p2859
S'GRB2:SOS1'
p2860
S'binds'
p2861
tp2862
(lp2863
s(S'MYCN'
p2864
S'MAX'
p2865
S'increases'
p2866
tp2867
(lp2868
s(S'STAT5A'
p2869
S'CYP26A1'
p2870
S'increases'
p2871
tp2872
(lp2873
s(S'GATA3'
p2874
S'EN1'
p2875
S'increases'
p2876
tp2877
(lp2878
s(S'E4F1'
p2879
S'FOXD3'
p2880
S'increases'
p2881
tp2882
(lp2883
s(S'MYB'
p2884
S'ONECUT1'
p2885
S'increases'
p2886
tp2887
(lp2888
s(S'Cadmium Chloride'
p2889
S'NRAS PROTEIN'
p2890
S'increases'
p2891
tp2892
(lp2893
s(S'Deoxycholic Acid'
p2894
S'HRAS PROTEIN'
p2895
S'increases_activity'
p2896
tp2897
(lp2898
s(S'HLF'
p2899
S'CYP26A1'
p2900
S'increases'
p2901
tp2902
(lp2903
s(S'GMCSF/GMR ALPHA/CSF2RB/JAK2 (DIMER)'
p2904
S'YWHAZ'
p2905
S'binds'
p2906
tp2907
(lp2908
s(S'HNF1A'
p2909
S'FOXF2'
p2910
S'increases'
p2911
tp2912
(lp2913
s(S'FOXF2'
p2914
S'GATA6'
p2915
S'increases'
p2916
tp2917
(lp2918
s(S'Arsenic'
p2919
S'GSS PROTEIN'
p2920
S'increases'
p2921
tp2922
(lp2923
s(S'COMPLEX (SOS/GRB2)'
p2924
S'FGFR1-4'
p2925
S'binds'
p2926
tp2927
(lp2928
s(S'MYOD1'
p2929
S'NRAS'
p2930
S'increases'
p2931
tp2932
(lp2933
s(S'MECOM'
p2934
S'CYP26A1'
p2935
S'increases'
p2936
tp2937
(lp2938
s(S'PBX1'
p2939
S'CYP26A1'
p2940
S'increases'
p2941
tp2942
(lp2943
s(S'MAZ'
p2944
S'MEIS1'
p2945
S'increases'
p2946
tp2947
(lp2948
s(S'PAX4'
p2949
S'ELK1'
p2950
S'increases'
p2951
tp2952
(lp2953
s(S'ESRRA'
p2954
S'MECOM'
p2955
S'increases'
p2956
tp2957
(lp2958
s(S'CEBPD'
p2959
S'TLX2'
p2960
S'increases'
p2961
tp2962
(lp2963
s(S'CRX'
p2964
S'FOXA1'
p2965
S'increases'
p2966
tp2967
(lp2968
s(S'GABPB1'
p2969
S'NRAS'
p2970
S'increases'
p2971
tp2972
(lp2973
s(S'CRX'
p2974
S'MEIS1'
p2975
S'increases'
p2976
tp2977
(lp2978
s(S'pirinixic acid/PPARA protein'
p2979
S'KRAS MRNA'
p2980
S'increases'
p2981
tp2982
(lp2983
s(S'BACH2'
p2984
S'FOXA1'
p2985
S'increases'
p2986
tp2987
(lp2988
s(S'JUN'
p2989
S'MECOM'
p2990
S'increases'
p2991
tp2992
(lp2993
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2994
S'KRAS MRNA'
p2995
S'decreases'
p2996
tp2997
(lp2998
s(S'SRY'
p2999
S'FOXO4'
p3000
S'increases'
p3001
tp3002
(lp3003
s(S'PI3K'
p3004
S'AKT1'
p3005
S'adds_modification'
p3006
tp3007
(lp3008
s(S'GATA3'
p3009
S'CYP26A1'
p3010
S'increases'
p3011
tp3012
(lp3013
s(S'RAS:GTP'
p3014
S'P-EPHBS:EFNBS:RASA1'
p3015
S'binds'
p3016
tp3017
(lp3018
s(S'STAT5A'
p3019
S'MECOM'
p3020
S'increases'
p3021
tp3022
(lp3023
s(S'RAS family/GTP'
p3024
S'RAF1'
p3025
S'increases_activity'
p3026
tp3027
(lp3028
s(S'RHOA/GTP'
p3029
S'PLD1-2'
p3030
S'increases_activity'
p3031
tp3032
(lp3033
s(S'FOXJ2'
p3034
S'CYP26A1'
p3035
S'increases'
p3036
tp3037
(lp3038
s(S'LEF1'
p3039
S'MECOM'
p3040
S'increases'
p3041
tp3042
(lp3043
s(S'GABPB2'
p3044
S'CDC5L'
p3045
S'increases'
p3046
tp3047
(lp3048
s(S'ESRRA'
p3049
S'CYP26A1'
p3050
S'increases'
p3051
tp3052
(lp3053
s(S'PI-3-4-5-P3'
p3054
S'WAVE2/NAP1/SRA1/ABI1/HSPC300'
p3055
S'translocates'
p3056
tp3057
(lp3058
s(S'CUX1'
p3059
S'MECOM'
p3060
S'increases'
p3061
tp3062
(lp3063
s(S'MAX'
p3064
S'CYP26A1'
p3065
S'increases'
p3066
tp3067
(lp3068
s(S'RXRB'
p3069
S'FOXD3'
p3070
S'increases'
p3071
tp3072
(lp3073
s(S'IRF1'
p3074
S'NRAS'
p3075
S'increases'
p3076
tp3077
(lp3078
s(S'MECOM'
p3079
S'MAX'
p3080
S'increases'
p3081
tp3082
(lp3083
s(S'PAX6'
p3084
S'CYP26A1'
p3085
S'increases'
p3086
tp3087
(lp3088
s(S'GRB2/SOS1'
p3089
S'EGFR/EGFR/EGF/EGF/P46 SHC'
p3090
S'binds'
p3091
tp3092
(lp3093
s(S'POU6F1'
p3094
S'POU2F1'
p3095
S'increases'
p3096
tp3097
(lp3098
s(S'RUNX1'
p3099
S'MYOD1'
p3100
S'increases'
p3101
tp3102
(lp3103
s(S'COMPLEX (GRB2/SOS)'
p3104
S'EGFR'
p3105
S'binds'
p3106
tp3107
(lp3108
s(S'MAZ'
p3109
S'MECOM'
p3110
S'increases'
p3111
tp3112
(lp3113
s(S'REPIN1'
p3114
S'EN1'
p3115
S'increases'
p3116
tp3117
(lp3118
s(S'RAS family/GTP'
p3119
S'RAF1'
p3120
S'adds_modification'
p3121
tp3122
(lp3123
s(S'E4F1'
p3124
S'CYP26A1'
p3125
S'increases'
p3126
tp3127
(lp3128
s(S'Rac'
p3129
S'MEKK1-5'
p3130
S'adds_modification'
p3131
tp3132
(lp3133
s(S'HAND1'
p3134
S'CYP26A1'
p3135
S'increases'
p3136
tp3137
(lp3138
s(S'Quercetin'
p3139
S'NRAS PROTEIN'
p3140
S'decreases'
p3141
tp3142
(lp3143
s(S'HRAS:GTP'
p3144
S'CRAF'
p3145
S'binds'
p3146
tp3147
(lp3148
s(S'REPIN1'
p3149
S'FOXA1'
p3150
S'increases'
p3151
tp3152
(lp3153
s(S'hsa-miR-155-5p'
p3154
S'KRAS'
p3155
S'decreases'
p3156
tp3157
(lp3158
s(S'PAX4'
p3159
S'EN1'
p3160
S'increases'
p3161
tp3162
(lp3163
s(S'FOXN1'
p3164
S'JUN'
p3165
S'increases'
p3166
tp3167
(lp3168
s(S'TFCP2'
p3169
S'GATA1'
p3170
S'increases'
p3171
tp3172
(lp3173
s(S'SHC'
p3174
S'GRAP2'
p3175
S'binds'
p3176
tp3177
(lp3178
s(S'CEBPG'
p3179
S'NRAS'
p3180
S'increases'
p3181
tp3182
(lp3183
s(S'FOXN1'
p3184
S'FOXO4'
p3185
S'increases'
p3186
tp3187
(lp3188
s(S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/IRS1-2'
p3189
S'PI3K'
p3190
S'binds'
p3191
tp3192
(lp3193
s(S'POU1F1'
p3194
S'EN1'
p3195
S'increases'
p3196
tp3197
(lp3198
s(S'FOXJ1'
p3199
S'POU2F1'
p3200
S'increases'
p3201
tp3202
(lp3203
s(S'YY1'
p3204
S'POU2F1'
p3205
S'increases'
p3206
tp3207
(lp3208
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p3209
S'NRAS MRNA'
p3210
S'increases'
p3211
tp3212
(lp3213
s(S'EGF/EGFR'
p3214
S'HRAS/GDP'
p3215
S'increases_activity'
p3216
tp3217
(lp3218
s(S'TFAP4'
p3219
S'GABPB2'
p3220
S'increases'
p3221
tp3222
(lp3223
s(S'TFAP2A'
p3224
S'POU3F2'
p3225
S'increases'
p3226
tp3227
(lp3228
s(S'TCF12'
p3229
S'CBFA2T3'
p3230
S'increases'
p3231
tp3232
(lp3233
s(S'STAT3'
p3234
S'IRF1'
p3235
S'increases'
p3236
tp3237
(lp3238
s(S'MYOD1'
p3239
S'GATA1'
p3240
S'increases'
p3241
tp3242
(lp3243
s(S'REPIN1'
p3244
S'HRAS'
p3245
S'increases'
p3246
tp3247
(lp3248
s(S'PAX4'
p3249
S'MAX'
p3250
S'increases'
p3251
tp3252
(lp3253
s(S'PAX2'
p3254
S'FOXA1'
p3255
S'increases'
p3256
tp3257
(lp3258
s(S'Lipopolysaccharides'
p3259
S'HRAS PROTEIN'
p3260
S'increases_activity'
p3261
tp3262
(lp3263
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p3264
S'KRAS MRNA'
p3265
S'increases'
p3266
tp3267
(lp3268
s(S'REPIN1'
p3269
S'GATA1'
p3270
S'increases'
p3271
tp3272
(lp3273
s(S'Formaldehyde'
p3274
S'HRAS MRNA'
p3275
S'increases'
p3276
tp3277
(lp3278
s(S'ESRRA'
p3279
S'STAT5A'
p3280
S'increases'
p3281
tp3282
(lp3283
s(S'farnesylthiosalicylic acid'
p3284
S'HRAS PROTEIN'
p3285
S'decreases'
p3286
tp3287
(lp3288
s(S'JUN'
p3289
S'RUNX1'
p3290
S'increases'
p3291
tp3292
(lp3293
S'as co-activators for several transcription factors including p53, pRB, MYB, JUN, FOS, and RUNX1 ['
p3294
as(S'FOXD3'
p3295
S'RUNX1'
p3296
S'increases'
p3297
tp3298
(lp3299
s(S'SOX9'
p3300
S'CYP26A1'
p3301
S'increases'
p3302
tp3303
(lp3304
s(S'hexabromocyclododecane'
p3305
S'HRAS MRNA'
p3306
S'increases'
p3307
tp3308
(lp3309
s(S'RUNX2'
p3310
S'KRAS'
p3311
S'increases'
p3312
tp3313
(lp3314
s(S'PGR'
p3315
S'CYP26A1'
p3316
S'increases'
p3317
tp3318
(lp3319
s(S'CYP26A1'
p3320
S'MAZ'
p3321
S'increases'
p3322
tp3323
(lp3324
s(S'RAC1/GTP'
p3325
S'AKT1'
p3326
S'adds_modification'
p3327
tp3328
(lp3329
s(S'FOXO3'
p3330
S'CYP26A1'
p3331
S'increases'
p3332
tp3333
(lp3334
s(S'MAX'
p3335
S'SRF'
p3336
S'increases'
p3337
tp3338
(lp3339
s(S'RUNX2'
p3340
S'NRAS'
p3341
S'increases'
p3342
tp3343
(lp3344
s(S'HSF2'
p3345
S'CYP26A1'
p3346
S'increases'
p3347
tp3348
(lp3349
s(S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/SHP2'
p3350
S'PI3K'
p3351
S'binds'
p3352
tp3353
(lp3354
s(S'SPI1'
p3355
S'STAT5A'
p3356
S'increases'
p3357
tp3358
(lp3359
s(S'ZHX2'
p3360
S'MYC'
p3361
S'increases'
p3362
tp3363
(lp3364
s(S'RAF1-BRAF'
p3365
S'MEK1-2'
p3366
S'increases_activity'
p3367
tp3368
(lp3369
s(S'SHC'
p3370
S'GRB2'
p3371
S'binds'
p3372
tp3373
(lp3374
S'The MAPK signaling pathway involves the tyrosine phosphorylation of SH2 inositol 5-phosphatase 1 (SHIP1), which binds to EpoR and recruits adapter proteins like SHC and growth factor receptor-bound protein 2 (GRB2) to the receptor ['
p3375
as(S'RB1'
p3376
S'GATA1'
p3377
S'increases'
p3378
tp3379
(lp3380
s(S'TCF3'
p3381
S'FOXJ2'
p3382
S'increases'
p3383
tp3384
(lp3385
s(S'FOXJ2'
p3386
S'NRAS'
p3387
S'increases'
p3388
tp3389
(lp3390
s(S'REPIN1'
p3391
S'LEF1'
p3392
S'increases'
p3393
tp3394
(lp3395
s(S'Aflatoxin B1'
p3396
S'HRAS MRNA'
p3397
S'increases'
p3398
tp3399
(lp3400
s(S'PAX4'
p3401
S'MEIS1'
p3402
S'increases'
p3403
tp3404
(lp3405
s(S'FOXF2'
p3406
S'FOXD3'
p3407
S'increases'
p3408
tp3409
(lp3410
s(S'CBFA2T3'
p3411
S'RUNX1'
p3412
S'increases'
p3413
tp3414
(lp3415
s(S'FOXC1'
p3416
S'HOXA9'
p3417
S'increases'
p3418
tp3419
(lp3420
s(S'DBP'
p3421
S'CYP26A1'
p3422
S'increases'
p3423
tp3424
(lp3425
s(S'TGIF'
p3426
S'EN1'
p3427
S'increases'
p3428
tp3429
(lp3430
s(S'PI-3-4-5-P3'
p3431
S'P62DOK'
p3432
S'adds_modification'
p3433
tp3434
(lp3435
s(S'JUN'
p3436
S'TLX2'
p3437
S'increases'
p3438
tp3439
(lp3440
s(S'Benzo(a)pyrene'
p3441
S'HRAS MRNA'
p3442
S'increases'
p3443
tp3444
(lp3445
s(S'STAT4'
p3446
S'CYP26A1'
p3447
S'increases'
p3448
tp3449
(lp3450
s(S'EGFR/EGFR/EGF/EGF'
p3451
S'SRC'
p3452
S'adds_modification'
p3453
tp3454
(lp3455
s(S'FOXQ1'
p3456
S'FOXD3'
p3457
S'increases'
p3458
tp3459
(lp3460
s(S'FOXJ1'
p3461
S'NRAS'
p3462
S'increases'
p3463
tp3464
(lp3465
s(S'TCF3'
p3466
S'POU2F1'
p3467
S'increases'
p3468
tp3469
(lp3470
s(S'MYB'
p3471
S'CYP26A1'
p3472
S'increases'
p3473
tp3474
(lp3475
s(S'GATA4'
p3476
S'CYP26A1'
p3477
S'increases'
p3478
tp3479
(lp3480
s(S'ELK1'
p3481
S'STAT4'
p3482
S'increases'
p3483
tp3484
(lp3485
s(S'CYP26A1'
p3486
S'LEF1'
p3487
S'increases'
p3488
tp3489
(lp3490
s(S"Guanosine-5'-Diphosphate"
p3491
S'HRAS'
p3492
S'increases_activity'
p3493
tp3494
(lp3495
s(S'ETV4'
p3496
S'CYP26A1'
p3497
S'increases'
p3498
tp3499
(lp3500
s(S'EPHRIN B/EPHB2'
p3501
S'RASGAP'
p3502
S'binds'
p3503
tp3504
(lp3505
s(S'ESR1'
p3506
S'FOXF2'
p3507
S'increases'
p3508
tp3509
(lp3510
s(S'CDC5L'
p3511
S'FOXA1'
p3512
S'increases'
p3513
tp3514
(lp3515
s(S'MAZ'
p3516
S'HOXA9'
p3517
S'increases'
p3518
tp3519
(lp3520
s(S'HIF1A'
p3521
S'MAX'
p3522
S'increases'
p3523
tp3524
(lp3525
s(S'FOXN1'
p3526
S'HOXA9'
p3527
S'increases'
p3528
tp3529
(lp3530
s(S'LEF1'
p3531
S'BACH1'
p3532
S'increases'
p3533
tp3534
(lp3535
s(S'PDX1'
p3536
S'FOXO3'
p3537
S'increases'
p3538
tp3539
(lp3540
s(S'CBFA2T3'
p3541
S'CYP26A1'
p3542
S'increases'
p3543
tp3544
(lp3545
s(S'Rabex5'
p3546
S'HRAS/GTP'
p3547
S'adds_modification'
p3548
tp3549
(lp3550
s(S'CBFA2T3'
p3551
S'RUNX2'
p3552
S'increases'
p3553
tp3554
(lp3555
s(S'PI-3-4-5-P3'
p3556
S'ARAP3'
p3557
S'translocates'
p3558
tp3559
(lp3560
s(S'CART1'
p3561
S'CYP26A1'
p3562
S'increases'
p3563
tp3564
(lp3565
s(S'Arsenic'
p3566
S'NRAS MRNA'
p3567
S'increases'
p3568
tp3569
(lp3570
s(S'NRF1'
p3571
S'CDC5L'
p3572
S'increases'
p3573
tp3574
(lp3575
s(S'Quercetin'
p3576
S'HRAS PROTEIN'
p3577
S'decreases'
p3578
tp3579
(lp3580
s(S"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE"
p3581
S'HRAS'
p3582
S'increases_activity'
p3583
tp3584
(lp3585
s(S'TFDP1'
p3586
S'FOXD3'
p3587
S'increases'
p3588
tp3589
(lp3590
s(S'AR'
p3591
S'TLX2'
p3592
S'increases'
p3593
tp3594
(lp3595
s(S'hsa-miR-181c-5p'
p3596
S'KRAS'
p3597
S'decreases'
p3598
tp3599
(lp3600
s(S'SMAD3'
p3601
S'CBFA2T3'
p3602
S'increases'
p3603
tp3604
(lp3605
s(S'HOXA9'
p3606
S'NRAS'
p3607
S'increases'
p3608
tp3609
(lp3610
s(S'PITX2'
p3611
S'CYP26A1'
p3612
S'increases'
p3613
tp3614
(lp3615
s(S'ATF3'
p3616
S'CYP26A1'
p3617
S'increases'
p3618
tp3619
(lp3620
s(S'E2F1'
p3621
S'MAZ'
p3622
S'increases'
p3623
tp3624
(lp3625
s(S'Ethyl Methanesulfonate'
p3626
S'HRAS MRNA'
p3627
S'increases'
p3628
tp3629
(lp3630
s(S'LMO2'
p3631
S'FOXA1'
p3632
S'increases'
p3633
tp3634
(lp3635
s(S'FOXC1'
p3636
S'POU2F1'
p3637
S'increases'
p3638
tp3639
(lp3640
s(S'DDIT3'
p3641
S'CYP26A1'
p3642
S'increases'
p3643
tp3644
(lp3645
s(S'PAX8'
p3646
S'CYP26A1'
p3647
S'increases'
p3648
tp3649
(lp3650
s(S'LHX3'
p3651
S'EN1'
p3652
S'increases'
p3653
tp3654
(lp3655
s(S'KAT2B'
p3656
S'CYP26A1'
p3657
S'increases'
p3658
tp3659
(lp3660
s(S'P100'
p3661
S'MYB'
p3662
S'binds'
p3663
tp3664
(lp3665
s(S'SOX9'
p3666
S'FOXA1'
p3667
S'increases'
p3668
tp3669
(lp3670
s(S'HIF1A'
p3671
S'EN1'
p3672
S'increases'
p3673
tp3674
(lp3675
s(S'REPIN1'
p3676
S'RUNX1'
p3677
S'increases'
p3678
tp3679
(lp3680
s(S'MYOD1'
p3681
S'BACH1'
p3682
S'increases'
p3683
tp3684
(lp3685
s(S'EBF2'
p3686
S'REPIN1'
p3687
S'increases'
p3688
tp3689
(lp3690
s(S'bisphenol A'
p3691
S'HRAS MRNA'
p3692
S'increases'
p3693
tp3694
(lp3695
s(S'E2F1'
p3696
S'EN1'
p3697
S'increases'
p3698
tp3699
(lp3700
s(S'MYC/Max/MIZ-1'
p3701
S'GALECTIN-1'
p3702
S'decreases'
p3703
tp3704
(lp3705
s(S'PI-3-4-5-P3'
p3706
S'WAVE2/NAP1/SRA1/ABI1/HSPC300'
p3707
S'adds_modification'
p3708
tp3709
(lp3710
s(S'FOXF2'
p3711
S'FOXO3'
p3712
S'increases'
p3713
tp3714
(lp3715
s(S'REPIN1'
p3716
S'STAT5A'
p3717
S'increases'
p3718
tp3719
(lp3720
s(S'RUNX1'
p3721
S'NRAS'
p3722
S'increases'
p3723
tp3724
(lp3725
s(S'benzo(a)pyrene 7,8-dihydrodiol'
p3726
S'HRAS MRNA'
p3727
S'increases'
p3728
tp3729
(lp3730
s(S'RAC1/GTP'
p3731
S'PAK1 (DIMER)'
p3732
S'adds_modification'
p3733
tp3734
(lp3735
s(S'PAX4'
p3736
S'POU2F1'
p3737
S'increases'
p3738
tp3739
(lp3740
s(S'MYOD1'
p3741
S'CBFA2T3'
p3742
S'increases'
p3743
tp3744
(lp3745
s(S'STAT5A'
p3746
S'RUNX2'
p3747
S'increases'
p3748
tp3749
(lp3750
s(S'EBF2'
p3751
S'FOXJ2'
p3752
S'increases'
p3753
tp3754
(lp3755
s(S'Estradiol'
p3756
S'KRAS MRNA'
p3757
S'increases'
p3758
tp3759
(lp3760
s(S'RXRB'
p3761
S'CYP26A1'
p3762
S'increases'
p3763
tp3764
(lp3765
s(S'bisphenol A'
p3766
S'KRAS MRNA'
p3767
S'decreases'
p3768
tp3769
(lp3770
s(S'COMPLEX (GRB2/SOS)'
p3771
S'FGFR1-4'
p3772
S'binds'
p3773
tp3774
(lp3775
s(S'POU2F1'
p3776
S'RUNX1'
p3777
S'increases'
p3778
tp3779
(lp3780
s(S'TCF3'
p3781
S'TLX2'
p3782
S'increases'
p3783
tp3784
(lp3785
s(S'SPZ1'
p3786
S'POU2F1'
p3787
S'increases'
p3788
tp3789
(lp3790
s(S'TFAP4'
p3791
S'FOXO4'
p3792
S'increases'
p3793
tp3794
(lp3795
s(S'OR5I1'
p3796
S'MECOM'
p3797
S'increases'
p3798
tp3799
(lp3800
s(S'Rho Family GTPase-active'
p3801
S'JNK1'
p3802
S'adds_modification'
p3803
tp3804
(lp3805
s(S'TFDP1'
p3806
S'POU2F1'
p3807
S'increases'
p3808
tp3809
(lp3810
s(S'AHR'
p3811
S'MAX'
p3812
S'increases'
p3813
tp3814
(lp3815
s(S'BACH1'
p3816
S'CYP26A1'
p3817
S'increases'
p3818
tp3819
(lp3820
s(S'ZBTB14'
p3821
S'MAZ'
p3822
S'increases'
p3823
tp3824
(lp3825
s(S'TCF3'
p3826
S'FOXO4'
p3827
S'increases'
p3828
tp3829
(lp3830
s(S'MASTERMIND'
p3831
S'NICS'
p3832
S'binds'
p3833
tp3834
(lp3835
s(S'BPTF'
p3836
S'FOXO4'
p3837
S'increases'
p3838
tp3839
(lp3840
s(S'MYOD1'
p3841
S'RUNX1'
p3842
S'increases'
p3843
tp3844
(lp3845
s(S'JUN'
p3846
S'CYP26A1'
p3847
S'increases'
p3848
tp3849
(lp3850
s(S'BPTF'
p3851
S'CYP26A1'
p3852
S'increases'
p3853
tp3854
(lp3855
s(S'POU3F1'
p3856
S'CYP26A1'
p3857
S'increases'
p3858
tp3859
(lp3860
s(S'NRF1'
p3861
S'CYP26A1'
p3862
S'increases'
p3863
tp3864
(lp3865
s(S'TFAP2C'
p3866
S'POU3F2'
p3867
S'increases'
p3868
tp3869
(lp3870
s(S'NFAT1-C-4-INACTIVE2'
p3871
S'YWHAQ'
p3872
S'binds'
p3873
tp3874
(lp3875
s(S'STAT6'
p3876
S'ONECUT1'
p3877
S'increases'
p3878
tp3879
(lp3880
s(S'RUNX1'
p3881
S'RUNX2'
p3882
S'increases'
p3883
tp3884
(lp3885
g855
ag856
ag857
ag858
as(S'ZIC3'
p3886
S'MYCN'
p3887
S'increases'
p3888
tp3889
(lp3890
s(S'CYP26A1'
p3891
S'MAX'
p3892
S'increases'
p3893
tp3894
(lp3895
s(S'ETS2'
p3896
S'FOXO4'
p3897
S'increases'
p3898
tp3899
(lp3900
s(S'GATA6'
p3901
S'FOXA1'
p3902
S'increases'
p3903
tp3904
(lp3905
s(S'Doxorubicin'
p3906
S'HRAS MRNA'
p3907
S'increases'
p3908
tp3909
(lp3910
s(S'PPARA'
p3911
S'HOXA9'
p3912
S'increases'
p3913
tp3914
(lp3915
s(S'REPIN1'
p3916
S'GABPB2'
p3917
S'increases'
p3918
tp3919
(lp3920
s(S'FOXN1'
p3921
S'FOXA1'
p3922
S'increases'
p3923
tp3924
(lp3925
s(S'Dronabinol'
p3926
S'KRAS MRNA'
p3927
S'increases'
p3928
tp3929
(lp3930
s(S'FOXO1'
p3931
S'RUNX1'
p3932
S'increases'
p3933
tp3934
(lp3935
s(S'SMAD4'
p3936
S'HOXA9'
p3937
S'increases'
p3938
tp3939
(lp3940
s(S'PAX4'
p3941
S'JUN'
p3942
S'increases'
p3943
tp3944
(lp3945
s(S'Raf-1'
p3946
S'MEK'
p3947
S'adds_modification'
p3948
tp3949
(lp3950
g655
ag656
ag657
ag676
ag694
ag697
ag699
ag715
ag716
as(S'PIM1'
p3951
S'MYC/MAX'
p3952
S'binds'
p3953
tp3954
(lp3955
s(S'YY1'
p3956
S'MECOM'
p3957
S'increases'
p3958
tp3959
(lp3960
s(S'NRF1'
p3961
S'MAZ'
p3962
S'increases'
p3963
tp3964
(lp3965
s(S'GATA1'
p3966
S'MECOM'
p3967
S'increases'
p3968
tp3969
(lp3970
s(S'PDGF/PDGFRA'
p3971
S'SHC/GRB2/SOS1'
p3972
S'increases_activity'
p3973
tp3974
(lp3975
s(S'GRB2/SOS1'
p3976
S'FAK'
p3977
S'binds'
p3978
tp3979
(lp3980
s(S'HNF4A'
p3981
S'HOXA9'
p3982
S'increases'
p3983
tp3984
(lp3985
s(S'FOXA2'
p3986
S'CYP26A1'
p3987
S'increases'
p3988
tp3989
(lp3990
s(S'FOXI1'
p3991
S'CYP26A1'
p3992
S'increases'
p3993
tp3994
(lp3995
s(S'GRB2 BOUND TO TIE2'
p3996
S'SOS1'
p3997
S'binds'
p3998
tp3999
(lp4000
s(S'PHOSPHORYLATED BRF1 (SER54, SER92, SER203):MRNA COMPLEX'
p4001
S'YWHAB'
p4002
S'binds'
p4003
tp4004
(lp4005
s(S'COMPLEX (GRB2/SOS)'
p4006
S'GAB'
p4007
S'binds'
p4008
tp4009
(lp4010
s(S'NFE2'
p4011
S'TLX2'
p4012
S'increases'
p4013
tp4014
(lp4015
s(S'MAX'
p4016
S'FOXF2'
p4017
S'increases'
p4018
tp4019
(lp4020
s(S'GRB2:SOS1'
p4021
S'ACTIVATED FGFR:P-FRS2'
p4022
S'binds'
p4023
tp4024
(lp4025
s(S'FOXO4'
p4026
S'MECOM'
p4027
S'increases'
p4028
tp4029
(lp4030
s(S'TCF3'
p4031
S'LEF1'
p4032
S'increases'
p4033
tp4034
(lp4035
s(S'ZIC1'
p4036
S'LEF1'
p4037
S'increases'
p4038
tp4039
(lp4040
s(S'NFIL3'
p4041
S'CYP26A1'
p4042
S'increases'
p4043
tp4044
(lp4045
s(S'RAF1'
p4046
S'MEK1'
p4047
S'increases_activity'
p4048
tp4049
(lp4050
S'Western blot analysis was used to evaluate the effects of DADS on the protein levels of RAF1, MEK1, phosphor-MEK1 (p-MEK1), ERK1/2 and p-ERK1/2 in ECA109 xenograft tumors.'
p4051
aS'Our results showed a significant down-regulation of RAF1, p-MEK1, ERK1/2 and p-ERK1/2 protein expressions in 20 and 40 mg/kg DADS groups ('
p4052
aS'The protein expression levels of RAF1, MEK1, phosphor-MEK1 (p-MEK1), ERK1/2 and p-ERK1/2 from the negative control group, 20 mg/kg DADS group and 40 mg/kg DADS group were assessed by western blot analysis.'
p4053
as(S'AR'
p4054
S'FOXA1'
p4055
S'increases'
p4056
tp4057
(lp4058
S'The A-class of FOX proteins, especially FOXA1, functions as a pioneer factor to facilitate AR transactivation and PCa growth.'
p4059
aS'The present review focuses primarily on recent advances in the epigenetic, mechanistic and clinical relevant aspects of regulation of the AR by FOXA1 and FOXO1 factors in PCa.'
p4060
aS'FOXA1 is a pioneer factor for the AR-mediated transcriptional program '
p4061
aS'FOXA1 is a global mediator of AR action in hormone-dependent PCa.'
p4062
aS'High throughput chromatin immunoprecipitation-sequencing (ChIP-seq) has delineated the genome-wide binding sites of AR and FOXA1 (the AR and FOXA1 cistromes) in parental LNCaP-1F5 cells and cells depleted of FOXA1 protein.'
p4063
aS'High-throughput analyses revealed a complex relationship between FOXA1, AR and histone markers '
p4064
aS'FOXA1 can also form a complex with AR and its target genes.'
p4065
aS'NKX3.1, AR, and FOXA1 coordinate with each other, thereby increasing PCa cell survival by directly upregulating RAB3B, a member of the RAB GTPase family '
p4066
aS'FOXA1 also modulates AR activity in metastatic PCa.'
p4067
aS'Increased expression of FOXA1 results in an overactive AR complex that is responsive to low levels of DHT'
p4068
aS'Although previous studies have focused on ligand-dependent AR signaling, a FOXA1-independent function of AR activity has been discovered under androgen deprived conditions '
p4069
aS'Taken together, these findings suggest that increased FOXA1 results in an overactive AR complex, which is responsive to low levels of DHT in CRPC.'
p4070
aS'On the other hand, AR also has a FOXA1-independent function to open and maintain chromatin structure.'
p4071
aS'Thus, these AR bound DNA regions do not require FOXA1 for relaxing the chromatin.'
p4072
aS'Apart from FOXA1, FOXO1 blocks AR activity '
p4073
aS'Additionally, FOXA1 was shown to regulate a large number of genes considered to be AR-pathway-specific through binding and activating the glucocorticoid receptor ['
p4074
as(S'POU2F1'
p4075
S'POU3F2'
p4076
S'increases'
p4077
tp4078
(lp4079
s(S'PCBP1'
p4080
S'MAZ'
p4081
S'increases'
p4082
tp4083
(lp4084
s(S'LEF1'
p4085
S'HOXA9'
p4086
S'increases'
p4087
tp4088
(lp4089
s(S'NR6A1'
p4090
S'CYP26A1'
p4091
S'increases'
p4092
tp4093
(lp4094
s(S'PI3K'
p4095
S'BTK'
p4096
S'translocates'
p4097
tp4098
(lp4099
s(S'AHR'
p4100
S'RUNX1'
p4101
S'increases'
p4102
tp4103
(lp4104
s(S'NR1H4'
p4105
S'CYP26A1'
p4106
S'increases'
p4107
tp4108
(lp4109
s(S'NR2F2'
p4110
S'CYP26A1'
p4111
S'increases'
p4112
tp4113
(lp4114
s(S'GNB1/GNG2'
p4115
S'PI3K'
p4116
S'binds'
p4117
tp4118
(lp4119
s(S'RHOA/GTP'
p4120
S'PKN2'
p4121
S'increases_activity'
p4122
tp4123
(lp4124
s(S'MAZ'
p4125
S'LEF1'
p4126
S'increases'
p4127
tp4128
(lp4129
s(S'RFX1'
p4130
S'MECOM'
p4131
S'increases'
p4132
tp4133
(lp4134
s(S'RUNX1'
p4135
S'HOXA9'
p4136
S'increases'
p4137
tp4138
(lp4139
s(S'FOXL1'
p4140
S'POU2F1'
p4141
S'increases'
p4142
tp4143
(lp4144
s(S'GRB2:SOS1'
p4145
S'PHOSPHORYLATED ERBB2:EGFR HETERODIMERS'
p4146
S'binds'
p4147
tp4148
(lp4149
s(S'TFAP4'
p4150
S'MYCN'
p4151
S'increases'
p4152
tp4153
(lp4154
s(S'E2F1'
p4155
S'GATA1'
p4156
S'increases'
p4157
tp4158
(lp4159
S'HATs and DACs affect the acetylation status of lysine residues not only of histones but also of transcription factors (TF) (eg, p53, E2F1, GATA1, RelA, Y1, MAD/MAX, TFIIE and TFIIF, and hormone receptors).'
p4160
as(S'PTF1A'
p4161
S'GATA6'
p4162
S'increases'
p4163
tp4164
(lp4165
s(S'REL'
p4166
S'CYP26A1'
p4167
S'increases'
p4168
tp4169
(lp4170
s(S'MTF1'
p4171
S'JUN'
p4172
S'increases'
p4173
tp4174
(lp4175
s(S'ZEB1'
p4176
S'REPIN1'
p4177
S'increases'
p4178
tp4179
(lp4180
s(S'IRF8'
p4181
S'GATA6'
p4182
S'increases'
p4183
tp4184
(lp4185
s(S'P-Y349,350-SHC1:PHOSPHORYLATED ERBB2 HETERODIMERS'
p4186
S'GRB2:SOS1'
p4187
S'binds'
p4188
tp4189
(lp4190
s(S'BACH2'
p4191
S'EN1'
p4192
S'increases'
p4193
tp4194
(lp4195
s(S'GFI1'
p4196
S'MEIS1'
p4197
S'increases'
p4198
tp4199
(lp4200
s(S'FOXN1'
p4201
S'LEF1'
p4202
S'increases'
p4203
tp4204
(lp4205
s(S'CYP26A1'
p4206
S'JUN'
p4207
S'increases'
p4208
tp4209
(lp4210
s(S'TCF3'
p4211
S'ONECUT1'
p4212
S'increases'
p4213
tp4214
(lp4215
s(S'FOXF2'
p4216
S'POU2F1'
p4217
S'increases'
p4218
tp4219
(lp4220
s(S'MAZ'
p4221
S'MAX'
p4222
S'increases'
p4223
tp4224
(lp4225
s(S'FOXN1'
p4226
S'CYP26A1'
p4227
S'increases'
p4228
tp4229
(lp4230
s(S'HNF1A'
p4231
S'FOXD3'
p4232
S'increases'
p4233
tp4234
(lp4235
s(S'EGR2'
p4236
S'RUNX1'
p4237
S'increases'
p4238
tp4239
(lp4240
s(S'MYC'
p4241
S'RUNX2'
p4242
S'increases'
p4243
tp4244
(lp4245
s(S'TFAP2A'
p4246
S'IRF1'
p4247
S'increases'
p4248
tp4249
(lp4250
s(S'FOXO4'
p4251
S'YY1'
p4252
S'increases'
p4253
tp4254
(lp4255
s(S'VEGFR2 (dimer)/VEGFA (dimer)'
p4256
S'SRC'
p4257
S'adds_modification'
p4258
tp4259
(lp4260
s(S'resveratrol'
p4261
S'KRAS MRNA'
p4262
S'decreases'
p4263
tp4264
(lp4265
s(S'FOXO4'
p4266
S'CYP26A1'
p4267
S'increases'
p4268
tp4269
(lp4270
s(S'STAT3'
p4271
S'FOXO4'
p4272
S'increases'
p4273
tp4274
(lp4275
s(S'GRB2/SOS1'
p4276
S'FRS2 FAMILY/SHP2'
p4277
S'binds'
p4278
tp4279
(lp4280
s(S'LEF1'
p4281
S'CYP26A1'
p4282
S'increases'
p4283
tp4284
(lp4285
s(S'GTF2A2'
p4286
S'SRF'
p4287
S'increases'
p4288
tp4289
(lp4290
s(S'PPARA'
p4291
S'STAT5A'
p4292
S'increases'
p4293
tp4294
(lp4295
s(S'hsa-miR-143-3p'
p4296
S'KRAS'
p4297
S'decreases'
p4298
tp4299
(lp4300
s(S'GFI1'
p4301
S'CYP26A1'
p4302
S'increases'
p4303
tp4304
(lp4305
s(S'RAC1/GTP'
p4306
S'MKK4-MKK7'
p4307
S'increases_activity'
p4308
tp4309
(lp4310
s(S'REPIN1'
p4311
S'ETS1'
p4312
S'increases'
p4313
tp4314
(lp4315
s(S'ZIC1'
p4316
S'GATA6'
p4317
S'increases'
p4318
tp4319
(lp4320
s(S'INTERLEUKIN RECEPTOR COMPLEXES WITH ACTIVATED SHC1'
p4321
S'GRB2:SOS1'
p4322
S'binds'
p4323
tp4324
(lp4325
s(S'Selenium'
p4326
S'HRAS MRNA'
p4327
S'increases'
p4328
tp4329
(lp4330
s(S'HOXA4'
p4331
S'CYP26A1'
p4332
S'increases'
p4333
tp4334
(lp4335
s(S'NKX2-1'
p4336
S'POU2F1'
p4337
S'increases'
p4338
tp4339
(lp4340
s(S'VSX1'
p4341
S'MAX'
p4342
S'increases'
p4343
tp4344
(lp4345
s(S'FOXD1'
p4346
S'FOXD3'
p4347
S'increases'
p4348
tp4349
(lp4350
s(S'MAX'
p4351
S'NRAS'
p4352
S'increases'
p4353
tp4354
(lp4355
s(S'HOXA9'
p4356
S'TCF3'
p4357
S'increases'
p4358
tp4359
(lp4360
s(S'IRF1'
p4361
S'CYP26A1'
p4362
S'increases'
p4363
tp4364
(lp4365
s(S'HRAS'
p4366
S'RAF1'
p4367
S'adds_modification'
p4368
tp4369
(lp4370
s(S'CUX1'
p4371
S'HOXA9'
p4372
S'increases'
p4373
tp4374
(lp4375
s(S'ZHX2'
p4376
S'FOXA1'
p4377
S'increases'
p4378
tp4379
(lp4380
s(S'TFDP1'
p4381
S'MYC'
p4382
S'increases'
p4383
tp4384
(lp4385
s(S'RAC1/GTP'
p4386
S'PAK1'
p4387
S'increases_activity'
p4388
tp4389
(lp4390
s(S'AHR'
p4391
S'MAZ'
p4392
S'increases'
p4393
tp4394
(lp4395
s(S'BRAF/14-3-3'
p4396
S'KSR/14-3-3 /MEK1-2'
p4397
S'increases_activity'
p4398
tp4399
(lp4400
s(S'PPARA'
p4401
S'CYP26A1'
p4402
S'increases'
p4403
tp4404
(lp4405
s(S'REPIN1'
p4406
S'SRF'
p4407
S'increases'
p4408
tp4409
(lp4410
s(S'PAX5'
p4411
S'SRF'
p4412
S'increases'
p4413
tp4414
(lp4415
s(S'PAX4'
p4416
S'FOXJ2'
p4417
S'increases'
p4418
tp4419
(lp4420
s(S'REPIN1'
p4421
S'MYCN'
p4422
S'increases'
p4423
tp4424
(lp4425
s(S'RALA/GTP'
p4426
S'SRC'
p4427
S'adds_modification'
p4428
tp4429
(lp4430
s(S'FOXO4'
p4431
S'ETS1'
p4432
S'increases'
p4433
tp4434
(lp4435
s(S'TFDP1'
p4436
S'CDC5L'
p4437
S'increases'
p4438
tp4439
(lp4440
s(S'TFDP1'
p4441
S'CYP26A1'
p4442
S'increases'
p4443
tp4444
(lp4445
s(S'GATA6'
p4446
S'RUNX2'
p4447
S'increases'
p4448
tp4449
(lp4450
s(S'FOXM1'
p4451
S'CYP26A1'
p4452
S'increases'
p4453
tp4454
(lp4455
s(S'sodium arsenite'
p4456
S'HRAS PROTEIN'
p4457
S'increases'
p4458
tp4459
(lp4460
s(S'STAT5A'
p4461
S'RUNX1'
p4462
S'increases'
p4463
tp4464
(lp4465
s(S'CEBPA'
p4466
S'EN1'
p4467
S'increases'
p4468
tp4469
(lp4470
s(S'MSX1'
p4471
S'POU2F1'
p4472
S'increases'
p4473
tp4474
(lp4475
s(S'NHLH1'
p4476
S'CBFA2T3'
p4477
S'increases'
p4478
tp4479
(lp4480
s(S'Parathion'
p4481
S'HRAS PROTEIN'
p4482
S'increases'
p4483
tp4484
(lp4485
s(S'SMAD4'
p4486
S'CYP26A1'
p4487
S'increases'
p4488
tp4489
(lp4490
s(S'E2F1'
p4491
S'MYC'
p4492
S'increases'
p4493
tp4494
(lp4495
s(S'CYP26A1'
p4496
S'FOXO3'
p4497
S'increases'
p4498
tp4499
(lp4500
s(S'TCF3'
p4501
S'CBFA2T3'
p4502
S'increases'
p4503
tp4504
(lp4505
s(S'ZHX2'
p4506
S'FOXF2'
p4507
S'increases'
p4508
tp4509
(lp4510
s(S'POU2F1'
p4511
S'MECOM'
p4512
S'increases'
p4513
tp4514
(lp4515
s(S'CYP26A1'
p4516
S'POU2F1'
p4517
S'increases'
p4518
tp4519
(lp4520
s(S'MYOD1'
p4521
S'CYP26A1'
p4522
S'increases'
p4523
tp4524
(lp4525
s(S'RAF'
p4526
S'COMPLEX (RAS/GTP)'
p4527
S'binds'
p4528
tp4529
(lp4530
s(S'RET51/GFRalpha1/GDNF/DOK1'
p4531
S'HRAS/GDP'
p4532
S'increases_activity'
p4533
tp4534
(lp4535
s(S'MAFG'
p4536
S'CYP26A1'
p4537
S'increases'
p4538
tp4539
(lp4540
s(S'CRX'
p4541
S'CYP26A1'
p4542
S'increases'
p4543
tp4544
(lp4545
s(S'hsa-miR-126-3p'
p4546
S'KRAS'
p4547
S'decreases'
p4548
tp4549
(lp4550
s(S'EBF2'
p4551
S'CYP26A1'
p4552
S'increases'
p4553
tp4554
(lp4555
s(S'RUNX1'
p4556
S'CYP26A1'
p4557
S'increases'
p4558
tp4559
(lp4560
s(S'HOXA5'
p4561
S'FOXA1'
p4562
S'increases'
p4563
tp4564
(lp4565
s(S'benzo(a)pyrene-3,6-quinone'
p4566
S'HRAS MRNA'
p4567
S'increases'
p4568
tp4569
(lp4570
s(S'K 7174'
p4571
S'HRAS MRNA'
p4572
S'decreases'
p4573
tp4574
(lp4575
s(S'LEF1'
p4576
S'NRAS'
p4577
S'increases'
p4578
tp4579
(lp4580
s(S'SPI1'
p4581
S'FOXA1'
p4582
S'increases'
p4583
tp4584
(lp4585
s(S'hsa-let-7b-5p'
p4586
S'NRAS'
p4587
S'decreases'
p4588
tp4589
(lp4590
s(S'CEBPA'
p4591
S'JUN'
p4592
S'increases'
p4593
tp4594
(lp4595
s(S'GABPB2'
p4596
S'CYP26A1'
p4597
S'increases'
p4598
tp4599
(lp4600
s(S'PI-3-4-5-P3'
p4601
S'MTOR'
p4602
S'increases_activity'
p4603
tp4604
(lp4605
s(S'GRB2:SOS1'
p4606
S'EGF:P-6Y-EGFR'
p4607
S'binds'
p4608
tp4609
(lp4610
s(S'HNF1A'
p4611
S'CYP26A1'
p4612
S'increases'
p4613
tp4614
(lp4615
s(S'HIF1A'
p4616
S'FOXO4'
p4617
S'increases'
p4618
tp4619
(lp4620
s(S'FOXJ1'
p4621
S'HOXA9'
p4622
S'increases'
p4623
tp4624
(lp4625
s(S'hsa-miR-96-5p'
p4626
S'KRAS'
p4627
S'decreases'
p4628
tp4629
(lp4630
s(S'SRC'
p4631
S'SYNDECAN-2/RASGAP'
p4632
S'binds'
p4633
tp4634
(lp4635
s(S'FOXA1'
p4636
S'MEIS1'
p4637
S'increases'
p4638
tp4639
(lp4640
s(S'LEF1'
p4641
S'MEIS1'
p4642
S'increases'
p4643
tp4644
(lp4645
s(S'PAX3'
p4646
S'CYP26A1'
p4647
S'increases'
p4648
tp4649
(lp4650
s(S'PAX4'
p4651
S'HOXA9'
p4652
S'increases'
p4653
tp4654
(lp4655
s(S'hsa-miR-18a-3p'
p4656
S'KRAS'
p4657
S'decreases'
p4658
tp4659
(lp4660
s(S'FOXF2'
p4661
S'EN1'
p4662
S'increases'
p4663
tp4664
(lp4665
s(S'Pyk2'
p4666
S'SRC FAMILY KINASES'
p4667
S'increases_activity'
p4668
tp4669
(lp4670
s(S'TP53'
p4671
S'HOXA9'
p4672
S'increases'
p4673
tp4674
(lp4675
s(S'Genistein'
p4676
S'KRAS MRNA'
p4677
S'decreases'
p4678
tp4679
(lp4680
s(S'POU1F1'
p4681
S'CYP26A1'
p4682
S'increases'
p4683
tp4684
(lp4685
s(S'manumycin'
p4686
S'KRAS PROTEIN'
p4687
S'decreases_activity'
p4688
tp4689
(lp4690
s(S'Ginkgo biloba extract 761'
p4691
S'GCLC PROTEIN'
p4692
S'increases'
p4693
tp4694
(lp4695
s(S'GATA1'
p4696
S'NRAS'
p4697
S'increases'
p4698
tp4699
(lp4700
s(S'CBFA2T3'
p4701
S'FOXF2'
p4702
S'increases'
p4703
tp4704
(lp4705
s(S'PCBP1'
p4706
S'ELK1'
p4707
S'increases'
p4708
tp4709
(lp4710
s(S'MYC'
p4711
S'FOXF2'
p4712
S'increases'
p4713
tp4714
(lp4715
s(S'hsa-mir-622'
p4716
S'KRAS'
p4717
S'decreases'
p4718
tp4719
(lp4720
s(S'TCF3'
p4721
S'MAZ'
p4722
S'increases'
p4723
tp4724
(lp4725
s(S'STAT2'
p4726
S'MEIS1'
p4727
S'increases'
p4728
tp4729
(lp4730
s(S'CYP26A1'
p4731
S'YY1'
p4732
S'increases'
p4733
tp4734
(lp4735
s(S'CYP26A1'
p4736
S'EN1'
p4737
S'increases'
p4738
tp4739
(lp4740
s(S'GRB2/SOS1'
p4741
S'SHC'
p4742
S'binds'
p4743
tp4744
(lp4745
s(S'BAD'
p4746
S'YWHAZ'
p4747
S'binds'
p4748
tp4749
(lp4750
s(S'SPI1'
p4751
S'MAX'
p4752
S'increases'
p4753
tp4754
(lp4755
s(S'PI-3-4-5-P3'
p4756
S'CENTA1'
p4757
S'translocates'
p4758
tp4759
(lp4760
s(S'XBP1'
p4761
S'CYP26A1'
p4762
S'increases'
p4763
tp4764
(lp4765
s(S'PAX4'
p4766
S'NRAS'
p4767
S'increases'
p4768
tp4769
(lp4770
s(S'PI3K'
p4771
S'EPHRIN A1/EPHA2'
p4772
S'binds'
p4773
tp4774
(lp4775
s(S'POU1F1'
p4776
S'MEIS1'
p4777
S'increases'
p4778
tp4779
(lp4780
s(S'NR3C1'
p4781
S'ETS1'
p4782
S'increases'
p4783
tp4784
(lp4785
s(S'MAZ'
p4786
S'POU3F2'
p4787
S'increases'
p4788
tp4789
(lp4790
s(S'Estradiol'
p4791
S'HRAS MRNA'
p4792
S'increases'
p4793
tp4794
(lp4795
s(S'Aflatoxin B1'
p4796
S'HRAS PROTEIN'
p4797
S'increases'
p4798
tp4799
(lp4800
s(S'ETV7'
p4801
S'STAT4'
p4802
S'increases'
p4803
tp4804
(lp4805
s(S'PBX1'
p4806
S'LEF1'
p4807
S'increases'
p4808
tp4809
(lp4810
s(S'CEBPB'
p4811
S'CYP26A1'
p4812
S'increases'
p4813
tp4814
(lp4815
s(S'MAZ'
p4816
S'JUN'
p4817
S'increases'
p4818
tp4819
(lp4820
s(S'FOXF2'
p4821
S'MYC'
p4822
S'increases'
p4823
tp4824
(lp4825
s(S'FOXJ2'
p4826
S'HOXA9'
p4827
S'increases'
p4828
tp4829
(lp4830
s(S'Capsaicin'
p4831
S'HRAS MRNA'
p4832
S'increases'
p4833
tp4834
(lp4835
s(S'POU3F1'
p4836
S'GATA6'
p4837
S'increases'
p4838
tp4839
(lp4840
s(S'EIF2A'
p4841
S'14-3-3 E'
p4842
S'binds'
p4843
tp4844
(lp4845
s(S'RAS family/GTP'
p4846
S'RAF1-BRAF'
p4847
S'increases_activity'
p4848
tp4849
(lp4850
s(S'GATA6'
p4851
S'GATA1'
p4852
S'increases'
p4853
tp4854
(lp4855
g769
as(S'RASA1'
p4856
S'PHOSPHO PDGF BETA RECEPTOR: PDGF CHAIN B HOMODIMER'
p4857
S'binds'
p4858
tp4859
(lp4860
s(S'CART1'
p4861
S'POU2F1'
p4862
S'increases'
p4863
tp4864
(lp4865
s(S'ZIC3'
p4866
S'POU2F1'
p4867
S'increases'
p4868
tp4869
(lp4870
s(S'TCF4'
p4871
S'FOXA1'
p4872
S'increases'
p4873
tp4874
(lp4875
s(S'PKC theta'
p4876
S'RASGRP1'
p4877
S'adds_modification'
p4878
tp4879
(lp4880
s(S'PTF1A'
p4881
S'STAT5A'
p4882
S'increases'
p4883
tp4884
(lp4885
s(S'SPI1'
p4886
S'FOXO4'
p4887
S'increases'
p4888
tp4889
(lp4890
s(S'HNF1A'
p4891
S'GATA6'
p4892
S'increases'
p4893
tp4894
(lp4895
s(S'FOXJ1'
p4896
S'RUNX1'
p4897
S'increases'
p4898
tp4899
(lp4900
s(S'STAT2'
p4901
S'GATA6'
p4902
S'increases'
p4903
tp4904
(lp4905
s(S'RAS FAMILY/GTP'
p4906
S'PI3K'
p4907
S'binds'
p4908
tp4909
(lp4910
s(S'PAX4'
p4911
S'IRF1'
p4912
S'increases'
p4913
tp4914
(lp4915
s(S'PAX3'
p4916
S'HOXA9'
p4917
S'increases'
p4918
tp4919
(lp4920
s(S'MYB'
p4921
S'MAZ'
p4922
S'increases'
p4923
tp4924
(lp4925
s(S"Guanosine-5'-Triphosphate"
p4926
S'HRAS'
p4927
S'increases_activity'
p4928
tp4929
(lp4930
s(S'alpha9/beta1 Integrin/Tenascin C'
p4931
S'SRC'
p4932
S'adds_modification'
p4933
tp4934
(lp4935
s(S'RAF1'
p4936
S'MEK1'
p4937
S'adds_modification'
p4938
tp4939
(lp4940
g4051
ag4052
ag4053
as(S'JUN'
p4941
S'FOXA1'
p4942
S'increases'
p4943
tp4944
(lp4945
s(S'NFE2L2'
p4946
S'BACH1'
p4947
S'increases'
p4948
tp4949
(lp4950
g2677
ag2678
as(S'CUX1'
p4951
S'FOXD3'
p4952
S'increases'
p4953
tp4954
(lp4955
s(S'JUN'
p4956
S'EN1'
p4957
S'increases'
p4958
tp4959
(lp4960
s(S'ESR1'
p4961
S'CYP26A1'
p4962
S'increases'
p4963
tp4964
(lp4965
s(S'ESRRA'
p4966
S'FOXA1'
p4967
S'increases'
p4968
tp4969
(lp4970
s(S'POU2F1'
p4971
S'MEIS1'
p4972
S'increases'
p4973
tp4974
(lp4975
s(S'TFCP2'
p4976
S'FOXA1'
p4977
S'increases'
p4978
tp4979
(lp4980
s(S'PI-3-4-5-P3'
p4981
S'PDK1'
p4982
S'increases_activity'
p4983
tp4984
(lp4985
s(S'TCF3'
p4986
S'FOXA1'
p4987
S'increases'
p4988
tp4989
(lp4990
s(S'STAT3'
p4991
S'CYP26A1'
p4992
S'increases'
p4993
tp4994
(lp4995
s(S'CYP26A1'
p4996
S'POU3F2'
p4997
S'increases'
p4998
tp4999
(lp5000
s(S'Curcumin'
p5001
S'KRAS MRNA'
p5002
S'decreases'
p5003
tp5004
(lp5005
s(S'STAT1'
p5006
S'CYP26A1'
p5007
S'increases'
p5008
tp5009
(lp5010
s(S'GFI1'
p5011
S'POU2F1'
p5012
S'increases'
p5013
tp5014
(lp5015
s(S'ZIC1'
p5016
S'POU2F1'
p5017
S'increases'
p5018
tp5019
(lp5020
s(S'PI-3-4-5-P3'
p5021
S'AKT3'
p5022
S'adds_modification'
p5023
tp5024
(lp5025
s(S'BACH1'
p5026
S'NRAS'
p5027
S'increases'
p5028
tp5029
(lp5030
s(S'SCF/KIT'
p5031
S'SHC/GRB2/SOS1'
p5032
S'increases_activity'
p5033
tp5034
(lp5035
s(S'CDX2'
p5036
S'CYP26A1'
p5037
S'increases'
p5038
tp5039
(lp5040
s(S'RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK'
p5041
S'HRAS/GDP'
p5042
S'decreases_activity'
p5043
tp5044
(lp5045
s(S'BETAPIX'
p5046
S'RAC1/GTP'
p5047
S'binds'
p5048
tp5049
(lp5050
s(S'RHOA/GTP'
p5051
S'CITRON'
p5052
S'increases_activity'
p5053
tp5054
(lp5055
s(S'P-SHC1:GRB2:SOS'
p5056
S'P-5Y-LAT-2'
p5057
S'binds'
p5058
tp5059
(lp5060
s(S'PAX4'
p5061
S'CYP26A1'
p5062
S'increases'
p5063
tp5064
(lp5065
s(S'TCF3'
p5066
S'KRAS'
p5067
S'increases'
p5068
tp5069
(lp5070
s(S'GRB2:SOS1'
p5071
S'PHOSPHORYLATED ERBB2:ERBB4 HETERODIMERS'
p5072
S'binds'
p5073
tp5074
(lp5075
s(S'CDX2'
p5076
S'MEIS1'
p5077
S'increases'
p5078
tp5079
(lp5080
s(S'SP3'
p5081
S'RUNX1'
p5082
S'increases'
p5083
tp5084
(lp5085
s(S'REST'
p5086
S'CYP26A1'
p5087
S'increases'
p5088
tp5089
(lp5090
s(S'PTF1A'
p5091
S'CYP26A1'
p5092
S'increases'
p5093
tp5094
(lp5095
s(S'PI-3-4-5-P3'
p5096
S'PI3K/GAB1'
p5097
S'translocates'
p5098
tp5099
(lp5100
s(S'LMO2'
p5101
S'FOXO4'
p5102
S'increases'
p5103
tp5104
(lp5105
s(S'STAT4'
p5106
S'ETS1'
p5107
S'increases'
p5108
tp5109
(lp5110
s(S'GTF2A2'
p5111
S'HOXA9'
p5112
S'increases'
p5113
tp5114
(lp5115
s(S'FOXF2'
p5116
S'POU3F2'
p5117
S'increases'
p5118
tp5119
(lp5120
s(S'GATA1'
p5121
S'GABPB2'
p5122
S'increases'
p5123
tp5124
(lp5125
s(S'Polychlorinated Biphenyls'
p5126
S'KRAS MRNA'
p5127
S'decreases'
p5128
tp5129
(lp5130
s(S'GRB2/SOS1'
p5131
S'EGF/EGFR DIMER/SHC'
p5132
S'binds'
p5133
tp5134
(lp5135
s(S'CYP26A1'
p5136
S'FOXF2'
p5137
S'increases'
p5138
tp5139
(lp5140
s(S'EGR1'
p5141
S'CYP26A1'
p5142
S'increases'
p5143
tp5144
(lp5145
s(S'MAX'
p5146
S'FOXO3'
p5147
S'increases'
p5148
tp5149
(lp5150
s(S'T-DHT/AR/PELP1'
p5151
S'SRC'
p5152
S'binds'
p5153
tp5154
(lp5155
s(S'CUX1'
p5156
S'FOXF2'
p5157
S'increases'
p5158
tp5159
(lp5160
s(S'CEBPD'
p5161
S'CYP26A1'
p5162
S'increases'
p5163
tp5164
(lp5165
s(S'CBFA2T3'
p5166
S'NRAS'
p5167
S'increases'
p5168
tp5169
(lp5170
s(S'Cisplatin'
p5171
S'HRAS MRNA'
p5172
S'translocates'
p5173
tp5174
(lp5175
s(S'BAD/BCL-X(L)'
p5176
S'YWHAZ'
p5177
S'binds'
p5178
tp5179
(lp5180
s(S'GATA1'
p5181
S'FOXA1'
p5182
S'increases'
p5183
tp5184
(lp5185
s(S'RREB1'
p5186
S'CYP26A1'
p5187
S'increases'
p5188
tp5189
(lp5190
s(S'STAT4'
p5191
S'RUNX2'
p5192
S'increases'
p5193
tp5194
(lp5195
s(S'FOXD3'
p5196
S'NRAS'
p5197
S'increases'
p5198
tp5199
(lp5200
s(S'NDEL1'
p5201
S'14-3-3 E'
p5202
S'binds'
p5203
tp5204
(lp5205
s(S'CYP26A1'
p5206
S'REPIN1'
p5207
S'increases'
p5208
tp5209
(lp5210
s(S'MAF'
p5211
S'CDC5L'
p5212
S'increases'
p5213
tp5214
(lp5215
s(S'CYP26A1'
p5216
S'ELK1'
p5217
S'increases'
p5218
tp5219
(lp5220
s(S'MYC'
p5221
S'FOXD3'
p5222
S'increases'
p5223
tp5224
(lp5225
s(S'MAX'
p5226
S'FOXD3'
p5227
S'increases'
p5228
tp5229
(lp5230
s(S'POU1F1'
p5231
S'GATA6'
p5232
S'increases'
p5233
tp5234
(lp5235
s(S'POU2F1'
p5236
S'STAT4'
p5237
S'increases'
p5238
tp5239
(lp5240
s(S'GTF3A'
p5241
S'FOXO3'
p5242
S'increases'
p5243
tp5244
(lp5245
s(S'MYB'
p5246
S'FOXF2'
p5247
S'increases'
p5248
tp5249
(lp5250
s(S'ZIC3'
p5251
S'CYP26A1'
p5252
S'increases'
p5253
tp5254
(lp5255
s(S'POU2F1'
p5256
S'EN1'
p5257
S'increases'
p5258
tp5259
(lp5260
s(S'JUN'
p5261
S'STAT1'
p5262
S'increases'
p5263
tp5264
(lp5265
s(S'TEF'
p5266
S'CYP26A1'
p5267
S'increases'
p5268
tp5269
(lp5270
s(S'MAF'
p5271
S'CYP26A1'
p5272
S'increases'
p5273
tp5274
(lp5275
s(S'PAX4'
p5276
S'GATA6'
p5277
S'increases'
p5278
tp5279
(lp5280
s(S'ZIC2'
p5281
S'GATA6'
p5282
S'increases'
p5283
tp5284
(lp5285
s(S'hsa-miR-181d-5p'
p5286
S'HRAS'
p5287
S'decreases'
p5288
tp5289
(lp5290
s(S'BACH2'
p5291
S'CYP26A1'
p5292
S'increases'
p5293
tp5294
(lp5295
s(S'TCF12'
p5296
S'CYP26A1'
p5297
S'increases'
p5298
tp5299
(lp5300
s(S'GATA1'
p5301
S'FOXO4'
p5302
S'increases'
p5303
tp5304
(lp5305
s(S'RFX1'
p5306
S'FOXD3'
p5307
S'increases'
p5308
tp5309
(lp5310
s(S'FOXJ1'
p5311
S'CYP26A1'
p5312
S'increases'
p5313
tp5314
(lp5315
s(S'GTF2A2'
p5316
S'POU2F1'
p5317
S'increases'
p5318
tp5319
(lp5320
s(S'YY1'
p5321
S'SRF'
p5322
S'increases'
p5323
tp5324
(lp5325
s(S'AHR'
p5326
S'REPIN1'
p5327
S'increases'
p5328
tp5329
(lp5330
s(S'MAZ'
p5331
S'CYP26A1'
p5332
S'increases'
p5333
tp5334
(lp5335
s(S'Quercetin'
p5336
S'HRAS MRNA'
p5337
S'increases'
p5338
tp5339
(lp5340
s(S'ELK1'
p5341
S'NRAS'
p5342
S'increases'
p5343
tp5344
(lp5345
s(S'HIF1A'
p5346
S'ONECUT1'
p5347
S'increases'
p5348
tp5349
(lp5350
s(S'FOXF2'
p5351
S'CYP26A1'
p5352
S'increases'
p5353
tp5354
(lp5355
s(S'SOX9'
p5356
S'ETS1'
p5357
S'increases'
p5358
tp5359
(lp5360
s(S'HSF1'
p5361
S'JUN'
p5362
S'increases'
p5363
tp5364
(lp5365
s(S'CEBPA'
p5366
S'CYP26A1'
p5367
S'increases'
p5368
tp5369
(lp5370
s(S'NR1H4'
p5371
S'MEIS1'
p5372
S'increases'
p5373
tp5374
(lp5375
s(S'SMAD1'
p5376
S'GATA1'
p5377
S'increases'
p5378
tp5379
(lp5380
s(S'Quercetin'
p5381
S'HRAS MRNA'
p5382
S'decreases'
p5383
tp5384
(lp5385
s(S'Glycyrrhetinic Acid'
p5386
S'HRAS PROTEIN'
p5387
S'decreases'
p5388
tp5389
(lp5390
s(S'HOXA4'
p5391
S'POU2F1'
p5392
S'increases'
p5393
tp5394
(lp5395
s(S'FOXQ1'
p5396
S'CYP26A1'
p5397
S'increases'
p5398
tp5399
(lp5400
s(S'FOXI1'
p5401
S'CEBPA'
p5402
S'increases'
p5403
tp5404
(lp5405
s(S'GTF3A'
p5406
S'MYCN'
p5407
S'increases'
p5408
tp5409
(lp5410
s(S'LMO2'
p5411
S'IRF1'
p5412
S'increases'
p5413
tp5414
(lp5415
s(S'FOXO1'
p5416
S'CYP26A1'
p5417
S'increases'
p5418
tp5419
(lp5420
s(S'Copper Sulfate'
p5421
S'NRAS MRNA'
p5422
S'increases'
p5423
tp5424
(lp5425
s(S'TFAP2A'
p5426
S'CYP26A1'
p5427
S'increases'
p5428
tp5429
(lp5430
s(S'FOXJ1'
p5431
S'EN1'
p5432
S'increases'
p5433
tp5434
(lp5435
s(S'MEIS1'
p5436
S'RUNX1'
p5437
S'increases'
p5438
tp5439
(lp5440
s(S'MAZ'
p5441
S'FOXA1'
p5442
S'increases'
p5443
tp5444
(lp5445
s(S'ETS1'
p5446
S'FOXO4'
p5447
S'increases'
p5448
tp5449
(lp5450
s(S'ZBTB14'
p5451
S'FOXD3'
p5452
S'increases'
p5453
tp5454
(lp5455
s(S'FOXC1'
p5456
S'LEF1'
p5457
S'increases'
p5458
tp5459
(lp5460
s(S'IRF1'
p5461
S'EN1'
p5462
S'increases'
p5463
tp5464
(lp5465
s(S'NR3C1'
p5466
S'CYP26A1'
p5467
S'increases'
p5468
tp5469
(lp5470
S'Downregulated genes within the development cluster were as follows: sprouty homologue 1 (SPRY1), MAPK14, dystroglycan (DAG1), crystallin, alpha B (CRYAB), prolactin receptor (PRLR), nebulin (NEB), and chromosome 1 open-reading frame 68 (C1orf68), CYP26A1, DHRS9, NR3C1 and MAPK14 were identified in both cluster 1 and 2.'
p5471
as(S'VSX1'
p5472
S'BACH1'
p5473
S'increases'
p5474
tp5475
(lp5476
s(S'CYP26A1'
p5477
S'ETS1'
p5478
S'increases'
p5479
tp5480
(lp5481
s(S'CEBPA'
p5482
S'MEIS1'
p5483
S'increases'
p5484
tp5485
(lp5486
s(S'ELF1'
p5487
S'FOXO4'
p5488
S'increases'
p5489
tp5490
(lp5491
s(S'RXRA'
p5492
S'CYP26A1'
p5493
S'increases'
p5494
tp5495
(lp5496
s(S'CREB1'
p5497
S'CYP26A1'
p5498
S'increases'
p5499
tp5500
(lp5501
s(S'IRF7'
p5502
S'GATA6'
p5503
S'increases'
p5504
tp5505
(lp5506
s(S'ZEB1'
p5507
S'CYP26A1'
p5508
S'increases'
p5509
tp5510
(lp5511
s(S'AR'
p5512
S'CYP26A1'
p5513
S'increases'
p5514
tp5515
(lp5516
s(S'TFDP2'
p5517
S'MYC'
p5518
S'increases'
p5519
tp5520
(lp5521
s(S'hsa-mir-217'
p5522
S'KRAS'
p5523
S'decreases'
p5524
tp5525
(lp5526
s(S'MEK'
p5527
S'ERK'
p5528
S'adds_modification'
p5529
tp5530
(lp5531
S'It includes the MAPK kinase (MEK) which is just downstream BRAF, the extracellular signal-regulated protein kinase (ERK), and the p38 MAPK and the Jun NH2-terminal protein kinase (JNK) activation pathways ['
p5532
aS'Chromatin immunoprecipitation assays revealed that H2A.Z was enriched at previously characterized u-PAR-regulatory regions (promoter and a downstream enhancer) and that it dissociated upon activation of gene expression by PMA in an MEK1,2-ERK1,2-dependent way ['
p5533
aS'For example, activated MEK1-ERK signaling contributes to increased IL-1'
p5534
aS' G0/G1 transition is controlled by cytokines and oxidative stress activating intracellular signalling pathways including MEK/ERK, STAT3, and JNK ['
p5535
aS'Interestingly, the stimulation by EGF induced phosphorylation of ERK1/2 proteins demonstrating the activation of the MEK/ERK pathway but failed to induce cyclin D1 and Cdk1 expression and DNA replication confirming that hepatocytes in cultured slices were arrested in mid-G1 phase of the cell cycle in presence of growth factor.'
p5536
aS'Numerous studies have shown that growth factor could enhance cell proliferation and survival through the activation of the MEK1/2-ERK1/2 pathway, including hepatocytes in primary culture.'
p5537
ag653
aS'This model emphasizes that early EGF stimulation of hepatocytes in the absence of FCS and transient or sustained inhibition of the MEK/ERK pathway represent serum-free models ('
p5538
aS'The MEK/ERK signaling pathway plays a central role in the regulation of various physiological processes such as proliferation, survival or cell motility.'
p5539
aS'In addition, the ERK1/2 kinases could also undergo a more intense stimulation through the overexpression of various components of the MEK/ERK pathway.'
p5540
aS'The MEK/ERK overactivation in hepatocarcinoma cells will promote various cellular processes.'
p5541
aS'The critical involvement of the MEK/ERK pathway in HCC tumorigenesis strongly suggests that the kinases MEK1/2 or ERK1/2 could be promising therapeutic targets.'
p5542
aS'Long-term survival/differentiation in EGF stimulated cells and sequential MEK/ERK inhibitions allowing multiple divisions waves.'
p5543
aS'Hepatocytes are cultured in presence or absence (-GF) of EGF and after one week of culture, transient inhibitions of MEK/ERK by U0126 allow EGF-cultured hepatocytes to re-enter in new cell cycles.'
p5544
ag2417
aS'Tyrosine kinase type receptors, such as VEGFR, PDGFR, EGFR, FGFR, and IGFR, activate intracellular RAS in the RAF/MEK/ERK pathway ['
p5545
aS'The RAF/MEK/ERK and the PI3K/AKT/mTOR signaling pathways are shown.'
p5546
aS'Proangiogenic and proliferative growth factors activate the RAF/MEK/ERK pathway.'
p5547
aS'Intermediate signaling is regulated by MEK, which is responsible for phosphorylating and activating the final downstream signaling ERK molecules.'
p5548
aS'PCK cholangiocytes are hyperresponsive to EGF, and the increase in their proliferation is accompanied by activation of the MEK5/ERK5 pathway ['
p5549
ag654
ag655
ag658
ag660
ag661
ag662
ag663
aS'Concentration dependent expression pattern of MAPK signaling proteins studied are pERK and pMEK1/2.'
p5550
ag664
ag665
aS'In fact this interaction through direct contact or through the secretion of cytokines triggers the activation of different signaling pathways such as the PI3K/AKT, MAPK/MEK/ERK or JAK/STAT pathways, that ends up in a proliferative advantage for myelomatous plasma cells and a drug resistance phenotype ['
p5551
aS'Furthermore, as MKNK-1/2 is down-stream of the RAS/MEK/ERK signaling pathway, LY2801653 may have anti-tumor activity in tumors bearing KRAS-activating mutations in addition to the over-expression of the above mentioned RTK targets.'
p5552
aS'The angiogenic activity of CX3CL1 required two signal pathways: RAF-1/MEK/ERK and PI3K/Akt/eNOS/NO.'
p5553
aS'Crosstalk between the phosphoinositide 3-kinase (PI3K)/ Akt and MEK/ERK cascades is a central regulator of cell metabolism, proliferation and survival ('
p5554
aS'Rapamycin-induced apoptosis was enhanced following the inhibition of the MEK/ERK pathway.'
p5555
aS'The present study demonstrates that rapamycin induces autophagy in Nara-H cells by activating the MEK/ERK signaling pathway, and the rapamycin-induced apoptosis can be enhanced by the MEK inhibitor, U0126.'
p5556
aS'These results suggest that self-protective mechanisms involving mTOR inhibitors in Nara-H cells are prevented by the inhibition of the MEK/ERK pathway.'
p5557
aS'In conclusion, the present study demonstrates that rapamycin induces cytoprotective autophagy in Nara-H cells by activating the MEK/ERK signaling pathway and that rapamycin-induced apoptosis can be enhanced by MEK inhibitors.'
p5558
aS'These results suggest that self-protective mechanisms involving mTOR inhibitors in Nara-H cells are prevented by the inhibition of the MEK/ERK pathway.'
p5559
aS'In other words, the MEK/ERK signaling pathway is activated by rapamycin as a self-defense mechanism, and cytoprotective autophagy is induced.'
p5560
aS'Effects of hepatocyte growth factor (HGF) on c-Met-MEK-ERK signaling.'
p5561
aS'Activation of the MEK-ERK signal cascade enhances the replication of viruses, such as the human immunodeficiency ('
p5562
aS'However, the curcumin-inhibited MEK-ERK mechanism contributes negatively to its anti-HCV activity.'
p5563
aS'Impaired activation of signalling pathways, such as the serine/threonine-specific protein kinase pathways and the MEK/ERK pathway, have been demonstrated to account for decreased T cell activation associated with ageing ('
p5564
aS'In vitro studies of A549 cells and in vivo studies with rats demonstrate tobacco smoke-mediated induction of c-Fos, MEK1, and ERK2 MAP kinase activities ('
p5565
aS'MEK1/2 activation leads to phosphorylation of ERK1/2 MAP kinase, which can translocate to the nucleus and phosphorylate transcription factors which bind to regulatory elements in the promoters of target genes, inducing their expression.'
p5566
aS'Several other targeted agents currently under evaluation in preclinical and clinical trials include inhibitors of epidermal growth factor receptor (EGFR), dual EGFR and HER2 inhibitors, VEGF/VEGFR inhibitors, and agents that interfere with crucial signaling pathways such as PI3K/AKT/mTOR and RAS/MEK/ERK; agents against other tyrosine kinases such as Src, insulin-like growth factor (IGF)/IGF-receptor (IGFR); agents that promote apoptosis such as Poly ADP ribose polymerase inhibitors; agents that target invasion and metastasis such as matrix metalloproteinases inhibitors and others.'
p5567
aS'Other target agents that have evolved in recent times include tyrosine kinases such as Src, insulin-like growth factor (IGF)/IGF-receptor (IGFR); agents that interfere with critical pathways, such as PI3K/AKT/mTOR inhibitors, RAS/MEK/ERK inhibitors; agents that promote apoptosis such as Poly ADP ribose polymerase (PARP) inhibitors; agents that target invasion and metastasis such as MMP inhibitors, and others.'
p5568
aS'PD 0325901, a second generation MEK inhibitor, was found to significantly improve pharmacologic and pharmaceutical activity and reduced pERK in tumor tissue of patients with advanced cancer.'
p5569
ag669
ag670
ag671
aS'To assess a possible role of MEK/ERK signalling in anandamide-mediated protection, we used Western blotting to examine the effect of anandamide on the phosphorylation status of ERK1/2.'
p5570
aS'Cannabinoids have been shown to activate PI3K/Akt and MEK/ERK signalling pathways    ['
p5571
aS'In the event that clinical situations can be identified where the Ras-driven signal may be predominantly through a single pathway, such as that through ERK MAPK that can be selectively blocked with MEK inhibitors, there would presumably be high potential for resistance to develop via selection of a subclone that has oncogenic signaling through, for example, the PI 3-kinase/Akt pathway.'
p5572
ag672
aS'It is known that IGF-1 mediates its effects through different signaling cascades such as MEK-ERK, 14.4.4-raf, PI3K-AKT and p38-MAPKAP-K3.'
p5573
aS'AT1R: Ang II type 1 receptor; AT2R: Ang II type 2 receptor; ERK1/2: extracellular signal-regulated kinase 1/2; JAK: Janus-activated kinase; MAPK: mitogen-activated protein kinase; p38: p38 MAPK; PKC: protein kinase C; STAT: signal transducer and activator of transcription; NO: nitric oxide; SHP-1: protein tyrosine phosphatase SH2 domain-containing phosphatase 1; MEK: mitogen/ERK kinase.'
p5574
ag673
aS'Pretreatment with PD98059, a MEK inhibitor, prevented the ERK1/2 phosphorylation and proliferation induced by silica NPs.'
p5575
aS'We confirmed the effect of silica NPs on ERK signaling by inhibiting MEK, an upregulator of ERK signaling.'
p5576
aS'The proliferation-related MEK-ERK1/2 signaling pathway is suppressed by PD98059 via MEK signaling inhibition,'
p5577
aS'All complementary peptides were almost unable to activate efficiently phosphorylation of MEK1/2 and ERK1/2, p38 and JNK ('
p5578
aS' Activation of D1 receptor/PKA/DARPP-32 signaling cascade leads to the inactivation of PP1 and allows for the activation of MEK and its downstream kinase ERK.'
p5579
aS'Abbreviations: AC, adenylatecyclase; cAMP, cyclic AMP; PKA, protein kinase A; DARPP-32, 32-kDa DA and cAMP-regulated phosphoprotein; ERK, extracellular signal-regulated kinase; MEK, mitogen-activated protein/ERK kinase; GIRK, G protein-coupled inwardly rectifying potassium channels; PLC, phospholipase C; PKC, protein kinase C; IP'
p5580
ag1251
aS'Crosstalk between PI3-K/Akt and MEK-ERK pathways in different cell types has been demonstrated ('
p5581
aS'MP1 was first identified as a scaffold protein enhancing the efficiency of the MAPK pathway by facilitating the interaction between MEK1 and ERK1 upon serum stimulation (Schaeffer et al. '
p5582
aS'The MEK/ERK signaling pathway plays a crucial role in the self-renewing state of ES cells; PD0325901 inhibitor suppresses ERK activation, thereby inhibiting ES cell differentiation (Buehr et al. '
p5583
ag675
aS'SB203580 (a specific inhibitor of the p38-MAPK pathway) and PD98059 (an MAP2K1 [mitogen-activated protein kinase kinase 1, previously, MEK1] inhibitor) were used to inhibit p38-MAPK and ERKs, respectively.'
p5584
aS'Whilst the MEK/ERK pathway served similar roles for cytokine production, marked differences were observed between myDC and moDC for p38 MAPK.'
p5585
aS'In contrast to p38, myDC and moDC responded similarly to inhibition of the MEK-ERK pathway [Fig. '
p5586
aS'Abbreviations: CBP, CREB binding protein; CRE, cAMP response element; ERK, extracellular signal regulated kinase; JNK, Jun N-terminal kinase; MEK, MAPK kinase; NF-IL6, nuclear factor interleukin 6; PEA3, polyomavirus enhancer activator 3; PI3K, phosphatidylinositol 3-kinase; PLA2, phopholipase A2; RNA Pol II, RNA polymerase II; TBP, TATA-binding protein (derived from ('
p5587
aS'To investigate the activation of cell proliferation and survival pathways associated with PAK1 overexpression in IBD and CAC, MEK/ERK, PI3K/AKT, and mTOR pathways were examined.'
p5588
aS'After CaSR stimulation, many intracellular signaling events occur via MEK1/ERK1,2 and PLC pathways and lead to proliferation of vascular smooth muscle cells.'
p5589
aS'PI3K-AKT-mTOR and RAF-MEK-ERK signaling have been shown to be important in the resistance of thyroid cancer cells to apoptosis and the promotion of tumor progression.'
p5590
ag677
aS'IRS can activate the RAF-MEK-ERK pathway (aka the mitogen-activated protein-kinase (MAPK) pathway, '
p5591
ag678
ag679
aS'Temporal changes in phosphoactivation of three proteins (EGFR, MEK1/2, and ERK1/2) were measured at five-minute intervals across a twenty-minute time course of EGF stimulation.'
p5592
aS'Ligand binding activates a chain of signaling events, which includes successive phosphorylation of the EGFR, MEK, and ERK proteins.'
p5593
ag680
aS'The classical MAPK pathway consists of RAS, RAF, MEK and ERK, sequentially relaying proliferative signals generated at the cell surface receptors and through cytoplasmic signaling into the nucleus ('
p5594
aS'The mitogen-activated protein (MAP) kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) pathway and the phosphatidylinositol 3-kinase (PI3K)-Akt pathway play critical roles in the regulation of cell proliferation, growth, differentiation and survival ('
p5595
aS'Effect of quercetin aglycone and PAC DP-9 (12-h treatment) on cellular expression of MEK (A), phospho-ERK1/2 (B), phospho-histone H3 (C), cyclin D1 (D), DNA-PK (E) and p21 (F) in SKOV-3 and OVCAR-8 cells.'
p5596
aS'MEK, cyclin D1 and p21 were probed by DyLight 488 secondary antibody (green); phospho-ERK1/2, phospho-histone H3 and DNA-PK were probed by DyLight 594 secondary antibody (red).'
p5597
ag681
ag682
ag683
aS'Following radiation, ERK1/2 is activated through dual tyrosine and threonine phosphorylation by MEK1/2 and the activation, in turn, leads to the phosphorylation/activation of over 160 substrates ('
p5598
aS'Radiation induces activation of HER receptors, which, in turn, leads to the activation of PI3K/AKT and RAS/RAF/MEK/ERK signaling pathways that promote cell survival.'
p5599
ag684
aS'The pharmacodynamic analysis reported that the activity of vemurafenib was characterized as exposure-dependent tumor response corresponding with percentage of inhibition of MEK and ERK phosphorylation.'
p5600
ag685
aS'The PI3K/AKT/mTOR and RAS/RAF/MEK/ERK pathways interact at multiple points, resulting in cross-activation, cross-inhibition, pathway convergence and these observations have driven the development of small molecule inhibitors that target various nodes of both pathways ('
p5601
ag686
ag687
aS'Interestingly, we found that both NVP-BEZ235 monotherapy and combination treatment caused increased phosphorylation of MEK1/2, and ERK1/2.'
p5602
ag688
ag689
aS'Levels of total MEK and total ERK and JNK pathway related proteins were unchanged.'
p5603
aS'Together, these findings indicate that administration of CFZ and CPT-11 or CFZ alone leads to MEK/ERK pathway inactivation and MKP-1 downregulation, accompanied by PI3K/AKT pathway dephosphorylation and survivin inhibition.'
p5604
aS'CFZ alone or combined with CPT-11 blocks the phosphorylation of MEK/ERK and PI3K/AKT pathway, as well as expression of MKP-1 and survivin in SW620 cells.'
p5605
aS'(A) Changes of the expression and phosphorylation levels of MEK, ERK, Smad2/3 and Akt in RMG-I, RMG-I-C and RMG-I-H cells.'
p5606
aS'The RAS/RAF/MEK/ERK and PI3K/v-Akt murine thymoma viral oncogene (Akt)/mTOR pathways are the two major signal transduction cascades that are often hyper-activated in various human cancers, including melanoma ('
p5607
ag1252
aS'With the aim of blocking the hyper-activation of this pathway and the related uncontrolled neoplastic cell growth and dissemination, several small inhibitors have been synthesized and many strategies have been investigated to target the RAS/RAF/MEK/ERK pathway by vertical inhibition ('
p5608
aS'Resistance to targeted therapies can arise from several mechanisms, including the hyper-activation of one or more pro-survival signaling pathways, like the PI3K/Akt/mTOR and RAS/RAF/MEK/ERK cascades that are known to interact at multiple points, resulting in cross-activation, cross-inhibition and pathway convergence ('
p5609
aS'Signaling through RTKs ultimately leads to the activation of two main pathways, MEK/ERK and PI3K/mTOR ('
p5610
aS'One of the most promising approaches to sensitize melanoma cells to TRAIL-mediated cell death is the simultaneous targeting with inhibitors of either MEK/ERK or PI3K/mTOR pathways.'
p5611
aS'Furthermore, sensitivity of MEK-inhibitor-resistant melanoma cell lines to MEK/ERK blockade could be restored by inhibition of Stat3, which is constitutively activated in human melanoma and contributes to cell growth and survival ('
p5612
aS'Preclinical studies evaluating vertical targeting of RAS/MEK/ERK pathway.'
p5613
aS'Preclinical studies co-targeting RAS/MEK/ERK and PI3K/Akt/mTOR pathways.'
p5614
aS'Akt, v-akt murine thymoma viral oncogene homolog; Bcl, B-cell lymphoma; cFLIP, cellular FLICE-inhibitory protein; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; ErbB, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog; FGFR, fibroblast growth factor receptor; IGF-1R, insulin-like growth factor-1 receptor; LN, lymph node; MEK, mitogen-activated protein/extracellular signal-regulated kinase; mTOR, mammalian target of rapamycin; PPP, cyclolignan picropodophyllin; RTKs, receptor tyrosine kinases; TRAIL, TNF-related apoptosis-inducing ligand; Stat, Signal transducers and activators of transcription; VEGF, vascular-endothelial growth factor; VEGFR, VEGF receptor.'
p5615
aS'Commercially available slides with IHC controls (#8103, SignalSlide Phospho-p44/42 MAPK (Thr202/Tyr204) IHC Controls, Cell Signaling Technology) that consisted of paraffin-embedded NIH/3T3 cells, treated with U0126 (a specific and potent inhibitor of MEK1/2) or TPA (12-O-tetra-decanoylphorbol-13 acetate, a strong inducer of ERK1/2 activity through PKC modulation) were used as negative and positive controls for phospho-ERK1/2 antibody, respectively.'
p5616
aS'Recently, a study of predictive biomarkers of efficacy of trametinib (GSK1120212), a new inhibitor of MEK1/2 (2 kinases that are upstream of ERK1/2 in the MAPK pathway) that is being tested in clinical trials ('
p5617
aS'Under HCV NS5A expression, RNA interference (RNAi) targeting of NS5ATP9 could reverse the inhibition of HepG2 cell proliferation, suggesting that NS5ATP9 might be an anti-proliferation gene that plays an important role in the suppression of cell growth mediated by HCV NS5A via MEK/ERK signaling pathway.'
p5618
aS'Under conditions of HCV NS5A expression, interfering RNA targeting of NS5ATP9 could reverse the inhibition of HepG2 cell proliferation, suggesting that NS5ATP9 could be an anti-proliferation gene that plays an important role in the suppression of cell growth mediated by HCV NS5A via MEK/ERK signaling pathway.'
p5619
aS'We observed that at 72 h after co-transfection, the protein levels of MEK and total ERK were not significantly different from the control; however, the phosphorylation status of MEK and ERK (p-MEK and p-ERK1/2) were significantly elevated ('
p5620
aS'Our results demonstrate that NS5ATP9 accounted for the suppression of cell growth by HCV NS5A through interfering with MEK/ERK signaling pathway, at least partially.'
p5621
aS'Under conditions of HCV NS5A expression, RNAi targeting of NS5ATP9 could reverse the inhibition of HepG2 cell proliferation, suggesting that NS5ATP9 might be an anti-proliferation gene that plays an important role in the suppression of cell growth mediated by HCV NS5A via MEK/ERK signaling pathway.'
p5622
aS'MEK/ERK signaling pathway is involved in NS5ATP9-mediated proliferation inhibition under HCV NS5A expression.'
p5623
aS'Since the PI3K/Akt/mTOR pathway plays such a prominent role in the signaling network, it must be subject to strict internal regulations (e.g., by the feedback loops, as already introduced) and external regulations (e.g., by crosstalk with other signaling pathways, such as the Ras/MEK/ERK- and AMPK-related pathway ['
p5624
ag690
aS'We next investigated whether the PI3K/Akt and MEK/ERK signaling pathways were involved in increasing the expression of cyclin D1.'
p5625
aS'Because the phosphorylated forms of Akt and ERK 1/2 have been shown to be indirect indicators of the activities of their upstream signaling molecules PI3K and MEK, respectively, we determined the involvement of PI3K and MEK in the HBx-induced effects using a pharmacological approach to block their activities.'
p5626
aS'After treating with LY294002, a PI3K inhibitor, or PD184352, a MEK inhibitor, for 24 h, HBx-induced activation of Akt and ERK, as well as up-regulation of cyclin D1 protein levels, were greatly suppressed compared with non-treated controls ('
p5627
aS'After confirming that overexpression of HBx activated the PI3K/Akt and MEK/ERK signaling pathways and promoted proliferation in oval cells, we examined whether activation of these pathways play a vital role in HBx-induced proliferation in oval cells.'
p5628
aS'We used the inhibitor of MEK 1/2 (SL327) that inhibits ERK 1/2 phosphorylation and activation, the inhibitor of PI 3-kinase (LY294002) that inhibits phosphorylation and activation of downstream Akt (protein kinase B), and the inhibitor of PKC (GF109203X).'
p5629
aS'In our studies, the inhibitor of MEK 1/2 SL327 prevents the ERK 1/2 activation by H'
p5630
ag691
aS'To characterize the effect of sorafenib on MAPK signaling in UCCs, we investigated the effect of sorafenib on phosphorylation of ERK and MEK in T24 and VMCub1 cells.'
p5631
aS'Since a measurement at a single time point might be misleading, a time course of sorafenib effects on MEK, ERK and AKT phosphorylation was performed in VMCub1.'
p5632
ag4051
ag4052
aS'DADS down-regulated RAF/MEK/ERK pathway in ECA109 xenograft tumor.'
p5633
ag4053
aS'The RAF/mitogen-activated protein kinase/extracellular signal-regulated kinase (RAF/MEK/ERK) pathway plays a prominent role in the regulation of cell growth ['
p5634
aS'It is known that NGF induces the activation (phosphorylation) of MEK (MAPK kinase) 1/2, which then phosphorylates ERK1/2 ['
p5635
aS'For example, NBT induces neurite outgrowth of PC12D cells, which were subcloned from the original PC12 cells, by activating a cAMP/PKA/MEK/ERK-dependent pathway ['
p5636
aS'Furthermore, melatonin activates the insulin receptor-mediated phosphoinositide 3-kinase (PIK3) and serine/threonine protein kinase B (PKB/Akt) and the mitogen-activated extracellular signal-regulated kinase kinase (MEK/ERK) pathway by inducing phosphorylation of the tyrosine moiety of the insulin receptor substrates 1 and 2 (IRS) in rat islets and INS-1 cells ['
p5637
aS'Previous studies have showed that the MEK1-ERK2 signaling pathway is involved in the regulation of cell survival ['
p5638
aS'Rabbit anti-human phosphorylation HSP27 (Ser-82), ras, raf, ERK1/2, MEK1/2, p38MAPK and MAPKAPK2 antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA).'
p5639
ag692
ag693
ag694
aS'It was found that the formation of CNV might have been inhibited or stopped by downregulation of the activity of the crucial key downstream effectors, Akt and ERK, of the PI3K/Akt and MEK/ERK pathway ['
p5640
aS'In conclusion, the data presented here provide the first evidence that(R,R) ZX-5 has positive effects on NOS (eNOS and iNOS) and choroidal blood flow via the MEK/ERK- and PI3K/Akt -dependent signaling pathways.'
p5641
aS'One of the first reports on clinical use of a PI3K/AKT/mTOR inhibitor in ovarian cancer looked at the utility of the dual-targeting strategy involving PI3K/AKT/mTOR and RAF/MEK/ERK pathways ['
p5642
aS'Tpl2 has a major role in the activation of ERK1/2 through its direct substrate, the mitogen-activated extracellular signal-regulated kinase (MEK, a MAP2K) ['
p5643
aS'Tpl2 promoted tumorigenesis and cancer progression via the phosphorylation of Pin1 resulting cyclin D1 up-regulation and induced EMT by IL-22/MEK/ERK, JNK/STAT3/AP-1 signaling pathway in breast cancer ['
p5644
aS'Tpl2 facilitated tumor growth by PAUF-mediated MEK/ERK signaling pathway, resulting in increasing expression of pro-tumorigenic cytokines ['
p5645
aS'Elevated Tpl2 activity promoted CRPC growth via activation of MEK/ERK and NF-kB signaling pathway ['
p5646
aS'Tpl2 plays an important role in promoting IL-17A-induced tumorigenesis in colon cancer, cervical cancer and breast cancer via IL-17A-activated Tpl2 signaling pathway to function upstream of MEK/ERK and JNK/c-Jun ['
p5647
aS'Finally, Tpl2 participates as an upstream of the MEK-ERK pathway in the positive regulation effects of IL-12 on the functions of human effector memory CD8'
p5648
aS'Although small molecule inhibitors exist for the targeting of the Tpl2-MEK-ERK pathway, side effects could be a serious issue.'
p5649
ag695
aS'After that, they phosphorylate the MAPKKs (MEK1 and MEK2), that activate ERK1 and ERK2 in the cytosol, which are then translocated into the nucleus, where they can phosphorylate numerous substrates ['
p5650
ag696
aS'The mitogen-activated protein/extracellular signal-regulated kinase (MEK)/extracellular signal-regulated kinase (ERK), mitogen-activated protein kinase (MKK)3/6/p38 and MKK4/c-Jun '
p5651
aS'To this respect, an increased phosphorylation of MEK3/JNK and ERK1/2 by the reduced expression of miR-214 and increase of miR-133b has been shown.'
p5652
aS'Finally, inhibition of ERK MAPK phosphorylation with a selective MEK1 inhibitor (PD98059) significantly reduced isoflurane-mediated (2.5% for 3 hours) induction of SK1 mRNA in EA.hy926 human endothelial cells ('
p5653
aS'Inhibition of ERK MAPK phosphorylation with PD98059 (a selective MEK1 inhibitor) significantly reduced isoflurane-mediated induction of SK1 mRNA in EA.hy926 human endothelial cells.'
p5654
aS'To test whether ERK activity is necessary and sufficient for EGF stimulated IC-2C phosphorylation, we co-transfected mRFP-tagged IC-2C with either empty vector or constitutively active (ca) MEK1 in which the sites of activating phosphorylation, Serines 218 and 222, are mutated to phosphomimetic aspartate residues ['
p5655
aS'These observations indicate that some intermediate chain is likely phosphorylated on Serine 81 by kinases distinct from ERK and/or resides in compartments not accessed by the MEK inhibitors.'
p5656
ag697
aS'RAS can stimulate migration and proliferation in a ROS-dependent manner in colon cancer cells, and RAS signaling upregulates NOX1 expression via the MEK-ERK-GATA-6 pathway.'
p5657
aS'In addition, gallic acid also acts by phosphorylating and activating melanogenesis inhibitory proteins such as Akt and mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK).'
p5658
aS'Using inhibitors against PI3K/Akt (LY294002) or MEK/ERK-specific (PD98059), the hypopigmentation effect was suppressed, and the gallic acid-initiated activation of MEK/ERK and PI3K/Akt was also revoked.'
p5659
aS'Recent studies have suggested that the MEK-ERK kinase cascade and the phosphatidylinositol 3-kinase (PI3K)/Akt pathway are involved in the regulation of melanin synthesis ['
p5660
aS'As gallic acid decreases the intracellular cAMP levels and reduces melanin synthesis by increasing the phosphorylation and activation of PI3K/Akt and MEK/ERK, we further investigated whether the effects of gallic acid on tyrosinase activity and melanin synthesis are responsible for MEK/ERK and PI3K/Akt phosphorylation.'
p5661
aS'We studied the melanin content and tyrosinase activity in B16F10 cells co-treated with gallic acid and PI3K/Akt-specific inhibitor (LY294002) or MEK/ERK-specific inhibitor (PD98059).'
p5662
aS'In order to ensure that these signaling factors are responsible for the gallic acid-induced inhibitory effects on melanogenesis, we blocked PI3K/Akt or MEK/ERK signaling in the presence of gallic acid and evaluated melanin production and tyrosinase activity in B16F10 cells.'
p5663
aS'Our results demonstrated that the specific PI3K inhibitor, LY294002, significantly retrieved melanin production and tyrosinase activity, and the MEK/ERK inhibitor, PD98059, markedly inhibited the gallic acid suppressive effects on MITF, tyrosinase, TRP-1, and Dct expression.'
p5664
aS'The findings support that gallic acid may inhibit the signaling pathways related to melanogenesis, which include the inhibition of MITF-tyrosinase signaling, in particular the activation of PI3K/Akt or MEK/ERK signaling.'
p5665
aS'In this study, gallic acid was found to inhibit melanogenesis in B16F10 cells by inhibiting the expressions of MITF, tyrosinase, TRP1, and Dct, which are mediated by PI3K/Akt or MEK/ERK phosphorylation.'
p5666
aS'These data indicate the possible mechanisms of inhibitory effects of gallic acid against melanogenesis may contain the decrease in cAMP as well as PI3K/Akt and MEK/ERK phosphorylation.'
p5667
aS'Recovery effect of co-treatment with PI3K/Akt or MEK/ERK specific inhibitors and gallic acid on cellular melanin content, cellular tyrosinase activity and melanogenesis-related proteins expression in B16F10 cells.'
p5668
aS'Similar to the raf/MEK/ERK (MEK/ERK) pathway, the phosphatidylinositol 3-kinase (PI3K)/Akt pathway is also constitutively active at a low level in epidermal keratinocytes and both ERK and Akt are upregulated by UVR ['
p5669
aS'Acupuncture can increase the expression of BDNF (Brain-derived neurotrophic factor) via PI3K/Akt (Phosphatidylinositol-4,5-bisphosphate 3-kinase) and MEK/ERK1/2 (extracellular-signal-regulated kinases) signaling pathway by activating the tropomyosin receptor kinase B (TrkB), a high affinity catalytic receptor for several neurotrophins that induce the activation of survival signaling pathway.'
p5670
aS'Anti-phospho-ERK1/2, phospho-JNN, phospho-p38, phospho-Akt polyclonal antibodies, LY294002 (PI3 kinase inhibitor) U0126 (MEK1/2 inhibitor), SB202190 (p38 inhibitor) and SP600125 (JNK inhibitor) were purchased from Cell Signaling Technology (Beverly, MA, USA).'
p5671
aS'Despite the data indicating the full activation of ERK1/2 and MEK requires EGFR endocytosis, that may just be the start of the story.'
p5672
aS'Recent studies indicate that PI3K/Akt and MEK/ERK signalling pathways are important intracellular mediators in ER-induced phase II enzymes in intestinal epithelial Caco-2 cells ['
p5673
aS'The involvement of the PI3K, TOR or ERK signaling pathways in the mechanism by which insulin activates DNA synthesis of silk gland cells was analyzed by investigating the effects of the specific inhibitors of PI3K (LY294002), MEK (U0126) or TORC1 (rapamycin) on the DNA synthesis induced by insulin '
p5674
aS'The mitogen-activated protein kinase (MAPK)/ERK kinase (MEK) inhibitor (U0126) and the TORC1 inhibitor (rapamycin) were purchased from Calbiochem (San Diego, CA, USA).'
p5675
aS'An increase in sodium-iodide symporter (NIS) gene expression has been demonstrated through the inhibition of MEK/ERK and SAPK/JNK cytoplasmic pathways, individually and in combination, suggesting that blocking these pathways is the mechanism by which sunitinib exerts its direct antiproliferative effect ['
p5676
aS'Most of them act on the mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase), whose substrates are ERK1/2. '
p5677
aS'As MEK1/2 are specific kinases that mediate the activation of extracellular signal-regulated protein kinase 1/2 (ERK1/2), we detected the effect of TIPP on the level of phosphorylation of MEK1/2.'
p5678
aS'It is known that neurotrophic factors induce the activation of MEK1/2, which are MAPK kinases that phosphorylate ERK1/2 ['
p5679
aS'Effects of MEK inhibitors on HMF-induced ERK2 activation in cultured rat cortical neurons.'
p5680
aS'The RAS/MEK/ERK and PI3K/Akt pathways are well known to be involved in mechanisms of radioresistance ['
p5681
aS'Multiple lines of evidence support the interaction between Hh signaling and RAS/MEK/ERK and PI3K/Akt pathways.'
p5682
aS'The PI3K/AKT and RAS/MEK/ERK pathways have been shown to non-canonically activate Gli1 in a Smo-independent manner ['
p5683
aS'Mitogen-activated protein kinase kinase MEK (MEK MAPKK)-driven phosphorylation of the Tyr and Thr residues within the activation loop of ERK MAPK (mitogen-activated protein kinase ERK) was shown to be dramatically affected by macromolecular crowding with PEG 6000 ['
p5684
ag700
aS'Regarding the substrate specificities within this pathway, ERK and MEK are in great contrast to each other.'
p5685
aS'While ERK1/2 are the only described substrates of MEK1/2 so far, ERK1/2 has a myriad of substrates in the cytosol and the nucleus.'
p5686
aS'For example, ERK1/2 is able to phosphorylate MEK1 at Thr292 and Thr386 '
p5687
ag702
ag704
ag705
ag706
aS'Apart from inducing apoptosis, signaling partners like the MEK/ERK pathway or the protein kinase C (PKC) can activate salvage programs such as cell proliferation that do not ameliorate, but rather worsen their outcome.'
p5688
aS'The MEK/ERK pathway is the main signal transduction cascade involved.'
p5689
aS'In 1997, England found that the application of the MEK inhibitor PD98059 inhibited hippocampal LTP, the first evidence of a role of ERK signaling in synaptic plasticity.'
p5690
aS'In addition, PD98059 significantly induced reduction of p-MEK, p-ERK, and p-Stat3 proteins ('
p5691
ag708
aS'Effects of LicoA on sUV-dependent phosphorylation of the Akt/ mammalian target of rapamycin (mTOR), mitogen-activated protein kinase kinase (MEK)1/ extracellular signal-regulated kinases (ERKs)/p90 ribosomal protein S6 kinase (RSK), c-Jun '
p5692
aS'MKK6, MKK7, and MEK are upstream of p38, JNK, and ERK, respectively.'
p5693
aS'To further study the mechanism of rhOPN-induced FoxM1 expression, additions of U0126 (a specific inhibitor of mitogen activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK); 10'
p5694
aS'Rabbit anti-ERK, phospho-ERK 1/2, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibodies and U0126 (a specific inhibitor of MEK/ERK; 10'
p5695
aS'It is known that PI3K/AKT/mTOR signaling is a complex process, which interacts with the RAS/RAF/MEK/ERK pathway.'
p5696
aS'Since the inhibition by a MEK or PKC inhibitor of ERK/CREB phosphorylation elicited by EDN1 stimulation attenuates the EDN1-stimulated pigmentation of HEEs, we asked if the WSE elicits an abrogating effect on the EDN1-stimulated pigmentation in HEEs.'
p5697
aS'Upon hormonal release from Pro-I arrest, maturing oocytes undergo activation of the MAPK cascade involving protein expression and/or enzymatic activation of Mos (MAPKKK), MEK (MAPKK), ERK (MAPK), and RSK.'
p5698
ag716
aS'Analysis of survival pathways downstream of Syk showed that BAFF-induced activation of ERK and Akt is decreased in the absence of Syk, and genetic rescue experiments showed that the survival of Syk-deficient B cells could be enhanced by ectopic expression of caMEK1 or by deletion of PTEN.'
p5699
aS'This may stem from the upregulation of both the insulin receptor and insulin-like growth factor receptor, which promotes a dual survival and proliferation advantage through targets of the phosphatidylinositol 3-kinase/serine/threonine kinase AKT signaling pathway and activation of the mitogen kinases, MEK, and ERK, respectively ['
p5700
aS'IGFR - insulin-like growth factor receptor, EGFR - epidermal growth factor receptor, FGFR - fibroblast growth factor receptor, MAPK mitogen-activated protein kinases, MAPKK - MAPK kinases, MAPKKK - MAPKK kinases, DLK - Dual leucine zipper bearing kinase, MEK - Mitogen-activated protein kinase/ERK kinase, ERK - extracellular signal-related kinase, JNK - c-Jun-N-terminal kinases, PI3K- phosphoinositol 3-kinase, PIP - phosphatidylinositol phosphate, AR - androgen receptor, P - phosphorylation, ARE - androgen response elements'
p5701
ag717
aS'Extracellular signal regulated protein kinase 1/2 is a key physiological substrate of MEK; MEK1 kinase can cause double phosphorylation of threonine and tyrosine at ERK1/2 residues to activate ERK1/2; activation of ERK1/2 can subsequently lead to phosphorylation of downstream transcription factors, such as p90Rsk kinase, CREB, and c-Myc.'
p5702
ag718
as(S'ZBTB18'
p5703
S'ONECUT1'
p5704
S'increases'
p5705
tp5706
(lp5707
s(S'TGIF'
p5708
S'MAX'
p5709
S'increases'
p5710
tp5711
(lp5712
s(S'ETS1'
p5713
S'NRAS'
p5714
S'increases'
p5715
tp5716
(lp5717
s(S'KLF12'
p5718
S'GATA1'
p5719
S'increases'
p5720
tp5721
(lp5722
s(S'HRAS/GTP'
p5723
S'PAK2'
p5724
S'increases_activity'
p5725
tp5726
(lp5727
s(S'CYP26A1'
p5728
S'FOXD3'
p5729
S'increases'
p5730
tp5731
(lp5732
s(S'LMO2'
p5733
S'RUNX1'
p5734
S'increases'
p5735
tp5736
(lp5737
S'It is well known that a number of factors help to promote the differentiation of erythrocytes and megakaryocytes, including FOG-1, NF-E2, RUNX1, SCL/tal, LMO2, EKLF, and c-Myb ('
p5738
aS'Most of these genes, including NF-E2, RUNX1, LMO2, c-Myb, and FOG-1, were expressed in both U937-mock and U937-NDRG2 cells.'
p5739
as(S'MLK3'
p5740
S'MKK3/6'
p5741
S'adds_modification'
p5742
tp5743
(lp5744
s(S'TAK'
p5745
S'MKK3/6'
p5746
S'adds_modification'
p5747
tp5748
(lp5749
s(S'GRB2:SOS1'
p5750
S'HB-EGF:P-6Y-EGFR DIMER'
p5751
S'binds'
p5752
tp5753
(lp5754
s(S'FOXO4'
p5755
S'NRAS'
p5756
S'increases'
p5757
tp5758
(lp5759
s(S'MECOM'
p5760
S'NRAS'
p5761
S'increases'
p5762
tp5763
(lp5764
s(S'KLF12'
p5765
S'CYP26A1'
p5766
S'increases'
p5767
tp5768
(lp5769
s(S'RAS family/GTP/PI3K'
p5770
S'TRPV1'
p5771
S'adds_modification'
p5772
tp5773
(lp5774
s(S'hsa-let-7a-5p'
p5775
S'NRAS'
p5776
S'decreases'
p5777
tp5778
(lp5779
s(S'NF1'
p5780
S'HOXA9'
p5781
S'increases'
p5782
tp5783
(lp5784
s(S'REPIN1'
p5785
S'FOXD3'
p5786
S'increases'
p5787
tp5788
(lp5789
s(S'CYP26A1'
p5790
S'FOXJ2'
p5791
S'increases'
p5792
tp5793
(lp5794
s(S'FOXO4'
p5795
S'MEIS1'
p5796
S'increases'
p5797
tp5798
(lp5799
s(S'EBF2'
p5800
S'MECOM'
p5801
S'increases'
p5802
tp5803
(lp5804
s(S'ETS1'
p5805
S'FOXO3'
p5806
S'increases'
p5807
tp5808
(lp5809
s(S'SP3'
p5810
S'CYP26A1'
p5811
S'increases'
p5812
tp5813
(lp5814
s(S'LNXp80'
p5815
S'NUMB'
p5816
S'decreases'
p5817
tp5818
(lp5819
s(S'RUNX2'
p5820
S'CYP26A1'
p5821
S'increases'
p5822
tp5823
(lp5824
s(S'AHR'
p5825
S'FOXO3'
p5826
S'increases'
p5827
tp5828
(lp5829
s(S'VSX1'
p5830
S'FOXF2'
p5831
S'increases'
p5832
tp5833
(lp5834
s(S'BPTF'
p5835
S'RUNX1'
p5836
S'increases'
p5837
tp5838
(lp5839
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p5840
S'HRAS PROTEIN'
p5841
S'increases'
p5842
tp5843
(lp5844
s(S'TCF3'
p5845
S'POU3F2'
p5846
S'increases'
p5847
tp5848
(lp5849
s(S'TCF3'
p5850
S'IRF1'
p5851
S'increases'
p5852
tp5853
(lp5854
s(S'SREBF1'
p5855
S'EN1'
p5856
S'increases'
p5857
tp5858
(lp5859
s(S'FOXO4'
p5860
S'RUNX2'
p5861
S'increases'
p5862
tp5863
(lp5864
s(S'hsa-miR-181a-5p'
p5865
S'HRAS'
p5866
S'decreases'
p5867
tp5868
(lp5869
s(S'Myb'
p5870
S'NRAS'
p5871
S'decreases'
p5872
tp5873
(lp5874
s(S'HSPA8'
p5875
S'ADP'
p5876
S'binds'
p5877
tp5878
(lp5879
s(S'SOCS3'
p5880
S'RASGAP'
p5881
S'binds'
p5882
tp5883
(lp5884
s(S'ONECUT1'
p5885
S'NRAS'
p5886
S'increases'
p5887
tp5888
(lp5889
s(S'PITX2'
p5890
S'EN1'
p5891
S'increases'
p5892
tp5893
(lp5894
s(S'HGF(dimer)/MET(dimer)'
p5895
S'SRC'
p5896
S'adds_modification'
p5897
tp5898
(lp5899
s(S'2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine'
p5900
S'HRAS PROTEIN'
p5901
S'increases'
p5902
tp5903
(lp5904
s(S'GFI1'
p5905
S'POU3F2'
p5906
S'increases'
p5907
tp5908
(lp5909
s(S'FARNESYL DIPHOSPHATE'
p5910
S'KRAS'
p5911
S'increases_activity'
p5912
tp5913
(lp5914
s(S'IL2/IL2R BETA/GAMMA/JAK1/LCK/JAK3'
p5915
S'PI3K'
p5916
S'binds'
p5917
tp5918
(lp5919
s(S'GTF3A'
p5920
S'MECOM'
p5921
S'increases'
p5922
tp5923
(lp5924
s(S'EGR2'
p5925
S'CYP26A1'
p5926
S'increases'
p5927
tp5928
(lp5929
s(S'RUNX1'
p5930
S'FOXF2'
p5931
S'increases'
p5932
tp5933
(lp5934
s(S'IL3/IL3RA/CSF2RB (DODECAMER)'
p5935
S'YWHAZ'
p5936
S'binds'
p5937
tp5938
(lp5939
s(S'RAF1'
p5940
S'BRAF'
p5941
S'binds'
p5942
tp5943
(lp5944
S'Mutations in the PTPN11, SOS1, RAF1, KRAS, NRAS, and BRAF genes cause Noonan syndrome.'
p5945
aS'The PTPN11, SOS1, RAF1, KRAS, NRAS, and BRAF genes all provide instructions for making proteins that are important in signaling pathways needed for the proper formation of several types of tissue during development.'
p5946
aS'Paired-end transcriptome sequencing identified several other rearrangements involving genes of the RAF kinase pathway: SLC45A3-BRAF, AGTRAP-BRAF, ESRP1-RAF1, EPB41-BRAF and RAF1-ESRP1 ['
p5947
as(S'MYC'
p5948
S'CYP26A1'
p5949
S'increases'
p5950
tp5951
(lp5952
s(S'UBP1'
p5953
S'CYP26A1'
p5954
S'increases'
p5955
tp5956
(lp5957
s(S'MTF1'
p5958
S'REPIN1'
p5959
S'increases'
p5960
tp5961
(lp5962
s(S'HNF1A'
p5963
S'RUNX1'
p5964
S'increases'
p5965
tp5966
(lp5967
s(S'NHLH1'
p5968
S'FOXA1'
p5969
S'increases'
p5970
tp5971
(lp5972
s(S'HLF'
p5973
S'FOXA1'
p5974
S'increases'
p5975
tp5976
(lp5977
s(S'MEIS1'
p5978
S'GATA6'
p5979
S'increases'
p5980
tp5981
(lp5982
s(S'PDGF-BB/PDGFRB (DIMER)/SHP2'
p5983
S'GRB2/SOS1'
p5984
S'binds'
p5985
tp5986
(lp5987
s(S'ZBTB14'
p5988
S'EN1'
p5989
S'increases'
p5990
tp5991
(lp5992
s(S'alpha6/beta4 Integrin'
p5993
S'HRAS/GDP'
p5994
S'increases_activity'
p5995
tp5996
(lp5997
s(S'ErbB2'
p5998
S'HRAS/GDP'
p5999
S'increases_activity'
p6000
tp6001
(lp6002
s(S'MEIS1'
p6003
S'FOXO3'
p6004
S'increases'
p6005
tp6006
(lp6007
s(S'RELA'
p6008
S'IRF1'
p6009
S'increases'
p6010
tp6011
(lp6012
s(S'MYCN'
p6013
S'FOXO3'
p6014
S'increases'
p6015
tp6016
(lp6017
s(S'RHOA/GTP'
p6018
S'DIA'
p6019
S'increases_activity'
p6020
tp6021
(lp6022
s(S'Fluorouracil'
p6023
S'KRAS PROTEIN'
p6024
S'decreases'
p6025
tp6026
(lp6027
s(S'ATF2'
p6028
S'CYP26A1'
p6029
S'increases'
p6030
tp6031
(lp6032
s(S'GNAI2/GTP'
p6033
S'SRC FAMILY KINASES'
p6034
S'increases_activity'
p6035
tp6036
(lp6037
s(S'HAND1'
p6038
S'POU2F1'
p6039
S'increases'
p6040
tp6041
(lp6042
s(S'PI5K Type 1 family'
p6043
S'PI-4-P'
p6044
S'translocates'
p6045
tp6046
(lp6047
s(S'HSF1'
p6048
S'CBFA2T3'
p6049
S'increases'
p6050
tp6051
(lp6052
s(S'BACH1'
p6053
S'FOXA1'
p6054
S'increases'
p6055
tp6056
(lp6057
s(S'PI-3-4-5-P3'
p6058
S'SGK1'
p6059
S'adds_modification'
p6060
tp6061
(lp6062
s(S'hsa-miR-20a-5p'
p6063
S'NRAS'
p6064
S'decreases'
p6065
tp6066
(lp6067
s(S'CYP26A1'
p6068
S'MECOM'
p6069
S'increases'
p6070
tp6071
(lp6072
s(S'FOXF2'
p6073
S'RUNX1'
p6074
S'increases'
p6075
tp6076
(lp6077
s(S'EGR2'
p6078
S'SRF'
p6079
S'increases'
p6080
tp6081
(lp6082
s(S'LEF1'
p6083
S'FOXD3'
p6084
S'increases'
p6085
tp6086
(lp6087
s(S'TFAP2C'
p6088
S'MECOM'
p6089
S'increases'
p6090
tp6091
(lp6092
s(S'SHC'
p6093
S'GRB2/SOS1'
p6094
S'binds'
p6095
tp6096
(lp6097
s(S'CA2+'
p6098
S'CAM'
p6099
S'binds'
p6100
tp6101
(lp6102
s(S'MYC'
p6103
S'POU3F2'
p6104
S'increases'
p6105
tp6106
(lp6107
s(S'PAX8'
p6108
S'HOXA9'
p6109
S'increases'
p6110
tp6111
(lp6112
s(S'TFDP2'
p6113
S'CDC5L'
p6114
S'increases'
p6115
tp6116
(lp6117
s(S'RAF1/14-3-3'
p6118
S'KSR/14-3-3 /MEK1-2'
p6119
S'increases_activity'
p6120
tp6121
(lp6122
s(S'DDIT3'
p6123
S'MEIS1'
p6124
S'increases'
p6125
tp6126
(lp6127
s(S'GNB1/GNG2'
p6128
S'HRAS/GDP'
p6129
S'increases_activity'
p6130
tp6131
(lp6132
s(S'ACTIVATED FGFR MUTANTS:P-FRS2ALPHA'
p6133
S'GRB2:SOS1'
p6134
S'binds'
p6135
tp6136
(lp6137
s(S'HIF1A'
p6138
S'CYP26A1'
p6139
S'increases'
p6140
tp6141
(lp6142
s(S'RAF1-BRAF'
p6143
S'ERK1-2'
p6144
S'increases_activity'
p6145
tp6146
(lp6147
s(S'SMAD4'
p6148
S'CBFA2T3'
p6149
S'increases'
p6150
tp6151
(lp6152
s(S'resveratrol'
p6153
S'HRAS PROTEIN'
p6154
S'increases'
p6155
tp6156
(lp6157
s(S'Malathion'
p6158
S'HRAS MRNA'
p6159
S'increases'
p6160
tp6161
(lp6162
s(S'NRF1'
p6163
S'FOXO4'
p6164
S'increases'
p6165
tp6166
(lp6167
s(S'CREB1'
p6168
S'JUN'
p6169
S'increases'
p6170
tp6171
(lp6172
S'NFKB1, JUNB, and CREB1 are central transcription factors of macrophage activation'
p6173
as(S'CDC5L'
p6174
S'HOXA9'
p6175
S'increases'
p6176
tp6177
(lp6178
s(S'CDX2'
p6179
S'HOXA9'
p6180
S'increases'
p6181
tp6182
(lp6183
s(S'HMGA1'
p6184
S'POU2F1'
p6185
S'increases'
p6186
tp6187
(lp6188
s(S'Coumestrol'
p6189
S'KRAS MRNA'
p6190
S'decreases'
p6191
tp6192
(lp6193
s(S'LEF1'
p6194
S'FOXO3'
p6195
S'increases'
p6196
tp6197
(lp6198
s(S'CYP26A1'
p6199
S'MEIS1'
p6200
S'increases'
p6201
tp6202
(lp6203
s(S'GTF2A2'
p6204
S'MEIS1'
p6205
S'increases'
p6206
tp6207
(lp6208
s(S'REPIN1'
p6209
S'CBFA2T3'
p6210
S'increases'
p6211
tp6212
(lp6213
s(S'hsa-miR-143-3p'
p6214
S'HRAS'
p6215
S'decreases'
p6216
tp6217
(lp6218
s(S'[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID'
p6219
S'KRAS'
p6220
S'increases_activity'
p6221
tp6222
(lp6223
s(S'TFDP1'
p6224
S'ONECUT1'
p6225
S'increases'
p6226
tp6227
(lp6228
s(S'YY1'
p6229
S'CYP26A1'
p6230
S'increases'
p6231
tp6232
(lp6233
s(S'PITX2'
p6234
S'RUNX1'
p6235
S'increases'
p6236
tp6237
(lp6238
s(S'STAT5A'
p6239
S'NRAS'
p6240
S'increases'
p6241
tp6242
(lp6243
s(S'Valproic Acid'
p6244
S'HRAS MRNA'
p6245
S'increases'
p6246
tp6247
(lp6248
s(S'Malathion'
p6249
S'HRAS PROTEIN'
p6250
S'increases'
p6251
tp6252
(lp6253
s(S'TFAP4'
p6254
S'CBFA2T3'
p6255
S'increases'
p6256
tp6257
(lp6258
s(S'TFAP4'
p6259
S'EN1'
p6260
S'increases'
p6261
tp6262
(lp6263
s(S'POU3F2'
p6264
S'CYP26A1'
p6265
S'increases'
p6266
tp6267
(lp6268
s(S'PAX3'
p6269
S'FOXD3'
p6270
S'increases'
p6271
tp6272
(lp6273
s(S'FOXA2'
p6274
S'RUNX2'
p6275
S'increases'
p6276
tp6277
(lp6278
s(S'MAX'
p6279
S'BACH1'
p6280
S'increases'
p6281
tp6282
(lp6283
s(S'PDX1'
p6284
S'CYP26A1'
p6285
S'increases'
p6286
tp6287
(lp6288
s(S'EPO/EPOR (dimer)/JAK2'
p6289
S'SHC/GRB2/SOS1'
p6290
S'increases_activity'
p6291
tp6292
(lp6293
s(S'E2F1'
p6294
S'MEIS1'
p6295
S'increases'
p6296
tp6297
(lp6298
s(S'FOXF2'
p6299
S'MEIS1'
p6300
S'increases'
p6301
tp6302
(lp6303
s(S'SPZ1'
p6304
S'FOXJ2'
p6305
S'increases'
p6306
tp6307
(lp6308
s(S'SRY'
p6309
S'NRAS'
p6310
S'increases'
p6311
tp6312
(lp6313
s(S'REPIN1'
p6314
S'CYP26A1'
p6315
S'increases'
p6316
tp6317
(lp6318
s(S'VEGFR3/VEGFC-D'
p6319
S'PKC'
p6320
S'increases_activity'
p6321
tp6322
(lp6323
s(S'MEIS1'
p6324
S'EN1'
p6325
S'increases'
p6326
tp6327
(lp6328
s(S'FOXJ1'
p6329
S'FOXD3'
p6330
S'increases'
p6331
tp6332
(lp6333
s(S'SPZ1'
p6334
S'FOXO4'
p6335
S'increases'
p6336
tp6337
(lp6338
s(S'RHOA/GTP'
p6339
S'ROCK1-ROCK2'
p6340
S'increases_activity'
p6341
tp6342
(lp6343
s(S'HMGA1'
p6344
S'ONECUT1'
p6345
S'increases'
p6346
tp6347
(lp6348
s(S'uPA/uPAR/alphav/beta3 Integrin/Vitronectin'
p6349
S'SRC'
p6350
S'adds_modification'
p6351
tp6352
(lp6353
s(S'ETS1'
p6354
S'CYP26A1'
p6355
S'increases'
p6356
tp6357
(lp6358
s(S'ESRRA'
p6359
S'TLX2'
p6360
S'increases'
p6361
tp6362
(lp6363
s(S'ROCK2'
p6364
S'RHO FAMILY GTPASE-ACTIVE'
p6365
S'binds'
p6366
tp6367
(lp6368
s(S'ATF4'
p6369
S'CYP26A1'
p6370
S'increases'
p6371
tp6372
(lp6373
s(S'OR5I1'
p6374
S'CYP26A1'
p6375
S'increases'
p6376
tp6377
(lp6378
s(S'PITX2'
p6379
S'GATA1'
p6380
S'increases'
p6381
tp6382
(lp6383
s(S'AHR'
p6384
S'ONECUT1'
p6385
S'increases'
p6386
tp6387
(lp6388
s(S'PTF1A'
p6389
S'MECOM'
p6390
S'increases'
p6391
tp6392
(lp6393
s(S'arsenic trioxide'
p6394
S'HRAS MRNA'
p6395
S'increases'
p6396
tp6397
(lp6398
s(S'TCF3'
p6399
S'REPIN1'
p6400
S'increases'
p6401
tp6402
(lp6403
s(S'STAT6'
p6404
S'FOXO3'
p6405
S'increases'
p6406
tp6407
(lp6408
s(S'POU1F1'
p6409
S'POU2F1'
p6410
S'increases'
p6411
tp6412
(lp6413
s(S'RHOA/GTP'
p6414
S'ROCK'
p6415
S'increases_activity'
p6416
tp6417
(lp6418
s(S'PITPNA'
p6419
S'PI-4-5-P2'
p6420
S'translocates'
p6421
tp6422
(lp6423
s(S'MDM-2'
p6424
S'P14/19 ARF'
p6425
S'binds'
p6426
tp6427
(lp6428
s(S'TEAD1'
p6429
S'FOXO3'
p6430
S'increases'
p6431
tp6432
(lp6433
s(S'MYC'
p6434
S'MAX'
p6435
S'increases'
p6436
tp6437
(lp6438
S'Ubiquitylation of MYC by ARF-BP1 promotes transcriptional activity of MYC/MAX heterodimers (green arrow).'
p6439
as(S'GRB2:SOS1'
p6440
S'EGF:PHOSPHO-EGFR:PHOSPHO-SHC'
p6441
S'binds'
p6442
tp6443
(lp6444
s(S'NF1'
p6445
S'RUNX1'
p6446
S'increases'
p6447
tp6448
(lp6449
S'Deregulation of miR-223 and miR-222-221 by RUNX1-ETO is known to affect their targets, NF1A and KIT.'
p6450
as(S'ZEB1'
p6451
S'GATA6'
p6452
S'increases'
p6453
tp6454
(lp6455
s(S'TBP'
p6456
S'EN1'
p6457
S'increases'
p6458
tp6459
(lp6460
s(S'FOXA1'
p6461
S'FOXD3'
p6462
S'increases'
p6463
tp6464
(lp6465
s(S'CART1'
p6466
S'EN1'
p6467
S'increases'
p6468
tp6469
(lp6470
s(S'MAX'
p6471
S'CEBPA'
p6472
S'increases'
p6473
tp6474
(lp6475
s(S'GATA6'
p6476
S'NRAS'
p6477
S'increases'
p6478
tp6479
(lp6480
s(S'PTF1A'
p6481
S'FOXO3'
p6482
S'increases'
p6483
tp6484
(lp6485
s(S'LEF1'
p6486
S'FOXA1'
p6487
S'increases'
p6488
tp6489
(lp6490
s(S'hsa-let-7g-5p'
p6491
S'KRAS'
p6492
S'decreases'
p6493
tp6494
(lp6495
s(S'ZBTB14'
p6496
S'CYP26A1'
p6497
S'increases'
p6498
tp6499
(lp6500
s(S'POU1F1'
p6501
S'FOXO4'
p6502
S'increases'
p6503
tp6504
(lp6505
s(S'PI3K'
p6506
S'PI-4-5-P2'
p6507
S'translocates'
p6508
tp6509
(lp6510
s(S'GABPB2'
p6511
S'NRAS'
p6512
S'increases'
p6513
tp6514
(lp6515
s(S'ELK1'
p6516
S'LEF1'
p6517
S'increases'
p6518
tp6519
(lp6520
s(S'Estrogens'
p6521
S'HRAS MRNA'
p6522
S'increases'
p6523
tp6524
(lp6525
s(S'CYP26A1'
p6526
S'CEBPA'
p6527
S'increases'
p6528
tp6529
(lp6530
s(S'SPI1'
p6531
S'POU2F1'
p6532
S'increases'
p6533
tp6534
(lp6535
s(S'PPARG'
p6536
S'CYP26A1'
p6537
S'increases'
p6538
tp6539
(lp6540
s(S'Asbestos, Serpentine'
p6541
S'HRAS PROTEIN'
p6542
S'increases'
p6543
tp6544
(lp6545
s(S'RET51/GFRALPHA1/GDNF/DOK1'
p6546
S'RASGAP'
p6547
S'binds'
p6548
tp6549
(lp6550
s(S'FOXO1'
p6551
S'GATA6'
p6552
S'increases'
p6553
tp6554
(lp6555
s(S'Cadmium'
p6556
S'KRAS PROTEIN'
p6557
S'increases'
p6558
tp6559
(lp6560
s(S'MAX'
p6561
S'EN1'
p6562
S'increases'
p6563
tp6564
(lp6565
s(S'TLX2'
p6566
S'NRAS'
p6567
S'increases'
p6568
tp6569
(lp6570
s(S'SREBF1'
p6571
S'CYP26A1'
p6572
S'increases'
p6573
tp6574
(lp6575
s(S'SMAD3'
p6576
S'MEIS1'
p6577
S'increases'
p6578
tp6579
(lp6580
s(S'Acetaminophen'
p6581
S'NRAS MRNA'
p6582
S'decreases'
p6583
tp6584
(lp6585
s(S'LEF1'
p6586
S'ETS1'
p6587
S'increases'
p6588
tp6589
(lp6590
s(S'SRF'
p6591
S'MEIS1'
p6592
S'increases'
p6593
tp6594
(lp6595
s(S'BRAF'
p6596
S'MKK3-MKK6'
p6597
S'increases_activity'
p6598
tp6599
(lp6600
s(S'HRAS/GTP'
p6601
S'RAF1'
p6602
S'adds_modification'
p6603
tp6604
(lp6605
s(S'MSX1'
p6606
S'CYP26A1'
p6607
S'increases'
p6608
tp6609
(lp6610
s(S'GATA4'
p6611
S'ETS1'
p6612
S'increases'
p6613
tp6614
(lp6615
s(S'E4F1'
p6616
S'FOXA1'
p6617
S'increases'
p6618
tp6619
(lp6620
s(S'FOXD1'
p6621
S'LEF1'
p6622
S'increases'
p6623
tp6624
(lp6625
s(S'CUX1'
p6626
S'MAX'
p6627
S'increases'
p6628
tp6629
(lp6630
s(S'CYP26A1'
p6631
S'CBFA2T3'
p6632
S'increases'
p6633
tp6634
(lp6635
s(S'CAM/CA2+'
p6636
S'KRAS ISOFORM 4B/GTP'
p6637
S'binds'
p6638
tp6639
(lp6640
s(S'MYOG'
p6641
S'STAT5A'
p6642
S'increases'
p6643
tp6644
(lp6645
s(S'MYOD1'
p6646
S'STAT5A'
p6647
S'increases'
p6648
tp6649
(lp6650
s(S'HNF1A'
p6651
S'POU3F2'
p6652
S'increases'
p6653
tp6654
(lp6655
s(S'EPH'
p6656
S'EPHR'
p6657
S'binds'
p6658
tp6659
(lp6660
S'PARAMETERS STUDIED FOR THE NEPHROPROTECTIVE ACTIVITY OF ETHANOL EXTRACTS OF '
p6661
aS'PHYTOCONSTITUENTS WITH ARI PROPERTY STUDIED IN DIABETIC NEPHROPATHY'
p6662
aS'ANALYSIS OF PRESCRIPTIONS IN DIABETIC NEPHROPATHY'
p6663
aS'DISTRIBUTION OF DRUGS IN DIFFERENT CATEGORIES BASED ON ATC CLASSIFICATION PRESCRIBED IN DIABETIC NEPHROPATHY'
p6664
as(S'PDGF:PHOSPHO-PDGF RECEPTOR DIMER'
p6665
S'GRB2:SOS1'
p6666
S'binds'
p6667
tp6668
(lp6669
s(S'HRAS/GTP'
p6670
S'PI3K'
p6671
S'increases_activity'
p6672
tp6673
(lp6674
s(S'RUNX1'
p6675
S'TLX2'
p6676
S'increases'
p6677
tp6678
(lp6679
s(S'MYOG'
p6680
S'CYP26A1'
p6681
S'increases'
p6682
tp6683
(lp6684
s(S'PAX2'
p6685
S'EN1'
p6686
S'increases'
p6687
tp6688
(lp6689
s(S'TFCP2'
p6690
S'CYP26A1'
p6691
S'increases'
p6692
tp6693
(lp6694
s(S'hsa-miR-145-5p'
p6695
S'NRAS'
p6696
S'decreases'
p6697
tp6698
(lp6699
s(S'KAT2B'
p6700
S'GATA1'
p6701
S'increases'
p6702
tp6703
(lp6704
s(S'P-EGFR MUTANTS:P-Y349,350-SHC1'
p6705
S'GRB2:SOS1'
p6706
S'binds'
p6707
tp6708
(lp6709
s(S'E2F1'
p6710
S'MECOM'
p6711
S'increases'
p6712
tp6713
(lp6714
s(S'GNB1/GNG2'
p6715
S'SRC'
p6716
S'adds_modification'
p6717
tp6718
(lp6719
s(S'ZBTB14'
p6720
S'MAX'
p6721
S'increases'
p6722
tp6723
(lp6724
s(S'RALGDS'
p6725
S'P21 RAS:GTP'
p6726
S'binds'
p6727
tp6728
(lp6729
s(S'RHOA/GTP'
p6730
S'ROCK2'
p6731
S'increases_activity'
p6732
tp6733
(lp6734
s(S'NR1H3'
p6735
S'FOXD3'
p6736
S'increases'
p6737
tp6738
(lp6739
s(S'TFAP4'
p6740
S'GATA1'
p6741
S'increases'
p6742
tp6743
(lp6744
s(S'FOXA1'
p6745
S'GATA6'
p6746
S'increases'
p6747
tp6748
(lp6749
s(S'GRB2:SOS1'
p6750
S'P-SHC'
p6751
S'binds'
p6752
tp6753
(lp6754
s(S'E2F1'
p6755
S'FOXO3'
p6756
S'increases'
p6757
tp6758
(lp6759
s.